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ABSTRACT
Bovine mastitis remains one of the costliest diseases affecting the dairy industry.
Individual susceptibility to mastitis and severity of infection varies between animals and
can only be partially explained by genetics. As such, understanding how genetic
predisposition coordinately interacts with epigenetic modifications and environmental
exposures is necessary to bridge the gap in missing heritability. The role of DNA
methylation in regulating the response to bacterial lipopolysaccharide (LPS) was first
determined by performing reduced representation bisulfite sequencing on fibroblasts
isolated from heifers at 5- and 16-months of age that exhibit an age-dependent upregulation in LPS-responsiveness. More than 14,000 differentially methylated sites were
identified between the two sets of cultures with a trend towards decreased methylation with
age. Young cultures were also hyper-methylated in gene promoters regulated by NF-κB
and exhibited lower expression in genes that regulate the innate immune response,
suggesting that methylation contributes to gene regulation in fibroblast innate response.
Previously, TLR4 expression was shown to differ in the age-dependent fibroblast
model, however, it was not known if variation in TLR4 expression would affect mastitis
severity. Therefore, fibroblasts were isolated from sixty lactating, adult Holstein cows and
their expression of TLR4, along with LPS-induced production of IL-8 and IL-6, was used
to rank the animals from high to low. Six high responders and six low responders were
then experimentally infected in one mammary gland with E. coli. Overall, severity of
mastitis was quite variable, with a few notable differences between high and low
responders. High responding animals had an earlier increase in somatic cell count and
febrile response that coincided with more efficient bacterial clearance. However, tissue
damage and milk production did not differ between the two groups, indicating that while
rapid up-regulation of the innate response addresses bacterial clearance, subsequent downregulation is required to alleviate damage within the mammary gland.
Finally, one-week old bull calves were subjected to treatment with either saline or
LPS to determine if neonatal exposure to endotoxin would make calves less responsive to
a second LPS challenge at 32-days of age. The initial treatment showed a large effect of
LPS as measured by higher plasma IL-6 and TNF-α concentrations in calves treated with
LPS over saline. Subsequent treatment of all 10 calves with LPS showed a very similar
response between the two treatment groups and significant inter-animal variability in
clinical response. Fibroblasts and monocyte-derived-macrophages (MDMs) were also
isolated following initial treatment to determine if any changes occurred at the cellular
level as a result of LPS exposure. Fibroblasts isolated from calves at 20-days of age had a
very low response to LPS that did not differ between the early life treatments. MDMs
isolated from calves at 28-days of age were more responsive to LPS, but again no
differences were detected between the early life treatments. In summary, our results
suggest that DNA methylation likely plays a role in the cellular response to LPS and may
partially contribute to differences between animals in severity of E. coli mastitis, however,
the appropriate in vitro phenotype to detect susceptible animals still needs to be
characterized before epigenetic biomarkers can be identified, and perhaps modified by
environmental interventions.
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CHAPTER 1: COMPREHENSIVE LITERATURE REVIEW

1.1 Bovine Mastitis: Prevalence and Economic Impacts
Mastitis, simply defined as inflammation of the mammary gland, is a significant
source of economic losses in the dairy industry. It is a disease that shows worldwide
prevalence as evidenced by numerous reports detailing the impacts of mastitis in every
inhabitable continent (Verbeke et al., 2014, Boujenane et al., 2015, Oliveira et al., 2015,
Yang et al., 2015). According to the 2014 USDA NAHMS Dairy Report, nearly a quarter
of all cows (24.8%) experienced a clinical case of mastitis in the United States in 2013,
ranging from 25.6%, 16.4% and 26.9% in small, medium and large operations, respectively
(USDA, 2014). In terms of economic effects, a single case of clinical mastitis that occurs
within the first 30 days of lactation costs the producer $444 (Rollin et al., 2015). In addition,
throughout the entire 305-day lactation period, primiparous cows cost $325 per case of
mastitis and multiparous cows cost $426 (Liang et al., 2017). The main source of economic
losses is due to lowered milk quantity and non-saleable milk, but also include direct costs
such as veterinary care, treatment, additional labor and early culling of high-producing
animals (Liang et al., 2017). Furthermore, clinical mastitis has a deleterious effect on cow
fertility, which reduces farm productivity and profitability, and it has been shown that the
negative economic impacts of lowered fertility are especially high among cows infected
with Gram-negative pathogens, Escherichia coli (E. coli) and Klebsiella spp. (Hertl et al.,
2014, Fuenzalida et al., 2015).

1

1.2 Causative Agents of Mastitis
Mastitis is caused by a large variety of etiologic agents that are mainly bacterial
in origin. To highlight the diversity of microorganisms that can cause mastitis,
researchers in the United Kingdom analyzed the causative agent in 6,005 milk samples
from clinical (43.8%) and subclinical (56.2%) mastitis cases and reported over 100
different organisms, with E. coli, Streptococcus uberis (S. uberis) and Staphylococcus
aureus (S. aureus) being the three most common bacteria isolated (Payne, 2013). While
E. coli and S. aureus are widely regarded as the two most common-mastitis causing
pathogens, pathogen prevalence is also dependent on geographic location, management
practices and identification method. A recent Finnish study based on PCR identification
rather than culture-based methods revealed coagulase-negative Staphylococci (CNS) as
the most prevalent pathogen among 93,529 cows with clinical or subclinical mastitis
(Vakkamaki et al., 2017), while in the United States non-traditional laboratory culture
showed greater prevalence of Streptococcus spp. and E. coli (Ganda et al., 2016).
However, the latter study contradicts earlier data generated from >100,000 milk samples
submitted to the Wisconsin Veterinary Diagnostic Laboratory, whereby CNS represented
the largest proportion (13.22%) of mastitis-causing pathogens by standard culture-based
methods (Makovec and Ruegg, 2003), a result that is more consistent with the known
prevalence of CNS (Vanderhaeghen et al., 2014).
Mastitis-causing pathogens are also sub-divided into contagious and
environmental pathogens. Contagious pathogens, such as S. aureus, are transmitted
between cows, while environmental pathogens, such as E. coli, are acquired from the
environment. Improvement of management practices in regards to herd hygiene through
2

mastitis control plans, such as the Five Point Plan developed in the 1960s, has alleviated
much of the effect of contagious pathogens. However, opportunistic, environmental
pathogens remain a significant and increasing concern for the dairy industry. Data from
741 clinical mastitis cases across 50 Wisconsin dairy farms showed that environmental
species of bacteria (E. coli, Klebsiella, and environmental streptococci) represented
42.2% of all mastitis cases, with very few being caused by the contagious pathogen S.
aureus (2.8%) (Oliveira et al., 2013). This data is representative of most large, modern
dairy farms in that management practices have reduced cow-to-cow transmission of
mastitis causing pathogens, however, the ability to deal with environmental pathogens
remains a significant challenge.

1.3 Between-Animal Variation in Mastitis Severity
Mastitis severity is highly variable, and among one of the first observations
describing the range in severity of mastitis was in the 1950s, when J.M Murphy (1956)
noted that clinical stages of mastitis ranged from non-clinical to mild to severe. He also
mentioned that while there were four major causative agents of mastitis, the severity of
mastitis within the different organisms did not occur at the same frequency, whereby
some organisms typically caused mild infection while others caused more severe
infection. His observations remain mostly true today in that clinical mastitis can be mild,
with only a few milk abnormalities, moderate, with changes in milk and local udder
swelling, or severe, which occurs with systemic signs of disease. Infections can also be
subclinical, resulting in no obvious signs of infection. As Murphy alluded to, severity of
mastitis does not occur equally among causal organism. Subclinical infections are
3

typically caused by Gram-positive pathogens, such as coagulase-negative Staphylococci
and S. aureus (Oliver et al., 2004, Thorberg et al., 2009). Conversely, environmental
pathogens, such as E. coli, rarely persist and more frequently result in severe infection
(Oliveira et al., 2013). However, even among bacterial pathogens that typically cause
clinical signs, the severity of infection differs between animals and is shown to be heavily
reliant on host variables, such as age, stage of lactation, and parity of the animal (Shuster
et al., 1996, Burvenich et al., 2003, Burvenich et al., 2007). Additionally, there is
evidence of a dose-dependency in the probability of infection, whereby different doses of
bacteria cause variable rates of infection in experimental challenges (Bramley, 1976),
indicating that a threshold of bacteria must be reached that supersedes innate mammary
defenses to cause infection.
Bacterial strain type is another factor that has the potential to determine the
severity of infection, however, reports showing whether this occurs in mastitis caused by
E. coli have been equivocal. Recently, it has been suggested that experimental bovine and
murine mastitis caused by environmental versus mammary pathogenic strains of E. coli
results in mastitis that differs in severity as evidenced by elevated milk cytokine levels
and somatic cell count in animals infected with pathogenic strains versus a commensal
strain (Blum et al., 2017, Roussel et al., 2017). However, an assessment of 25 E. coli
genomes, including 16 mammary associated strains, 8 fecal commensal strains and one
milk commensal strain, showed well-known E. coli virulence factors were present in both
mastitis-causing and fecal commensal strains. Furthermore, it was shown that genome
content is significantly associated with the likelihood of virulence or fitness factors
regardless of pathotype and that pathotypes are dispersed across phylogenetic groups.
4

The lack of an association between mammary associated strains and well-known
virulence factors suggests that commensal and mastitis associated strains may be equally
able to cause infection and likely cause infection through a variety of mechanisms,
however, this hypothesis should be confirmed experimentally (Leimbach et al., 2017). In
addition, even under experimental conditions, where cattle from different breeds were
challenged with the same E. coli strain, severity of infection varied within and between
breeds, indicating that the host response has a substantial role in infection outcome
(Bannerman et al., 2008).

1.4 Immune Response to Mastitis
Knowledge of how the immune system responds to mammary gland infection is
critical to understanding how between-animal variation in severity of mastitis is
regulated. As previously mentioned, the magnitude of the immune response and the
mediators that are activated are highly pathogen dependent. Transcriptional analysis
comparing the very early innate response events that occur within the udder post
infection with E. coli and S. aureus, the two-major mastitis-causing pathogens, has shown
a clear difference in their magnitude of response. Just one hour after experimental
infection, E. coli induces a response that is greater than 25 times stronger than S. aureus
and also enhances expression of several immune response genes that are not activated by
S. aureus (Petzl et al., 2016). This difference in early innate response is indicative of the
progression of infection mediated by the two pathogens, whereby E. coli induces a rapid,
acute, highly inflammatory response and S. aureus tends to elicit a more subdued
response that can lead to chronic infection.
5

In a second, similar study, whole transcriptome analysis of E. coli and S. aureus
infection (1-3 hrs. post-infection) showed the rapid induction of pro-inflammatory genes
by E. coli that are regulated by LPS, TNF-α and IL-1ß signaling pathways (Gunther et al.,
2017a). Again, this response is consistent with many reports that indicate E. coli induces
the rapid activation of Toll-like receptors (TLRs) and other pattern recognition receptors
(PRRs) to activate pro-inflammatory gene transcription resulting in acute mastitis (Petzl
et al., 2008, Schukken et al., 2011). Conversely, S. aureus failed to activate the majority
of pro-inflammatory signaling pathways and instead the response was found to be
regulated by immune-dampening transcription factors, TGFB1, ESR1 and SFR. Bacterial
invasion and cytoskeletal rearrangements were also detected in S. aureus infected cell
cultures, a result that was not seen in similar E. coli treated cultures (Gunther et al.,
2017a). The ability for S. aureus to invade epithelial cells is likely dependent on its
activation of immune-dampening mechanisms within the udder. Interestingly, E. coli
gains the ability to invade epithelial cells in mice deficient in TLR4/LPS signaling
(Elazar et al., 2010). This key difference in inflammatory response versus immunedampening mechanisms explains the much higher prevalence of chronic S. aureus
infections and acute E. coli infections.
Pathogen dependent differences aside, the early cellular responses to mastitiscausing pathogens are largely activated by sentinel cells that reside within the mammary
gland, the majority of which are mammary epithelial cells and some resident leukocytes
and lymphocytes. Epithelial cells are known to rapidly respond to infection by increasing
expression of pro-inflammatory cytokines, cathelicidins, and acute phase proteins prior to
leukocyte infiltration (Brenaut et al., 2014, Cubeddu et al., 2017). In addition, stromal
6

fibroblasts have recently been shown to be activated during mastitis infection and exhibit
cross-talk with mammary epithelial cells (Chen et al., 2016, Zhang et al., 2016).
Following activation of sentinel cells within the mammary gland, the main cellular
responders are neutrophils, followed by monocyte-derived-macrophages and natural
killer cells (Sipka et al., 2016). The infiltrating leukocytes are responsible for the increase
in somatic cell count (SCC) that is quickly seen following a mastitis infection. Moreover,
neutrophils are the primary leukocyte that are responsible for bacterial killing through the
release of a large arsenal of antimicrobial proteases, peptides, reactive oxygen species,
and neutrophil extracellular traps (Pechous, 2017). Ideally, bacterial killing by
neutrophils will be short-lived and effective to clear bacteria but with their effects limited
appropriately to reduce the cytotoxic effects of the neutrophil-derived molecules.
The adaptive immune response has been relatively understudied in comparison
to the innate response in bovine mastitis. However, the production of the IL-17 family of
cytokines (IL-17A, IL-17F and IL-22), typically produced in abundance by CD4 T helper
cells of the Th17 lineage, although also produced by innate lymphoid cells called ILC3s,
are up-regulated following intra-mammary challenge with E. coli and S. aureus, a finding
that is in line with a predominantly neutrophilic response. In addition, it has been shown
that IL-17 has synergistic effect on the production of a number of pro-inflammatory and
chemotactic proteins in cellular and in vivo mastitis models (Roussel et al., 2015, Rainard
et al., 2016) and aids in neutrophil-dependent bacterial clearance (Porcherie et al., 2016).
Therefore, Th-17 cells are likely to contribute to the mammary gland response to mastitis.
Knowledge of how other CD4+ and CD8+ T-cell subtypes respond are limited; however,
it is known that CD8+ cells proliferate and increase in their proportion in mammary
7

glands infected with E. coli (Mehrzad et al., 2008). Interestingly, in a recent study it was
shown that antibodies seem to be somewhat inessential to mammary gland response to E.
coli mastitis (Herry et al., 2017), a finding that is line with previous work where large
differences in milk IgG response were measured in response to experimental S. aureus
mastitis, with no difference in bacterial clearance (Benjamin et al., 2015b).

1.5 Inflammatory Response Regulation: What is the Appropriate Response?
The cellular and non-cellular components of immunity that define the
appropriate response depend on the type of infecting organism (e.g. bacterial, viral or
eukaryotic) and the location of intrusion. Response to infection is regulated at the level of
gene transcription, mRNA stabilization and processing, protein translation, and through
post-translational modifications, such as protein phosphorylation. Dysregulation of any of
these steps may influence the effective response to infection, potentially resulting in more
severe pathology or lowered ability to control infection. Under normal circumstances,
bacteria are prevented from entering the mammary gland through physical barriers
provided by the teat canal, including a keratin plug that seals off the mammary gland
from the outside environment during the dry period and between milkings. Variation in
cow and environmental factors appears to influence the probability that pathogens breach
these physical barriers. For example, cow teat shape and teat sphincter length and patency
are associated with pathogen specific susceptibility to infection, and reducing teat end
bacterial contamination through environmental and udder hygiene practices reduces
infection risk. If bacteria breach the physical barriers and escape killing by humoral milk
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components, a prompt leukocyte response is required to neutralize bacteria before
uncontrolled growth can occur (Rainard and Riollet, 2006).
The adequate response by the neutrophil has been the subject of years of
discussion. In numerous reports it has been suggested that a rapid neutrophil response is
essential to limiting severity of infection (Burvenich et al., 2003) and that during
parturition, when an animal is very susceptible to severe mastitis, host neutrophil
response is either suppressed or insufficient resulting in unnecessary damage to the
mammary gland (Vangroenweghe et al., 2005b). Differences in the kinetics of neutrophil
influx could be regulated at the level of extravasation. Successful neutrophil diapedesis
depends on the interaction of L-selectin with selectin molecules on endothelial cells and
by subsequent up-regulation and binding of ß2-integrins (CD11a, b, c & CD18) with
ICAM molecules on endothelial cells. An earlier report assessing the role of neutrophil
CD11a and CD11b expression in cows that experience severe versus moderate responses
to mastitis did not find a significant difference in receptor expression, however, they
noted a negative correlation between the severity of mastitis and total circulating preinfection neutrophil numbers and percent of both mature and phagocytic neutrophils in
blood (Dosogne et al., 1997). A number of other studies have researched the role of ß2integrins and L-selectin molecules on neutrophil function during parturition or in
response to E. coli or LPS-induced mastitis, with inconclusive results (Diez-Fraile et al.,
2002). Neutrophil properties, such as pre-infection neutrophil viability (Mehrzad et al.,
2004), elevated production of reactive oxygen species (Mehrzad et al., 2002) and
increased expression of genes downstream of the TLR4 signaling (Stevens et al., 2011)
have all been implicated in reducing severity of mastitis. In addition, both a causal and
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protective role have been hypothesized for complement protein and neutrophil
chemoattractant C5a. Expression of the C5a receptor (C5aR) is reduced in neutrophils
from early lactation cows, however, high concentrations of C5a contribute to excessive
cytokine production that is ultimately detrimental to the host and can result in sepsisrelated complications typical of very severe mastitis (Stevens et al., 2012).
In contrast to previous reports of immune-suppression during the transition
period, an overzealous innate immune response has also been associated with an increase
in mastitis severity during parturition. Mononuclear cells isolated from early lactation
cows produce significantly more TNF-α in response to LPS in comparison to midlactation cows (Sordillo et al., 1995). Induction of endotoxin tolerance within the
mammary gland has been shown reduce the severity of experimental mastitis for at least
72 hours post LPS pre-treatment, reducing SCC influx and febrile response and
increasing bacterial clearance. The protective effect of tolerance was shown to occur with
the concurrent down-regulation of CXCL8, SAA3 and IL-6 (Petzl et al., 2012). Similarly,
treatment with a steroidal anti-inflammatory together with antibiotic treatment reduces
the extent of mastitis severity in comparison to no treatment and to antibiotic treatment
alone (Sipka et al., 2013). Finally, animals ranked as high responders based on their
fibroblast production of IL-8 exhibit a prolonged neutrophil response to experimental E.
coli mastitis that delays their recovery to pre-infection milk production levels and
increases tissue damage within the mammary gland (Kandasamy et al., 2011)
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1.6 Cellular Models for in vivo Response
Due to the inherent variability of outbred species, such as dairy cattle, it may be
necessary to study a large number of animals to glean biologically relevant and
significant data. However, it is also often not feasible at the financial or ethical level to
experimentally infect a large number of cows. To address these issues, cellular models
have been developed to study how an animal might respond in vivo through in vitro
characterization of their cells. Numerous cellular models have been developed to study
mastitis and other infectious diseases, however, each has their inherent limitations and
applicability. Monocyte-derived-macrophages have been successfully used to model
response to bovine tuberculosis, whereby virulent strains of Mycobacterium bovis induce
expression of numerous pro-inflammatory genes to a greater extent in macrophages
isolated from resistant versus susceptible cattle (Alfonseca-Silva et al., 2016). This result
makes sense for M. bovis infection because the bacteria primarily infect macrophages and
often escape killing through immune-dampening mechanisms. On the other hand, using
macrophages to model mastitis infection does not seem to accurately portray disease
progression. Bovine-derived macrophages, which may be useful to measure broad nonspecific responses, have been shown to lack the ability to distinguish between the
pathogen-specific immune responses elicited by E. coli versus S. aureus (Gunther et al.,
2016b) and therefore, may not be a sensitive enough model to measure the variable
responses that occurs between-animals to the same pathogen.
The mammary epithelial cell is another potential cell model that has been used
extensively to study the pathogenicity of mastitis-causing organisms (Pang et al., 2017),
along with the differential host innate immune response to various pathogens and sub11

strains of the same pathogen (Gunther et al., 2016a, Gunther et al., 2016b). Interestingly,
a novel use for the primary bovine mammary epithelial cell has very recently been
developed to identify new expression biomarkers from cows that were described as high
or low responders based on antibody production in response to Clostridium difficile
immunization, in an effort to produce milk with high levels of anti-C. difficile IgA
(Hillreiner et al., 2017). Epithelial cells isolated from high responders, in agreement with
antibody production in vivo, expressed higher levels of numerous innate response genes,
including CXCL8, CXCL5, C3 and SAA3.
To avoid primary sampling of mammary epithelial cells, bovine mammary
epithelial cell lines have also been used to study the immune response to mastitis causing
pathogens (Roussel et al., 2015) and to study the effects of haplotypes in response to the
same pathogen (Meade et al., 2012). However, mammary epithelial cell line response to
different strains of E. coli did not accurately reflect the murine response to the identical
pathogens, whereby the P4 strain of E. coli caused the most severe infection, with high
levels of milk cytokines, but elicited a much more subdued cellular cytokine response in
comparison to other strains (Roussel et al., 2017). Epithelial cell lines may be useful for
studying the overall biological response to pathogens as they are less variable than
primary cells, but for the same reason may not be a good tool for understanding betweenanimal or between-pathogen responses.
The primary fibroblast is another, more easily accessible, cell type that responds
to TLR agonists and bacteria and are reflective of host response to infection (Gunther et
al., 2016b). Primary fibroblasts have been used to study the immunological mechanisms
that constitute response to infection in a number of host species, including human
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response to Chikungunya virus (Selvamani et al., 2014), non-natural host response to
herpes subtypes with varying degrees of virulence (Rogers et al., 2007) and in bovine
response to LPS in relation to mastitis (Kandasamy et al., 2011) and systemic LPS
response (Green et al., 2011a). Furthermore, primary dermal fibroblasts have been
utilized to discern animal-to-animal variation in mastitis severity. Production of IL-8
following fibroblast stimulation with synthetic TLR agonists (LPS and PAM2CSK4) has
been used as a marker to categorize animals as high or low responders and subsequent
experimental mastitis has shown that high responders respond more severely to E. coli or
S. aureus infection, respectively (Kandasamy et al., 2011, Benjamin et al., 2015b). Given
this, the primary dermal fibroblast is suggested to be the preferable cell model for their
ease of isolation, amenability to cryopreservation, responsiveness, and repeatability.
Furthermore, it has been shown that mammary stromal fibroblasts are an active cell in
response to mastitis, in that fibroblasts isolated from glands infected with mastitis versus
healthy glands exhibit a number of inflammation related changes and have the capacity to
decrease ß-casein secretion and up-regulate expression of TNF-α and IL-8 in
unstimulated epithelial cells (Chen et al., 2016). Alternatively, activated epithelial cells
can induce an inflammatory response in fibroblasts isolated from healthy cattle (Zhang et
al., 2016).
1.7 Genetics of the Immune Response to Mastitis
Ideally, the producer would like to be able to select animals that are inherently
less susceptible to mastitis, as has been done for milk production traits. Doing so would
reduce the costs associated with mastitis treatment and lowered milk production, and
decrease the use of antibiotics in food-producing animals. However, this is not a simple
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task. Resistance to mastitis is undoubtedly highly polygenic, and traits associated with
lower risk for one pathogen may increase the risk for other pathogens or even other
infectious diseases. The correct phenotype for mastitis resistance is also difficult to
elucidate in that mastitis is caused by such a varied group of microorganisms.
Unfortunately, unlike milk yield, genetic heritability of clinical mastitis has been
measured to be quite low. Heritability estimates have been reported anywhere from 0.02
to 0.10 depending on the model used (Lund et al., 1999, Rehbein et al., 2013, GovignonGion et al., 2016). Heritability based on characteristics that are correlated with mastitis,
such as somatic cell count or somatic cell score (SCS), has shown improved estimates for
heritability. Using a recursive model, based on the closest test-day before and the closest
test-day after clinical mastitis, one study showed that SCS has heritability of 0.12 and
0.16, respectively, between test day one and test day two (Rehbein et al., 2013). Splitting
test measurements among different stages of lactation improves heritability, albeit
slightly, to 0.17 (Jamrozik and Schaeffer, 2012). However, although correlation between
mastitis and SCS is high, in practice this may only work for chronic or subclinical
infections. Somatic cell measurements are typically only taken on a monthly basis and
would likely miss many short-lived, acute infections, such as those caused by E. coli.
Genetic differences in immune response genes, resulting in differential mastitis severity,
is another potential method for genetic selection. Genome-wide association studies
(GWAS) have been performed to try to identify specific gene regions that are associated
with risk of clinical mastitis. One GWAS found a number of QTLs with immune-relevant
genes across nine chromosomes, confirming the polygenic nature of mastitis resistance
(Tiezzi et al., 2015). Again, since the authors did not distinguish between pathogen type,
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this may also reflect that the importance of genes is variable in response to different
organisms. Other GWAS have tried to identify SNPs that are associated with increases in
SCS and clinical mastitis, and found QTLs on chromosomes 14 (Wang et al., 2015), 18
(Brand et al., 2011) and 20 (Kadri et al., 2015), associated with genes such as LIFR and
CARD6. Unfortunately, the functional consequences of genetic variation have not been
reported for most SNPs and QTLs.
Interestingly, one study that identified different haplotypes based on five SNPs
in the CXCR1 gene challenged three different haplotype combinations with Streptococcus
uberis to determine the effect of haplotype on severity of mastitis. Severity based on
SCC, bacterial counts, mammary and milk scores was significantly higher in one
homozygous haplotype and significantly lower in one heterozygous haplotype (Siebert et
al., 2017). Notably, CXCR1 is the receptor for IL-8, and genetic differences in the IL8
gene have also been found whereby two distinct haplotypes have been identified, one of
which is more responsive to LPS in vitro (Meade et al., 2012) and to intravenous LPS
treatment (Stojkovic et al., 2016). Furthermore, in response to in vitro stimulation with a
viral agonist, the opposite haplotype has the higher phenotype, suggesting that the two
haplotypes may have evolved based on exposure to bacterial or viral antigens (Stojkovic
et al., 2017).
1.8 Regulation of Immunity by Non-Genetic Mechanisms
There is substantial evidence that regulation of gene expression also occurs
through heritable non-genetic, or epigenetic, mechanisms. Epigenetic regulation has been
shown to occur through modification of histone proteins, regulation by miRNAs, and
through DNA modifications, such as CpG methylation and hydroxy-methylation. There
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are also varying degrees on what is known about how each of these modifications
functions in generating changes in immunity. For instance, very few studies have
identified a role for 5-hydroxymethylcytosine (5-hmC) in the regulation of the immune
response. However, relatively recent reports have shown that 5-hmC may contribute to
the regulation of T-cell development and activity (Ichiyama et al., 2015), along with
increased risk of systemic lupus erythematosus (Zhao et al., 2016). There are elevated
levels of 5-hmC in isolated CD4+ T-cells from patients with systemic lupus
erythematosus that results in a concurrent increase in gene expression of 131 genes, a
result that is in agreement with previous findings that 5-hmC up-regulates the expression
of genes through DNA de-methylation. In addition, 5-hmC was shown to contribute to Tcell differentiation (specifically Th1 and Th17 cells) through the up-regulation of lineage
specific transcription factors and cytokines, mediated by the Tet2 de-methylating enzyme
(Ichiyama et al., 2015).
Micro-RNAs (miRNAs or miRs) regulate the expression of genes posttranscriptionally through binding and de-stabilization of mRNA. There is substantially
more data to support the role of micro-RNAs in the immune response and in particular,
the regulation of TLR signaling in response to immune stimulus or infection (Drury et al.,
2017). Activation of TLR4 signaling in primary human monocytes increases the
expression of miR-187, which subsequently down-regulates pro-inflammatory cytokine
production in an IL-10 dependent manner. It was shown that miR-187 specifically targets
TNF-α and IκBζ mRNA, resulting in reduced expression of TNF-α, IL-6 and IL12-p40
(Rossato et al., 2012). Similarly, miR-146a inhibits TLR4 signaling through its
interactions with TRAF6 and IRAK1, and miR-146a is temporally regulated with miR16

155, another miRNA that enhances TLR4 signaling through its interactions with
transcripts of inhibitory proteins SHIP1 and SOCS1 (Mann et al., 2017). Interestingly,
expression of miR-146a is sufficient to induce endotoxin tolerance in the monocyte cell
line THP-1 and it can elicit its effects in both the presence and absence of LPS (Nahid et
al., 2009).
Numerous histone modifications have been identified that also contribute to the
regulation of the innate and adaptive immune response. Histone acetylation, typically
associated with transcriptional activation, contributes to cellular response to TLR3
ligands. Specifically, H3K9 and H4K8 acetylation is increased in cells following
treatment with a TLR3 agonist poly (I:C) and is hypothesized to contribute to early HIV1 trans-activation that occurs to a higher degree with TLR3 stimulation (Bhargavan et al.,
2016). In addition, bronchial epithelial cells that are primed with IFN-γ exhibit increased
expression of the antiviral protein RIG-I through the reduction of H3K9 tri-methylation
(H3K9me3), a histone modification that represses gene expression. This epigenetic effect
of IFN- γ on bronchial epithelial cells may partially protect against early-life
susceptibility to viral infection and/or increased asthma-associated viral infections
(Spalluto et al., 2017).
Finally, and by far the most extensively studied, is the role of DNA methylation
in differential susceptibility and severity of infection and other inflammation-related
disorders. In fact, TLRs themselves are frequently regulated by differential methylation,
making them the ideal candidates for assessing mechanisms of immune response
regulation (Hennessy and McKernan, 2016). It has been shown that infection with
Mycobacterium tuberculosis induces extensive re-programming of methylation patterns
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found within the TLR2 promoter that results in changes in TLR2 expression and also
correlates with the extent and severity of infection (Chen et al., 2014). Chondrocytes
isolated from patients with osteoarthritis versus healthy patient controls express
significantly higher IL-8 that occurs with decreased methylation of the IL8 promoter and
reduced transcription factor trans-activation (Takahashi et al., 2015). In summary,
epigenetic modifications significantly impact how the immune system responds to
infection. Epigenetic changes may also occur as the result of infection inducing an innate
“memory” response, as is the case in endotoxin tolerance and “trained” immunity (Netea
et al., 2016).

1.9 Epigenetic Regulation of Immunity in Agricultural Species
Epigenetic regulation of gene expression in agricultural species has been gaining
attention in recent years and has led to advances in both our understanding of the
biological consequences of epigenetic regulation and in the sequencing technologies
needed to identify epigenetic modifications in animals of agricultural importance. One
study has recently addressed the role of epigenetic regulation in bovine response to
Mycobacterium bovis. In comparison to their healthy counterparts, animals infected with
M. bovis acquire a number of DNA methylation changes within their CD4+ T-cell
population that is unique to their infected status. T-cells in infected animals become
significantly hypo-methylated in a number of genes that are regulated by TGF-ß, a
cytokine that regulates T-cell development and differentiation. In addition, the canonical
TH1 cytokine, IFNG, encoding IFN-γ, was discovered to be significantly hypomethylated and up-regulated in infected animals, whereas, TNFRSF4, a gene that
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transcribes the OX-40 co-receptor responsible for T-cell survival and proliferation, was
hyper-methylated and significantly repressed (Doherty et al., 2016).
Treatment of bovine peripheral blood mononuclear cells (PBMCs) with LPS
reduces the expression of key enzymes that mediate DNA methylation and histone deacetylation, consistent with up-regulation of gene expression (Doherty et al., 2013).
However, it is interesting to note that in the same study, treatment of PBMCs with
trichostatin A (TSA), an inhibitor of the histone de-acetylase enzyme, decreased the
expression of pro-inflammatory cytokines in response to LPS compared to untreated cells
stimulated with LPS. Since TSA is a pan-HDAC inhibitor it is possible that up-regulation
of anti-inflammatory proteins occurred as a result of treatment and over-shadowed the
effects of LPS. In addition, the mixed cell population may have confounded the study,
making these results difficult to interpret. It is thought that endotoxin tolerance is the
result of epigenetic modifications, however, treatment of primary bovine epithelial cells
with a number histone-modifying enzyme inhibitors also has very little effect on
subsequent response to E. coli (Gunther et al., 2017b). These results suggest that histone
modifications may play a lesser role than originally thought in response to LPS.
A number of epigenetic changes occur in the livers of animals challenged with
E. coli and as a result of increased concentrations of LPS induced by sub-acute ruminal
acidosis (SARA). Following E. coli mastitis, liver biopsies showed chromatin decondensation in genes transcribing TLR2, TLR4, haptoglobin (HP) and
lipopolysaccharide binding protein (LBP) along with increased expression. Interestingly,
correlation of TLR4 expression and chromatin remodeling was not as strong as for the
other three genes, however, TLR4 was also significantly hypo-methylated (Chang et al.,
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2015a). Differential methylation of TLR4 has also been shown to occur during SARA, a
metabolic condition in ruminants that decreases rumen pH such that microbial death
occurs and leads to the release of LPS into the circulation. When induced experimentally
in goats and dairy cows, the systemic release of LPS leads to an enhanced expression of
TLR4 and cytokine response in the liver that occurs concurrently with TLR4 chromatin
de-condensation and a substantial decrease in promoter methylation (Chang et al.,
2015c). In cows, increased hepatic expression of HP, SAA3 and LBP also occurs with a
significant reduction in promoter methylation and chromatin loosening (Chang et al.,
2015b).
Differential methylation of TLR4, therefore, seems like a potential mechanism of
gene regulation that may determine the susceptibility and severity of E. coli mastitis.
Using the primary dermal fibroblast as a model cell type, it has been previously shown
that as animals increase in age from 5- to 16-months, their fibroblasts exhibit a much
higher response to in vitro LPS treatment and increased expression of TLR4. Agedependent differences in fibroblast IL-8 production in response to LPS is also abolished
upon treatment with the DNA methylation inhibitor 5-aza-2′deoxycytidine (AZA),
indicating that DNA methylation plays a role in the age-dependent difference in response
(Green et al., 2015). As these cells were isolated from the same animals at two separate
ages and will not be confounded by genetic factors, this model is ideal for discovering
epigenetic differences that regulate response to LPS.
1.10 Environmental Effects on Epigenetic Modifications and Immunity
In addition to the identification of genetic and epigenetic markers that confer
susceptibility or resistance to severe mastitis, it is of interest to determine if epigenetic
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differences can be altered through early life environmental interventions. If financially
feasible, this would provide producers with another tool to lower the susceptibility of
their animals to severe mastitis. There is considerable data to suggest that environmental
exposures, particularly when they occur early in life, can influence disease susceptibility.
For example, there is a substantial difference in the prevalence of asthma in Hutterite
versus Amish children, whereby Amish children have a much lower risk of developing
asthma (Stein et al., 2016). The lowered prevalence and increased protection against
developing asthma is thought to occur as a result of a much higher (6.5-times) level of
endotoxin measured in house-dust collected from Amish households, resulting in a more
tolerant, hypo-responsive phenotype to everyday allergens. In support of this hypothesis,
stimulation of peripheral blood leukocytes isolated from Amish and Hutterite children
with LPS results in significantly lower cytokine concentrations in challenge supernatant
from the Amish population. Furthermore, treating mice with house-dust collected from
either Amish or Hutterite households showed a significant protective effect induced by
Amish house-dust to airway hyperresponsiveness and eosinophilia and suppression of
IgE and cytokine response to challenge with ovalbumin.
The aforementioned study is further supported by a number of other reports that
have found an immune-tolerizing effect of early life endotoxin on adult immunity. Rat
pups that were exposed to a single dose of LPS in early gestation exhibited lower
leukocyte recruitment into their lungs following ovalbumin-induced experimental asthma
(Kirsten et al., 2011). In addition, an earlier study showed that neonatal LPS treatment of
rat pups at 14-days of age has a significant effect on a subsequent LPS exposure in
adulthood. In comparison to their saline treated counterparts, LPS-treated pups had a
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lower response to a second LPS exposure that was reflected in an attenuated circulating
cytokine response along with a lower fever response. The authors attributed the LPSinduced suppression to increased corticosterone signaling in rats treated with LPS as pups
(Ellis et al., 2005). Interestingly, although similar results were measured in LPS-induced
circulating cytokine response in mice that were exposed to LPS at conception versus
saline treated mice, no differences were measured in corticosterone levels, indicating that
this may not be the only factor in determining neonatal LPS-induced suppression of adult
innate immunity (Williams et al., 2011). Finally, calves treated with LPS in late gestation
also exhibited changes to their innate immune response as young adults when exposed to
a second treatment with LPS. LPS-treated heifers tended to be less effected by LPS,
based on temperature response and sickness score, and also express higher levels of
neutrophil ß-defensin genes (Carroll et al., 2017).
Although substantial evidence for the effect of early life endotoxin exists, few
studies have addressed the mechanisms behind the phenotypic differences. One study,
however, revealed a large change in the regulatory T-cell (Treg) population found in cord
blood of pregnant mothers exposed to a farm environment in comparison to unexposed
mothers. The Treg population from farm-exposed mothers was more abundant and had an
increased capacity to down-regulate effector T-cell function (Schaub et al., 2009).
Notably, the change in Treg phenotype occurred in conjunction with decreased
methylation and increased expression of FOXP3, a transcription factor that is necessary
for Treg development.
Differences in early life maternal care have also been shown to affect epigenetic
programming in adult animals. Rat pups reared by low maternal care dams, as measured
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by lower levels of licking and grooming and arched back nursing, exhibit increased
methylation and reduced expression of hippocampal glucocorticoid receptor that is
reversible through cross-fostering or treatment with TSA, both of which result in demethylation of the glucocorticoid receptor promoter region. The effect of maternal care
on methylation of the glucocorticoid receptor was specifically attributed to differences in
care in the first 6 days of life, and as a result, low maternal care adult rats exhibit a
significantly higher corticosterone response to stress (Weaver et al., 2004). Interestingly,
a similar difference in maternal care exists in the upbringing of Angus versus Holstein
calves. In early life, Angus calves are allowed to remain with their dams and receive
maternal care through nursing and grooming, whereas Holstein calves are separated from
their dams soon after birth and raised by a calf handler in individual hutches. While not
yet directly correlated to differences in maternal care, fibroblasts isolated from the two
breeds exhibit disparate responses to LPS, with Holstein cows being much more hyperresponsive to the effects of LPS treatment (Benjamin et al., 2016a). How this difference
is regulated, either epigenetically or otherwise, remains to be determined.
1.11 Unanswered Questions
The relationship between genetic, epigenetic, and environmental factors and
their regulation of immunity in the bovine, especially how each of these contributes to
mastitis severity, has yet to be fully elucidated. It is known that there is substantial interanimal variation in mastitis severity to the same pathogen, such that some animals are
quick to recover and others suffer from severe, systemic responses that may result in
death of the animal. Genetic differences have been suggested to partially regulate the
difference in mastitis susceptibility and severity, but for the most part have not been
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tested in experimental models. The one exception to this is the role of CXCR1 haplotypes
in response to S. uberis, which may prove useful in future selection strategies (Siebert et
al., 2017). However, it is very likely that susceptibility to severe mastitis is polygenic and
pathogen-dependent. Clinical mastitis also has very low estimates of heritability,
however, the majority of studies classify the incidence of clinical mastitis categorically,
without addressing the severity of each case. As such, heritability of severe clinical
mastitis may be higher than initially predicted.
It has also become increasingly clear that the optimum innate response is undercharacterized and is not all or nothing. Many studies have used the transition cow as a
model for a “severe responder”, due to the increased risk of animals developing severe
mastitis at parturition. These studies suggest that the transition cow is immunecompromised. Therefore, much past and on-going research on mastitis control focuses on
boosting the immune system. However, mastitis severity is also associated with increased
production of TNF-α, IL1-ß and IL-8 (Wenz et al., 2010), and studies suggesting overall
immune-suppression fail to address the variability between animals in mastitis severity
even during early lactation. Therefore, it is of the author’s opinion that a dysregulated
rather than immune-suppressed response be attributed to the increased risk of severe
mastitis in transition cows. Efficient neutrophil response is necessary but it should not be
so exuberant to cause excessive tissue damage. Therefore, identifying the factors that
contribute to effective response and then recovery following infection are required, and
this may be facilitated by access to an accurate cellular model.
Beyond genetics, the study of the phenotypic effects of epigenetic differences is
still in its infancy in the bovine. As previously discussed, a variety of epigenetic
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modifications have been shown to contribute to regulation of the immune response in
several different species; as such, it is unlikely that this will be any different for the
bovine and suggests there is significant room for improving genetic resistance to mastitis.
Finally, it is of interest to identify treatments, such as dietary interventions or immune
stimulants, that are easy to implement and can be utilized early in calf development to
generate an adult phenotype that has a lower susceptibility to severe mastitis. In this case,
training the immune response to effectively respond to a pathogen without creating
excess damage or undermining immunity elsewhere, is highly desired.
To discover how genetic, epigenetic and the environmental factors collectively
regulate the bovine innate immune response and potentially alter susceptibility to severe
mastitis, I used a primary dermal fibroblast cell model to assess phenotypic differences
between animals in their innate response to LPS. The dermal fibroblast is a readily
accessible and TLR-responsive cell type that is useful for measuring the responses of a
large cohort of animals. Furthermore, the cell model was used in conjunction with in vivo
experiments to address my hypothesis:
Between-animal variation in the severity of E. coli mastitis is partially mediated
by differential methylation of genes that regulate the innate immune response,
resulting in susceptible and resistant phenotypes that can be altered through
early-life environmental interventions.
To first determine how DNA methylation regulates innate immunity, fibroblasts
that exhibit an age-dependent up-regulation in their response to LPS were used to identify
genome-wide differences in DNA methylation. As these cells were isolated from the
same animals at 5- and 16-months of age and show clear differences in their response to
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LPS, they are an ideal model to identify epigenetic differences that regulate the innate
response without the confounding effect of genetic variables. Next, to identify how
differential regulation of the TLR4 pathway contributes to mastitis severity, either at the
genetic or epigenetic level, expression of TLR4 and downstream signaling components
were measured in fibroblasts isolated from a large cohort of lactating adult cows. Cows
identified as either high or low responders were subsequently challenged with E. coli in
an experimental mastitis model to determine if high responders would experience more
severe mastitis, as was predicted.
Finally, since early life LPS exposure has been shown in numerous reports to
down-regulate immunity, presumably through epigenetic mechanisms, neonatal bull
calves were treated with either LPS or saline at one-week of age. Subsequent in vivo and
cellular responses were then analyzed to determine the effects of early life treatment. If
found to be beneficial, it may be of interest to producers to stimulate heifer calves at a
young age with a low-dose of endotoxin, or another immune stimulant, to modulate
heifer and adult cow response to E. coli. These works contribute to our understanding of
epigenetic regulation of bovine innate immunity, addresses the utility of the fibroblast
model to determine genetic and epigenetic biomarkers of mastitis resistance and, adds to
our knowledge of neonatal exposures and their ability to modify adult phenotype.
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CHAPTER 2: GENOME-WIDE METHYLATION ANALYSIS REVEALS
DIFFERENTIALLY METHYLATED LOCI THAT ARE ASSOCIATED WITH
AN AGE-DEPENDENT INCREASE IN BOVINE FIBROBLAST RESPONSE
TO LPS
2.1. Abstract
Background: Differences in DNA methylation are known to contribute to the
development of immune-related disorders in humans, but relatively little is known about
how methylation regulates immune function in cattle. Utilizing whole-transcriptome
analyses of bovine dermal fibroblasts, we have previously identified an age and breeddependent up-regulation of genes within the toll-like receptor 4 (TLR4) pathway that
correlates with enhanced fibroblast production of IL-8 in response to lipopolysaccharide
(LPS). Age-dependent differences in IL-8 production are abolished by treatment with 5aza-2-deoxycytidine and Trichostatin A (AZA-TSA), suggesting epigenetic regulation of
the innate response to LPS. In the current study, we performed reduced representation
bisulfite sequencing (RRBS) on fibroblast cultures isolated from the same animals at 5and 16-months of age to identify genes that exhibit variable methylation with age. To
validate the role of methylation in gene expression, six innate immune response genes
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that were hyper-methylated in young animals were assessed by RT-qPCR in fibroblasts
from animals at different ages and from different breeds.
Results: We identified 14,094 differentially methylated CpGs (DMCs) that
differed between fibroblast cultures at 5- versus 16-months of age. Of the 5065 DMCs
that fell within gene regions, 1117 were located within promoters, 1057 were within gene
exons, 2891 were within gene introns, and 67% were more methylated in young cultures.
Transcription factor enrichment of the promoter regions hyper-methylated in young
cultures revealed significant regulation by the key pro-inflammatory transcriptional
enhancer, NF-κB. Additionally, five out of six chosen genes (PIK3R1, FES, NFATC1,
TNFSF13, and RORA) that were more methylated in young cultures showed a significant
reduction in expression post-LPS treatment in comparison with older cultures. Two of
these genes, FES and NFATC1, were similarly down-regulated in Angus cultures that
also exhibit a low LPS response phenotype.
Conclusions: Our study has identified immune-related loci regulated by DNA
methylation in cattle that may contribute to differential cellular response to LPS, two of
which exhibit an identical expression profile in both low-responding age and breed
phenotypes. Methylation biomarkers of differential immunity may prove useful in
developing selection strategies for replacement cows that are less susceptible to severe
infections, such as coliform mastitis.
Keywords: DNA Methylation, Innate Immunity, LPS, Inflammation, RRBS
2.2. Introduction
The innate immune response is an organism’s first line of defense against
pathogenic microorganisms and the primary response to tissue damage. Innate immunity
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is mediated by specialized leukocytes and other cells that serve as a barrier to the
environment, such as epithelial cells and dermal fibroblasts. Innate immune cells are
characterized by their expression of germ-line encoded pattern recognition receptors
(PRRs), which recognize conserved molecular patterns (PAMPs), such as
lipopolysaccharide found on the outside of Gram-negative bacteria and viral nucleic
acids, and elicit the appropriate defense response upon recognition. The most thoroughly
characterized of these PRRs are Toll-like receptors (TLRs), a family of type-I
transmembrane proteins first discovered in Drosophila melanogaster when the Toll gene
was found to be essential for bacterial and fungal defenses (Lemaitre et al., 1996, Michel
et al., 2001). Upon TLR-ligand binding, an intracellular signaling cascade is activated
that allows for the transcription of numerous pro-inflammatory proteins, such as IL-6,
TNF-α and IL1-β, through the action of transcription factors NF-κB, AP-1, and Interferon
Response Factors (IRFs), among others (De Nardo, 2015). While it is clear that the
response elicited by TLRs and other PRRs are crucial to the defense against a variety of
bacterial, viral and eukaryotic pathogens (Sturdevant and Caldwell, 2014, Sacramento et
al., 2015, Uchiyama et al., 2015), an exacerbated or dysregulated innate response also
contributes to infection related inflammatory disorders, such as in antibody dependent
enhancement and the subsequent “cytokine storm” characteristic of Dengue hemorrhagic
fever (Callaway et al., 2015). In addition, the type I interferon response, normally
beneficial to the host during a viral infection, has been shown to actually increase
susceptibility to some bacterial, viral and protozoan infections (Stifter and Feng, 2015).
The innate immune response is also a key contributor to a number of sterile pro-
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inflammatory conditions, such as rheumatoid arthritis and asthma (Starkhammar et al.,
2015, Lacerte et al., 2016).
The severity of bovine mastitis, a primary cause of economic losses to dairy
milk production, is similarly more often associated with increased production of proinflammatory mediators, such as, TNF-α, IL1-ß, and IL-6, than it is with the number of
bacteria present within the mammary gland. Mastitis severity has also been shown to vary
greatly, even under controlled experimental settings in which pathogen factors are held
constant. This suggests host factors play a significant role in mastitis outcome
(Kornalijnslijper et al., 2003). Several studies have shown a dysregulated population of
milk and serum neutrophils, along with greater concentrations of TNF-α and reactive
oxygen species, during the peri-partum period when animals are highly susceptible to
severe mastitis (Ballou, 2012). Interestingly, priming of the mammary gland with 1 µg of
LPS, which causes a substantial but short-lived inflammation, reduces severity of
experimentally induced Escherichia coli (E. coli) mastitis 10 days post LPS priming
(Petzl et al., 2012). In an effort to explain the mechanism behind this reduction in mastitis
severity, a study by Gunther et al. (Gunther et al., 2012) measured gene expression in
response to heat killed E. coli in primary mammary epithelial cells following pretreatment with LPS. Priming of cells was found to increase expression of ß-defensins
while decreasing pro-inflammatory and apoptotic gene expression, including IL1-ß,
TRAF6, and TNF superfamily proteins (TNFSF13B and TNFSF10), indicating that the
previously measured benefit of LPS priming in an intra-mammary infection with E. coli
was due in part to a reduction in inflammatory response (Gunther et al., 2012). In a
murine mastitis model, administration of LPS into the mammary gland of TLR4(-/-) mice
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to induce mastitis showed that while knockout mice had significantly lower serum
cytokines CXCL1, IL1-ß, IL-6, IL-10, TNF-α, CCL2 and IP10, they also experienced a
lower degree of mammary gland involution while maintaining increased capacity for
milk production compared to wild-type littermates (Glynn et al., 2014). In agreement
with the aforementioned studies, our lab has shown that high responding dairy animals,
based on dermal fibroblast IL-8 production in response to TLR ligands, have greater
tissue damage and neutrophil influx into the mammary gland post-infection and a slower
return to pre-infection milk production levels in response to both Staphylococcus aureus
(S. aureus) and E. coli mastitis, without any benefit to their ability to clear bacteria
(Kandasamy et al., 2011, Benjamin et al., 2015b).
Several factors, including genetic differences, may contribute to variation within
an animal’s infection response phenotype. In one example, single nucleotide
polymorphisms in the TLR4 gene have been linked to increased susceptibility to
Mycobacterium avium subspecies tuberculosis, or Johne’s disease, in Canadian Holsteins
(Sharma et al., 2015). However, a recent study between 3 breeds indicated an estimated
heritability of clinical mastitis to be between 2% and 4%, suggesting a very large role for
non-genetic factors (Govignon-Gion et al., 2015). Epigenetic modifications, such as DNA
methylation, may help to explain discrepancies measured between large phenotypic
differences with little genetic basis. In agreement with this, DNA methylation in two
breeds of chicken has been shown to contribute to differential susceptibility to infectious
diseases such as avian flu and Salmonella infection. Whole genome bisulfite sequencing
(WGBS) revealed greater than 5,000 differentially methylated regions (DMRs) in lung
tissue between the two breeds, with a portion of DMRs falling within gene regions. The
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methylation data generated by WGBS together with mRNA expression data generated by
RNA-seq, also identified genes with both differential methylation and expression, most
notably TLR4 and PIK3CD (Li et al., 2015).
In support of epigenetic regulation of the bovine innate immune response, data
generated in our lab has shown that an age-dependent increase in dermal fibroblast
response to LPS is ameliorated following treatment with a DNA methylation and histone
deacetylase inhibitor, AZA-TSA (Green and Kerr, 2014). A subsequent study was
performed to identify methylation and gene expression differences in fibroblast cultures
isolated from female calves at 5- and 16-months of age. Transcriptome-wide analysis of
these two sets of cultures identified numerous genes within the TLR4 response pathway
that were up-regulated in older, more responsive cultures, including TLR4, CD14, IL-8
and TNF-α (Green et al., 2015). In the same study, we sought to identify changes in DNA
methylation between the young and old cultures that contribute to age-related differences
in innate immunity, however, the MIRA (methylated CpG island recovery assay)-seq
technique that was utilized does not have the resolution required to determine
methylation differences at the base pair level. As such, very little difference in
methylation was found between the two sets of cultures.
Another phenotypic difference we have identified is the differential response
between Holstein and Angus breeds, in which Holstein cattle exhibit a much higher
fibroblast response to LPS than Angus cattle. The few reports of mastitis in beef cows
have also suggested beef breeds are less susceptible to coliform mastitis, with no cases of
E. coli mastitis cases detected in several studies (Lents et al., 2002, Persson Waller et al.,
2014). In this case, genetic differences between breeds are likely to have an influence.
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However, calves from these two breeds experience highly disparate upbringing. In
contrast with Angus and other beef breeds, Holstein calves are immediately separated
from their dam, allowing for little to no maternal care, which has been shown to
contribute to differential methylation of hormone receptors in rats (Pena et al., 2013).
Again, transcriptome analysis of age-matched fibroblasts isolated from the two breeds
revealed a number of pro-inflammatory genes with differential expression, with Holstein
cultures exhibiting significant up-regulation as compared to Angus cultures. However,
little to no difference in DNA methylation was found using the MIRA-seq technique
(Benjamin et al., 2016a).
Knowledge of epigenetic regulation of the immune response in dairy cattle is
currently lacking, and will be important to understanding differences in mastitis
susceptibility. From the previous studies, it is clear that methylation differences at a base
pair resolution are required. As such, the aim of the current study was to identify basepair specific DNA methylation differences in fibroblasts taken from Holstein heifers at 5and 16-months of age, using reduced representation bisulfite sequencing (RRBS). Once
candidate differentially methylated genes were identified, we determined whether
methylation affects gene expression by measuring fibroblast gene expression at various
time points post-LPS treatment. Furthermore, we determined whether genes regulated by
methylation in young and old cultures also differed in gene expression between Angus
and Holstein cultures. Overall, the current study contributes to our knowledge of
candidate immune response genes that are subject to regulation by DNA methylation
within the genome of dairy cattle and may lead to a better understanding of the
mechanisms that regulate inter-animal variation in susceptibility to severe mastitis.
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2.3. Materials and Methods
2.3.1 Experimental Animals
Six pairs of dermal fibroblast samples, collected from Holstein heifers at 5 and
16 months of age, were used from a previously characterized cohort of 15 heifer
fibroblast samples (Green et al., 2011a). Primary dermal fibroblast collection and ranking
based on IL-8 production following in vitro LPS stimulation was previously described
(Green et al., 2011a). The six pairs of fibroblast samples chosen for DNA methylation
analysis were all selected from mid-responding animals to reduce inter-animal variation
within the two groups that could potentially interfere with any true age effects.
A second set of dermal fibroblasts was collected for the breed difference experiments.
Fibroblasts were isolated from four 19-month Holstein and four 19-month Black Angus
cows. Fibroblast collection, isolation and LPS response are described elsewhere
(Benjamin et al., 2016a).
In both the age and breed experiments, fibroblasts were stimulated with 100
ng/ml of LPS and RNA isolation was performed side-by-side in neighboring wells. From
the same vial of cryopreserved cells used in the LPS challenge, some cells were cultured
in a T-75 cm2 culture flask for DNA isolation. Cells were again cultured side-by-side and
untreated cultures were used for DNA extraction.
All experiments were approved by the Institutional Animal Care and Use
Committee at the University of Vermont.
2.3.2 Fibroblast Culturing and LPS Challenge
Growth media for fibroblast cultures was Dulbecco’s Modified Eagle Media
(DMEM; Hyclone Laboratories, Logan, UT) supplemented with 5% fetal bovine serum
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(FBS; Hyclone Laboratories), 1% penicillin-streptomycin (Hyclone Laboratories) and 1%
insulin-transferrin-selenium (ITS; Mediatech Inc., Herndon, VA). Fibroblasts were
revived from cryopreservation and expanded in a T-75 cm2 culture flask at 37°C 5% CO2
in a humidified incubator. Confluent flasks were then treated with 0.25% trypsin (MP
Biomedical, Santa Ana, CA) and cells were transferred to a 6-well plate at 1.25 x 105
cells/ml in a total volume of 2 ml, or 2.5 x 105 total cells and cultured for 24 hours for the
LPS challenge experiments. Remaining cells were transferred to a T-75 cm2 culture flask
and allowed to grow to confluency for subsequent DNA isolation.
After 24 hours, cells in the 6-well plates were treated with 100 ng/ml of ultrapure LPS isolated from Escherichia coli O111:B4 (Sigma-Aldrich, St. Louis, MO) for
either 0, 2, 8 or 36 hours. At 0 and 36 hours, media was collected for protein production
analysis. After removal from the wells, media was centrifuged at 10,000 x g for 1 minute
to remove cellular debris and stored at -20°C until further analysis. At every time point,
cells were rinsed gently with Dulbecco’s Phosphate Buffered Saline (DPBS; Hyclone
Laboratories) and cell lysate was collected by adding 500 µl cell lysis buffer (5 Prime,
Hamburg, Germany) to the well. Cell lysate was stored at -20°C until RNA isolation.
Cells that were grown in a T-75 cm2 culture flask for DNA isolation were treated with
trypsin at confluency and centrifuged at 400 x g. The cell pellet was then lysed with 300
µl cell lysis buffer (5 Prime) by adding the lysis buffer and vortexing for 15 seconds. The
cell lysate was stored at -20°C until DNA isolation.
2.3.3 Quantification of IL-8 and IL-6 Protein
Interleukin-8 production in media from LPS stimulated dermal fibroblasts was
determined with a sandwich ELISA (Mabtech Inc., Cincinnati, OH) per manufacturer’s
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protocol with slight modifications. Capture antibody was diluted 1:500 to 1 µg/ml in 0.05
M bi-carbonate buffer. Recombinant bovine IL-8 (Thermo Scientific, Rockford, IL) was
used as the assay standard with a detection limit of 156.25 pg/ml. Capture antibody was
diluted 1:20,000 in PBS-0.05% Tween-20 to a concentration of 0.025 µg/ml.
Streptavidin-horseradish peroxidase was diluted 1:15,000 in PBS-0.05% Tween-20 to a
concentration of 0.07 µg/ml.
Interleukin-6 production was also determined by a sandwich ELISA (Thermo
Scientific) per manufacturer’s instructions. Briefly, capture antibody was diluted 1:100 in
0.05 M bi-carbonate buffer. Recombinant bovine IL-6 (Thermo Scientific) was used as
the assay standard with a detection limit of 156.25 pg/ml. Detection antibody was diluted
1:100 in PBS-0.1% BSA. Streptavidin-horseradish peroxidase (Sigma-Aldrich) was
diluted 1:2000 in PBS-0.1% BSA to a concentration of 0.5 µg/ml. Development of IL-8
and IL-6 ELISA plates was done by adding 3,3’,5,5’-tetramethylbenzidine substrate
(TMB; Thermo Scientific) to the wells and the reaction stopped with 1 M H2SO4.
2.3.4 DNA extraction and preparation for RRBS
DNA was extracted from 5- and 16- month dermal fibroblasts using a 5-Prime
PerfectPureTM Archive DNA Extraction Kit (5 Prime) per manufacturer’s protocol. DNA
concentrations were then determined using a QubitTM 2.0 Spectrofluorometer (Life
Technologies, Carlsbad, CA). DNA was diluted to 40 ng/µl and a total of 2 µg was sent
to Zymo Research (Irvine, CA) for Methyl-MiniSeqTM RRBS library preparation.
Libraries were generated with 200-500 ng of DNA as previously described (Kanzleiter et
al., 2015). Briefly, DNA was sequentially digested with 60 units of TaqαI and 30 units of
MSPI (NEB, Ipswich, MA), which recognizes CCGG as a cut site and cleaves after the
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first cytosine, creating DNA products with CG dinucleotides on both ends of the DNA
and enriching for CG rich regions. Following enzymatic digestion, DNA products were
end-repaired, A-tailed, and extracted with DNA Clean and Concentrator KitTM (Zymo
Research). The extracted DNA was then ligated to methylated Illumina primers using the
Illumina DNA preparation kit and protocol (Illumina, San Diego, CA). Adaptor ligated
DNA was then size selected for desired input fragments (150-250 bp and 250-350 bp)
with a 2.5% NuSieve 3:1 agarose gel and extracted using the ZymocleanTM Gel DNA
Recovery Kit (Zymo Research). Successfully ligated and purified DNA was then bisulfite
converted using the EZ DNA Methylation-LightningTM Kit (Zymo Research). Control
DNA was similarly bisulfite converted to assess conversion rates, which were 99% for all
samples. Following conversion, preparative-scale PCR was performed with a total of 16
cycles and PCR products were purified with the DNA Clean and Concentrator KitTM
(Zymo Research). Individual DNA libraries were then sequenced on the Illumina
HiSeq2000 (Illumina), generating 50 bp paired-end reads and base-calling was performed
using standard Illumina base-calling software.
2.3.5 DNA Sequence Processing and Alignment
Following sequencing, bioinformatics analysis was performed at Zymo
Research using a proprietary analysis pipeline written in Python. Prior to alignment, reads
were assessed for quality using FastQC (v0.11.1, Babraham Bioinformatics, UK) and
Trim Galore (v0.3.7, Babraham Bioinformatics, UK). Bases with a Phred score greater
than 20 were kept for downstream analysis (--paired --phred33 -q 20). Illumina adaptor
trimming was done using Trim Galore with the default settings which are automatically
set to standard Illumina adaptors unless otherwise specified. Trim Galore also contains a
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setting specifically for trimming RRBS data (--rrbs), which was used to further modify
our reads. RRBS introduces artificial CpG sites which require trimming in order to avoid
them being used in methylation calling. To do so, Trim Galore trims the first 2 bases
from the 3’ end of the sequence so the C closest to the second enzyme cut site is not
included in methylation calling. Reads were then mapped to an in-silico bisulfite
converted reference genome (BosTau8/BTau_4.6.1) with the Babraham Bismark
software (v0.13.1, Babraham Bioinformatics, UK) using the
bismark_genome_preparation command, the entire reference genome and with the -non_directional parameter applied. Babraham Bismark is designed for aligning bisulfite
sequencing data while simultaneously making methylation calls. In the process of
bisulfite sequencing, un-methylated cytosines are converted to uracil, while methylated
cytosines are unaffected. The result of this is four sets of potential sequences at any given
locus. To determine which of these four potential sequences is correct, Bismark creates
two bisulfite converted reference genomes, one that is a C
aG

T conversion and one that is

A conversion to account for conversion on the reverse strand. Each sequence read

is also bisulfite converted in silico and is aligned to the pre-converted version of the
reference genome. The best alignment is then identified and used to make a methylation
call. Alignments that are uniquely mapped were kept for analysis. Alignments that
mapped to multiple regions were discarded. Due to enrichment-constraints of RRBS
libraries, duplicates measured as a result of shorter, overlapping paired end inserts were
not removed in the sequence data and were counted as two reads.
On average, mapping efficiencies were 25% and ranged between 23-27% and
the average number of unique CpGs identified were 6.0 million and ranged between 4.8
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and 6.6 million. Differentially methylated CpGs falling within -2.5 kb, +1.0 kb of an
annotated transcription start site (TSS) were defined as being within the promoter region
of a gene. Methylation ratios were used as the comparison parameter to test statistical
differences in DNA methylation and these were defined as the number of reads
overlapping a particular CpG site, which contained either a cytosine or thymine
nucleotide. Ratios were then calculated as Methylation Ratio (Mr) = (C)/(C + T).
2.3.6 Functional Analysis
KEGG (Kyoto Encyclopedia for Genes and Genomes) pathway, GO (Gene
Ontology) and UCSC (University of California Santa Cruz) Transcription Factor Binding
Site (TFBS) analyses were performed using the DAVID (the Database for Annotation,
Visualization, and Integrated Discovery) 6.8 platform (Huang da et al., 2009b, a). Four
lists of official gene IDs (all IDs or promoter only with ≥5X or ≥10X coverage) were
generated for sites located within annotated genes that were hyper-methylated in either
young or old cultures (Additional Files 1 and 2). A suggestive analysis was performed on
all differentially methylated genes with ≥5X coverage and a conserved analysis was
performed with only genes that had ≥10X coverage. Gene IDs from all three gene regions
(exon, intron and promoter) were inputted into DAVID, converted to Entrez gene IDs,
and default parameters were used for KEGG and GO analyses. Only those genes that
were covered by RRBS, either at the 5X or 10X level, were set as the background.
Promoter gene IDs were used in transcription factor enrichment analysis and TFBS
analysis was similarly run with default parameters and Homo sapiens as the background
due to a lack of support for Bos taurus within the UCSC_TFBS tool.
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2.3.7 Gene Expression of Selected Genes
Selected differentially methylated genes and LPS response genes were measured
in all fibroblast cultures exposed to LPS for 0, 2 and 8 hours. RNA was isolated using the
5 Prime PerfectPureTM RNA Cultured Cell Kit (5 Prime) per manufacturer’s instructions
and quantified using a QubitTM 2.0 Fluorometer (Life Technologies, Carlsbad, CA). First
strand cDNA synthesis was done using the ImpromIITM Reverse Transcriptase Kit
(Promega, Madison, WI). To determine gene expression, quantitative reverse
transcriptase PCR (RT-qPCR) was performed using Thermo Scientific™ Maxima™
SYBR™ Green/Fluorescein 2X qPCR Master Mix (Thermo Fisher) on a CFX96
Touch™ Real-Time PCR machine (Biorad, Hercules, CA) on the selected genes. The
gene β-Actin was used as a housekeeping gene control. Cycling conditions were as
follows: 95°C for 2 minutes followed by 40 cycles of 95°C for 15 seconds, 60°C for 1
minute and 72°C for 1 minute after which a melt curve was inserted. All oligonucleotide
primer sequences are shown in Table 2.1. Unless already published primers were
available, all primers were designed using Primer 3 on NCBI. An amplicon of 200 – 300
base pairs was designed and the primer binding site could not contain any known SNP.
Each primer sequence was then analyzed with an NCBI nucleotide BLAST search to
ensure only the intended Bos taurus gene was detected. Melt curve analysis was
performed on each primer pair and included a negative control reaction (no cDNA). Melt
curve analysis revealed only one peak, indicative of a single product, with no peaks
associated with the negative control.
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2.3.8 Statistical Analysis
To assess differences in cytokine protein production, a paired Student’s t test
was performed using GraphPad Prism Version 6.0 for Windows (GraphPad Software, La
Jolla, CA). Differences in DNA methylation at adequately covered (≥5X coverage based
on similar RRBS studies (Pan et al., 2012, Begue et al., 2017)) CpG sites was performed
at Zymo Research and determined using a paired Student’s t test comparing methylation
ratios (i.e. percent methylation of each fibroblast sample) at each site. Since all young
and old cultures were individually sequenced, statistical analysis to determine significant
differences in methylation were determined at a per individual basis taking into account
variation within a sample and comparing each animal’s young sample versus their old
sample. A p-value of <0.05 was applied to assess significance. In addition, a cut-off of at
least 25% difference in methylation was included when assessing gene expression levels
as these regions are much more likely to have an influence on expression.
A clustering dendogram was made according to methylation ratio on the top 100
differentially methylated sites, based on p-value. The clustering analysis was performed
at Zymo Research using a standard data analysis algorithm with a “complete” linkage
method and a “Euclidean Distance” metric. Significance for GO, KEGG and TFBS were
determined by a modified Fisher’s Exact test in DAVID as previously described (Huang
da et al., 2009b) and multiple comparisons correction were done using the BenjaminiHochberg method. Gene expression differences were determined using either a paired
(young vs. old) or unpaired (Angus vs. Holstein) Student’s t test at each time point in
GraphPad. Protein concentrations and delta Ct values are expressed as the mean +/standard error (SEM).
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2.4. Results
2.4.1 Fibroblast Cytokine Response to LPS
Dermal fibroblasts from the same six animals taken at 5 and 16 months of age
were revived from cryopreservation for a total of 12 cultures (6 young vs. 6 old). Cultures
were subsequently stimulated with LPS (100 ng/ml) for 36 hours to determine cytokine
protein concentration in the media. Media from unstimulated cultures was used as a
negative control. Protein concentrations of interleukin-8 (IL-8) are shown in figure 2.1,
panel A. As expected, the 16-month cultures produced significantly more IL-8 (P<0.01)
than the 5-month cultures. At 36 hours, older cultures had an approximately 5-fold higher
concentration of IL-8 than young cultures. No detectable IL-8 was produced in media
only controls. Interleukin-6 (IL-6) was also measured in media post 36-hour LPS
stimulation. In line with IL-8 protein, 16-month cultures produced significantly more IL6 (P<0.01) than 5-month cultures (Figure 2.1, panel B). This difference in older cultures
was about 2.5-fold more IL-6 than young cultures. Again, control media IL-6 levels fell
below detection limits of this assay.
Next, to determine if cytokine gene expression was also different between the
young and old cultures, RT-qPCR was performed on fibroblasts at 0, 2 and 8 hours post
LPS stimulation. In line with protein production, IL8 and IL6 gene expression levels were
upregulated (P<0.01) in old versus young cultures (figure 2.1, panels C and D). Older
fibroblast cultures had a 15.9 and 10.9-fold increase in IL8 gene expression and a 7.3 and
13.4-fold increase in IL6 gene expression over younger cultures at 2 and 8 hours post
LPS stimulation, respectively.
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Cytokine protein and expression analyses confirmed that the older dermal
fibroblast cultures were much more responsive to LPS than younger cultures. Genomic
DNA was then isolated from unstimulated cultures, grown from the same cryopreserved
stock used to assess LPS response, and analyzed by RRBS to determine whether
methylation differences may contribute to differences in the LPS-induced response.
2.4.2 Reduced Representation Bisulfite Sequencing in 5-month and 16-month
Dermal Fibroblasts
As outlined in the RRBS project workflow in figure 2.2, genomic DNA from all
the cultures were treated with a methylation insensitive restriction enzyme MSPI. The
restriction enzyme cuts at CCGG sites, following the first cytosine, yielding CG sites on
both ends of the resulting DNA fragments. This results in enrichment of fragments from
regions in the genomic DNA with many CpG sites, such as CpG islands, that are
typically associated with promoter regions of DNA (Deaton and Bird, 2011). In our
analysis, 65% of annotated promoter regions, defined as -2500 to +1000 bp from the
transcription start site (TSS), had greater than 50X coverage, 8% had less than 50X but
greater than 10X coverage, 4% had less than 10X coverage, and 23% were not
represented.
Following bisulfite conversion, sequencing, and post-sequencing bioinformatics,
a paired T-test was performed on the methylation ratios between young and old cultures
at each sequenced CpG site that met coverage requirements. Methylation analysis
revealed 14,094 differentially methylated CpG sites with P<0.05 and at least 5X
coverage. Of these, 9,351 (67%) were more methylated in young cultures and 4,743
(33%) were more methylated in old cultures. Clustering analysis was performed on the
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top 100 differentially methylated sites (i.e. sites with the greatest significant difference in
methylation ratios). The old cultures and young cultures clustered separately, indicating
that two distinct methylation profiles exist, where young cultures form one profile and
old cultures form a second (Additional File 3).
2.4.3 Suggestive Analysis of Differentially Methylated Genes
Next, we performed a comprehensive, but suggestive functional analysis of all
the sites that fell within gene regions and had ≥5X coverage. Of the 9,351 sites more
methylated in young cultures, 752 regions were located in annotated promoters, 720 in
gene exons, and 1926 in gene introns. Of the 4,743 sites more methylated in old cultures,
365 were located in annotated promoters, 337 in gene exons, and 965 in gene introns.
Sites that fell within annotated genes were used to generate lists of gene IDs with greater
methylation in either young or old cultures and functional analysis was performed using
DAVID. KEGG pathway analysis on genes more methylated in young cultures identified
5 significantly enriched pathways. These included the “Adherens Junction”,
“Proteoglycans in Cancer”, “Rap1 Signaling Pathway”, “Pathways in Cancer” and
“Melanogenesis”. It is worth noting that the “PI3K-Akt Signaling Pathway” was also
enriched with P=0.06 after multiple comparisons correction. In older cultures, 16
pathways were significantly enriched, with the “Cholinergic Synapse” pathway as the top
result. A number of secretory pathways and hormone synthesis pathways were also
significantly enriched. Among the 16 pathways, those that were of most interest to the
current study were the “Calcium Signaling Pathway”, “Inflammatory Mediator
Regulation of TRP Channels” and “cAMP Signaling Pathway”. Among the top
significantly enriched GO terms in genes with greater methylation in young cultures were
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“Transcription Repressor Activity”, “Sequence Specific DNA Binding”, and “RNA
Polymerase II Regulatory Region Sequence-Specific DNA Binding”. Interestingly, in
older cultures, only one GO term, “Plasma Membrane” was significant and, in contrast to
young cultures, lacked terms related to regulation of gene transcription.
Using the annotated genes from only the promoter sites with greater methylation
in either young or old cultures, a transcription factor enrichment analysis was performed
using DAVID and Homo sapiens as the background species, because Bos taurus is not
yet supported in the UCSC_TFBS function. Table 2.2 shows the top 15 most significantly
enriched transcription factors that regulate the inputted gene promoters more methylated
in young cultures and Table 2.3 shows transcription factors enriched in gene promoters
more methylated in old cultures. A number of transcription factors associated with
immune system regulation and the inflammatory response were associated with
promoters more methylated in both young and old cultures. Most noteworthy in young
cultures was greater methylation in NF-κB associated genes. Also, significantly more
methylated in young cultures were genes regulated by PAX5 (also known as B-cell
activating protein), and CREB (cAMP-regulated binding protein), a phosphorylation
responsive transcription factor that binds to cAMP responsive elements.
In old cultures, PAX5 was similarly enriched along with SP.1, p300 (a CREB
co-activator), and ATF or activating transcription factors, which are diverse members of
the ATF/CREB family of transcription factors with a range of physiological functions.
2.4.4 Conserved Analysis of Differentially Methylated Genes
In a second, conserved analysis we focused solely on sites with ≥10X coverage,
which is the minimum coverage that is necessary to accurately determine differentially
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methylated sites in an RRBS analysis. The additional filtering left 2,865 differentially
methylated sites. Of these, 1,922 were more methylated in young cultures and 943 were
more methylated in old cultures. In young cultures, 134 gene promoters, 98 exons, and
354 introns were hyper-methylated, and in old cultures only 42 gene promoters, 45 exons,
and 150 introns were hyper-methylated in comparison to young cultures. The genes
associated with these regions were used to conduct a conserved GO, KEGG and TFBS
analysis. Interestingly, with the additional filtering we found no significant GO terms
associated with either young or old cultures, although “Semaphorin Receptor Activity”
trended (P<0.10) towards significance in old cultures. Two KEGG pathways, “Adherens
Junction” and “Proteoglycans in Cancer” remained significantly associated with young
cultures and no KEGG pathways were found to be associated with old cultures. Finally,
21 transcription factors were identified as significantly enriched in hyper-methylated
promoter regions in young cultures, the top 10 of which are listed in table 2.4. We did not
identify any transcription factors enriched in our assessment of hyper-methylated
promoters in old cultures. Many of the transcription factors that were identified in the
suggestive analysis in young cultures remained significant, including PAX5 and most
notably, NF-κB that was found to be associated with 56 out of 134 gene promoters more
methylated in young cultures.
2.4.5 Fibroblast Gene Expression of Differentially Methylated Genes
Selected differentially methylated genes were analyzed by RT-qPCR to
determine whether changes in methylation resulted in differences in gene expression. The
rationale for choosing the analyzed genes was that there was a greater than 25%
methylation difference in at least one region in young versus old cultures, the sites had on
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average greater than 10X coverage across the 12 animals, methylation was greater in
young versus old cultures and, there was some evidence in the literature that the genes are
involved in immune response regulation. The six selected genes, and number and location
of differentially methylated regions, are listed in Table 2.5, along with a summary of
expression differences.
Gene expression analysis of the LPS responsiveness of the six selected genes
hyper-methylated in young versus old cultures is shown in Figure 2.3. Overall, 5 of the 6
selected genes showed a reduced expression in cultures established from the animals at 5
vs. 16 months of age. Two of the 6 genes, FES and PIK3R1, had reduced expression in
the younger cultures at all 3 time points, with a 5.7, 4.3, and 6.3-fold (P<0.01) lower
expression in FES and 3.0, 2.6, and 2.5-fold (P<0.01) lower expression in PIK3R1 at 0, 2,
and 8 hours post LPS stimulation, respectively. Both genes had differentially methylated
sites located in the promoter region, a single site located 23 base pairs upstream from the
transcription start site (TSS) of PIK3R1 and two sites, 4 and 6 base pairs, downstream of
the TSS in FES. Additionally, FES had two differentially methylated sites located within
exon regions and, PIK3R1 had one site located within the first intron of the gene.
Expression of these genes was not affected by LPS stimulation.
A gene that encodes a TNF superfamily member ligand, TNFSF13 also known
as APRIL, also showed significantly lower expression in young cultures at 0 and 8 hours
post LPS stimulation (2.0 and 2.8-fold, P<0.05), with a trend towards significantly lower
expression at 2 hours (1.6-fold, P<0.10), but was not affected by LPS stimulation.
TNFSF13 had one differentially methylated site in the gene promoter region, 145 bases
upstream from the TSS in the anti-sense position and directly downstream from a site on
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the positive strand with 93% sequence similarity to the consensus NF-κB binding site.
The gene, NFATC1, which encodes an LPS responsive transcription factor, had
significantly lower expression in young versus old cultures at 0 and 2 hours post LPS
stimulation, with both time points showing a 1.8-fold (P<0.05) lower expression in young
cultures. Expression of NFATc1 also increased 17.5 +/- 5.6-fold 2 hours post LPS
stimulation, with no difference in fold change between young and old cultures. By 8
hours post-challenge, expression returned to near basal levels. The NFATC1 gene had one
differentially methylated site located within a CpG island in the promoter region,
approximately 1000 bp upstream from the TSS and downstream of a potential Sp1
binding site. Two additional differentially methylated sites were located within the last
intron of the NFATC1 gene.
The only selected gene that did not have differences in promoter methylation,
RORA, had 6 differentially methylated sites located in the first intron of the gene. Gene
expression analysis showed significantly lower levels of expression in young versus old
cultures at 8 hours post LPS treatment (2.1-fold, P<0.001) with no change in response to
LPS. Finally, we measured TCF7, the gene that transcribes the transcription factor
TCF7, that had 2 differentially methylated sites located within a CpG island in the
promoter region. The first CpG was located approximately 1200 bp upstream from the
TSS and near to a potential NFAT5 binding site, and the second CpG was approximately
979 bp upstream from the TSS on the anti-sense strand. Interestingly, no significant
expression differences were detected in young versus old cultures. However, there was a
small increase in gene expression of TCF7 in response to LPS. Expression was increased

48

2.3 +/- 0.7-fold and 2.7 +/- 0.9-fold at 2 and 8 hours, respectively, with no difference
between young and old cultures.
2.4.6 Gene Expression of Differentially Methylated Genes in Angus vs. Holstein
Fibroblast Cultures
Finally, we wanted to determine whether differentially methylated genes
identified in young versus old cultures would differ in expression in a second high vs.
low LPS responsive cattle phenotype recently discovered in our laboratory. Just as with
the age difference, we have shown that dermal fibroblasts collected from the Holstein
breed are much more responsive to LPS than fibroblasts collected from the Angus breed
(Benjamin et al., 2016a). To determine whether similar gene expression differences could
be detected between breeds, RT-qPCR was performed on age-matched dermal fibroblast
cultures at 0, 2 and 8 hours post-LPS treatment. Greater LPS-induced IL-8 and IL-6
protein production and gene expression in Holstein vs. Angus cultures have been
described elsewhere (Benjamin et al., 2016a).
Gene expression analysis was performed on the same 6 genes that were
differentially methylated in the young versus old fibroblast cultures, where young
cultures had greater methylation and, with the exception of TCF7, lower expression. As
shown in figure 2.4 and summarized in Table 2.5, the majority of the genes were
similarly upregulated in Holstein cultures as they were in older cultures. Two notable
exceptions to the pattern seen in our young versus old analysis were in TNFSF13, where
no difference was measured in Angus versus Holstein cultures, and in TCF7, which was
upregulated in Holstein cultures at 0 and 8 hours post LPS treatment. Under basal
conditions, Holstein cultures expressed TCF7 4.5-fold (P<0.01) higher than Angus
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cultures and at 8 hours post LPS TCF7 expression was 4.3-fold (P<0.05) higher in
Holstein cultures. Interestingly, at 2 hours post LPS treatment, Angus cultures increased
TCF7 gene expression 5-fold, while Holstein cultures only increased expression 2-fold.
This fold increase at 2 hours was significantly higher in Angus cultures (P<0.05) as
compared to Holstein cultures, although Holstein cultures did have a significantly
(P<0.05) higher level of expression at 2 versus 0 hours. While Holstein cultures
continued to maintain elevated expression of TCF7, Angus cultures had started to return
to basal levels of expression at 8 hours post LPS, although expression was still
significantly higher (P<0.05) than without treatment.
Similar to old cultures, Holstein cultures had significantly (P<0.05) higher
expression of FES at 0 and 2 hours post LPS treatment, with expression levels being 3.7
and 5.4-fold higher, respectively, and a trend (4.8-fold, P<0.10) towards higher
expression in Holstein cultures at 8 hours post LPS. PIK3R1 also had higher levels of
expression (P<0.01) 2 hours post-LPS treatment in Holstein cultures. This difference was
due to a significant (P<0.01) 4-fold decrease in PIK3R1 gene expression in Angus
cultures that was not detected in Holstein cultures. By 8 hours post LPS treatment,
PIK3R1 expression returned to near-basal levels in Angus cultures.
Most noteworthy was the gene NFATC1, which showed a very similar gene
expression pattern between breeds as was seen in the age difference. Both Angus and
Holstein cultures significantly increased their expression of NFATc1 at 2 hours post LPS
treatment (30-fold and 12-fold respectively), with Holstein cultures having a 6.5-fold
higher (P<0.01) level of expression over Angus cultures at 2 hours post LPS. Holstein
cultures also trended towards greater expression (2.2 and 1.7-fold, P<0.10) at 0 and 8
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hours post-LPS. By 8 hours post LPS, both breeds returned to basal levels of expression.
Finally, RORA had higher (P<0.01) levels of expression in Holstein cultures at 0 and 2
hours post LPS treatment. At 0 hour, Holstein cultures had a 2.2-fold higher level of
expression and at 2 hours they had a 2.0-fold higher level of expression. No LPS
treatment effect was detected.
2.5. Discussion
An increase in the systemic production of pro-inflammatory mediators has been
well characterized as a component of the aging process, heightening the risk of
cardiovascular, neurodegenerative and other diseases in humans. This process, coined by
Franceschi et al.,(Franceschi et al., 2000) as “inflamm-aging”, is highlighted by increased
concentrations of serum TNF-α, IL1-ß and IL-6 along with acute phase proteins, such as
C reactive protein (Franceschi et al., 2000, Baylis et al., 2013). To determine the potential
mechanism behind an increase in chronic inflammation associated with age, both in
healthy aging individuals and during the diseased state, regulation of pro-inflammatory
gene expression by DNA methylation has been widely studied.
A substantial decrease in methylation at a single CpG site in the promoter of the
IL6 gene was measured in patients with rheumatoid arthritis versus healthy controls. In
the same study, ranking of healthy control macrophages in response to LPS showed that
an increase in LPS-induced IL-6 production was correlated with a decrease in IL6
promoter methylation (Nile et al., 2008). Epigenetic regulation of another pleiotropic proinflammatory cytokine gene, TNF, has been similarly described. In comparison to healthy
controls, patients with previous exposure to the Dengue virus have higher blood TNF-α
expression with a concomitant decrease in promoter methylation (Gomes et al., 2016).
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DNA methylation changes have also been reported to occur in TNF in humans as part of
the natural aging process. Macrophages obtained from 78 healthy individuals showed a
1.4% per decade decrease in three 5’ CpG motifs located within the TNF promoter
(Gowers et al., 2011). Increased methylation of TLR4, the key TLR in response to LPS,
has also been shown in the context of intestinal epithelial homeostasis, whereby intestinal
epithelial cells are made tolerant to stimulation by commensal microbiota through downregulation of TLR4 to avoid continuous inflammation (Takahashi et al., 2009). In that
study, a comparison between a high responding and a low responding intestinal epithelial
cell line showed that the lower responding cells not only exhibit decreased expression but
also enhanced methylation in 11 CpG sites in the gene promoter of the TLR4 gene.
Furthermore, inhibition of DNA methylation with AZA treatment in these two cell lines
abolished the difference in TLR4 expression, further establishing a causal role for DNA
methylation in the regulation of TLR4 (Takahashi et al., 2009).
Research on epigenetic regulation of the immune response in livestock species
has been somewhat more limited. However, it has been shown that in response to LPS
treatment, bovine PBMCs decrease expression of methylation and histone deacetylation
enzymes, suggesting LPS treatment may result in lower gene methylation and increased
histone acetylation (Doherty et al., 2013). The effects of Mycobacterium bovis infection
on global DNA methylation and gene expression have also been reported in bovine CD4+
T-cells, whereby, DNA methylation was negatively correlated with expression of
interferon-γ (IFNG) and a gene that encodes the OX-40 receptor (TNFRSF4). The two
genes, IFNG and TNFRSF4, are involved in T-cell response and proliferation,
respectively, and provide one potential mechanism that contributes to the shift from Th1
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to Th2 T-cell response following bovine tuberculosis infection (Doherty et al., 2016).
Epigenetic mechanisms have also been shown to play a role in the hepatic expression of
TLR4, lipopolysaccharide binding protein (LBP) and haptoglobin in response to E. coli
mastitis. Chromatin de-compaction and increased expression of key innate response
genes, LBP, HP, TLR2 and TLR4 occurs in liver biopsies following an intra-mammary
challenge with E. coli. In TLR4, the chromatin changes are also correlated with promoter
de-methylation (Chang et al., 2015a). In a similar study that assessed the effects of
feeding a high concentrate diet to induce sub-acute ruminal acidosis (SARA), chromatin
de-compaction and expression of these innate response genes was again increased in liver
biopsies with subsequent DNA de-methylation seen in all four genes. Presumably, these
changes were a result of greater concentrations of LPS found in the rumen, and hepatic
and portal veins of cows experiencing SARA (Chang et al., 2015b).
To elucidate the underlying causes of differences in innate response to mastitis
causing pathogens, we have taken advantage of two phenotypes with clear response
differences, age and breed, where fibroblasts from older versus younger animals (Green
et al., 2015), and Holstein versus Angus animals (Benjamin et al., 2016a), have much
higher in vitro responses. The age-dependent difference in response has also been shown
to be at least partially mediated by epigenetic mechanisms. Inhibition of DNA
methylation and histone deacetylation in fibroblasts isolated from the same animal at 5and 16-months of age abolishes differences in in vitro cytokine production, suggesting
methylation, chromatin modifications, or both contribute to the age-dependent increase in
response (Green and Kerr, 2014). To determine which genes are regulated by DNA
methylation, methylated CpG island recovery assay or MIRA-seq, was previously
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performed on both the age and breed phenotypes following RNA-seq analysis.
Unfortunately, this technique, which utilizes the protein complex MBD2b-MBD3L1
complex to enrich for methylated regions within the genome, has only moderate
resolution (~500 bp), and few differences were detected in both phenotypes that fell
within gene regions, while none of these differences were detected in regions with a role
in the innate response. Since it is known that small changes in methylation can be
effective in changing gene expression, it was necessary to utilize a more sensitive
technique, such as was performed in the current study.
2.5.1 Methylation Differences in 5- versus 16-month Dermal Fibroblasts
Reduced representation bisulfite sequencing was performed on fibroblasts taken
from 5- and 16-month old heifers that had significantly different IL-8 and IL-6 protein
production and gene expression. This analysis revealed 14,094 differentially methylated
CpG sites. Approximately two-thirds of these sites were more methylated in younger
cultures, consistent with previous data suggesting global hypo-methylation in older
individuals (Bacalini et al., 2014, Marttila et al., 2015). The transcription factor, NF-κB,
which is a major activator of pro-inflammatory gene expression downstream of a number
of pattern recognition receptors and TNF-associated receptors (van Delft et al., 2015),
was identified as significantly associated with hyper-methylated promoter regions in
young cultures. This suggests that increased methylation in young cultures may block
NF-κB binding sites, reducing transcription of pro-inflammatory genes. Blocking of NFκB gene transcription by DNA methylation has been shown to occur in patients with
secondary acute myeloid leukemia (sAML), where hematopoietic progenitor cells fail to
express Fas receptor, an activator of apoptosis. The FAS gene was shown to contain 3
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canonical NF-κB binding sites and increased methylation in bone marrow blast cells from
patients with sAML as compared to those with low-risk myelodysplastic syndrome
whose Fas expression remains intact. In addition, re-expression of Fas occurred in sAML
patients upon de-methylation with AZA (Ettou et al., 2013). Although only identified in
our suggestive (≥5X coverage) analysis, the transcription factor, cAMP regulated binding
protein (CREB), was also associated with gene promoters more methylated in young
cultures. Downstream of a wide variety of serine-threonine kinases (such as PKA, PKC,
and p38 MAPK) CREB regulates a multitude of processes, including the innate immune
response (Wen et al., 2010). Recently, CREB has been shown to mediate TNF-α
dependent GM-CSF production in primary asthmatic lung fibroblasts and human fetal
lung fibroblasts (Koga et al., 2016). CREB also increases LPS and TLR4 dependent IL-6
production in vascular smooth muscle cells which may contribute to the vascular
inflammation seen in atherosclerosis (Lee et al., 2016).
In older cultures, transcription factor binding sites for Sp1, p300, and ATF were
enriched in hyper-methylated genes. Numerous genes contain Sp1 binding sites, which
are located in GC-rich regions often regulated by DNA methylation. Somewhat
contradictory to our hypothesis, Sp1 does up-regulate expression of some innate response
genes. In intestinal epithelial cells, basal expression of TLR5 is regulated by Sp1.
Interestingly, inducible expression of TLR5 is also partially mediated by p300, in
agreement with our results that both Sp1 and p300 regulated genes were hypermethylated in older cultures (Thakur et al., 2016). Alternatively, in response to LPS, Sp1
enhances macrophage transcription of IL-10, a key anti-inflammatory cytokine (Wang et
al., 2014). ATFs are members of the activating transcription factor/cAMP responsive
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element binding protein (ATF/CREB) family of transcription factors. It was not clear
with DAVID analysis which of the family members were enriched in regulation of the
genes more methylated in older cultures, however, analysis of just the 106 genes
regulated by ATF showed that 62 were regulated by ATF6. ATF6 is a key transcription
factor that is activated under ER stress and mediates the unfolded protein response.
Again, contrary to our data, ER stress contributes to inflammation during an infection
with Brucella abortis in a NOD1/NOD2 dependent manner, and the unfolded protein
response has been shown to strengthen NF-κB dependent inflammation (Mohammed-Ali
et al., 2015, Keestra-Gounder et al., 2016). However, other ATFs, such as ATF3, have
been shown to have the opposite effect and reduce inflammatory gene expression (Labzin
et al., 2015). Furthermore, when additional stringency was applied to the TFBS analysis
to include only genes that contained differentially methylated sites with ≥10X coverage,
we failed to identify any transcription factors associated with genes hyper-methylated in
old cultures, unlike what was found in young cultures. An additional caveat to the
transcription factor binding data used in the current study is that conclusions were drawn
on sequence conservation found between human and rodent alignments. Sequence
conservation does not necessarily result in transcription factor binding and regulation and
whether enrichment of the identified transcription factors regulate cellular response
differences to LPS in a methylation-dependent manner would need to be validated in our
model.
2.5.2 Gene Expression Analysis of Differentially Methylated Genes
Methylation of DNA is most known for its role in repressing gene transcription.
To determine if the measured methylation differences had any effect on gene expression,
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we chose six genes that exhibited higher methylation in young cultures for RT-qPCR
analysis. We hypothesized these six genes would have lower expression in the young
cultures due to their increased methylation status. We chose the following six genes for
their potential role in the innate response: TNFSF13, PIK3R1, NFATC1, FES, TCF7 and
RORA. The TNF superfamily 13, or APRIL, protein is a surface or secreted ligand
recognized by the transmembrane activator and calcium-modulating cyclophilin ligand
interactor (TACI) and B-cell maturation antigen (BCMA) receptors and has been
implicated in the pathogenesis of numerous pro-inflammatory conditions such as
rheumatoid arthritis (Weldon et al., 2015), atherosclerosis (Sandberg et al., 2009), lupus
(Salazar-Camarena et al., 2016) and psioriasis (Alexaki et al., 2012). Moreover, APRIL
has been shown to activate NF-κB dependent cytokine production in macrophages (Lee et
al., 2011) and keratinocytes (Alexaki et al., 2012). In our analysis, fibroblast expression
was significantly up-regulated in older cultures at 0 and 8 hours post LPS treatment as we
expected. The single site hyper-methylated in young cultures was located near to the
consensus NF-κB binding sequence, 5′-GGGRNYY YCC-3′. However, since expression
of the gene did not increase after LPS treatment and was already up-regulated under basal
conditions, it is unlikely NF-κB regulates its transcription in response to LPS.
The gene, PIK3R1, transcribes the p85α subunit of phosphoinositide 3-kinase
(PI3K), a lipid kinase that phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP2)
to phosphatidylinositol 3,4,5-trisphosphate (PIP3). The p85α subunit is a regulator of
kinase activity, whereby it is thought to inhibit PI3K activity under most circumstances
(Cheung et al., 2015). Interestingly, in a murine model of polymicrobial sepsis, inhibition
of the PI3K pathway increased serum IL1-β, IL-6 and TNF-α levels, and decreased the
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survival rate of septic mice (Williams et al., 2004). Alternatively, pharmacological
activators of PI3K signaling have recently been suggested as anti-inflammatory drug
candidates (Kok and Saez, 2014). However, the role of PI3K in inflammation is complex,
since kinase activity can also activate leukocytes and is further complicated by the
existence of multiple isoforms of PI3K with a variety of physiological functions
(Hawkins and Stephens, 2015). In our model, PIK3R1 expression was up-regulated in
older cultures at all 3 time points post LPS with a fairly consistent fold change of 2.5 –
3.0-fold. A single CpG site in the promoter region was more highly methylated, only 23
base pairs from start site of the gene, potentially interfering with the progression of the
RNA polymerase enzyme complex.
Nuclear factor of activated T-cells, calcineurin dependent 1 (NFATc1), the gene
product of NFATC1, is a calcium dependent transcription factor that is necessary for
lymphocyte development and is expressed in a number of other cell types such as
dendritic cells (Zanoni et al., 2009), macrophages (Yarilina et al., 2011) and endothelial
cells (Suehiro et al., 2010), and is responsible for mediating TLR4 independent, CD14
dependent pro-inflammatory gene expression in response to microbial agonists, such as
LPS. Interestingly, the NFATC1 gene is less methylated and more expressed in
individuals with lower socioeconomic status which is a known risk factor for increased
inflammation that can lead to pathologies such as type II diabetes (Stringhini et al., 2015,
Stringhini et al., 2016). In our study, NFATc1 was induced following LPS stimulation in
both young and old fibroblasts, further solidifying its role as an LPS-responsive
transcription factor. In the promoter, the differentially methylated CpG was located
directly downstream of a Sp1 binding site that has been shown in numerous recent studies
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to bind at lower levels with increased DNA methylation status (Gopisetty et al., 2013,
Zhang et al., 2014, Cai et al., 2016). In addition, two other sites were located in the last
intron of the gene. This is of interest because an enhancer element within the last intron
of the NFATc1 gene that activates transcription to an even greater extent than the
promoter region of the gene has been identified using human lymphocytes (Rudolf et al.,
2014).
Feline sarcoma oncogene (FES) is a non-receptor tyrosine kinase that, in
humans, stimulates hematopoiesis, osteoclastogenesis, and mast cell activation (Hellwig
et al., 2012). It is worth mentioning that both FES and PI3K activate mast cells through a
similar SCF-c-Kit-integrin pathway, and the two proteins have been speculated to interact
with one another through tyrosine phosphorylation of PI3K by FES (Tan et al., 2003,
Smith et al., 2010). As with PIK3R1, FES kinase expression was also similarly upregulated at all time points in older cultures while younger cultures had two hypermethylated sites near to the transcriptional start site which again may interfere with
transcriptional elongation by RNA polymerase.
Transcription factor 7 (TCF7), transcribed from the gene TCF7, is a
transcription factor that is crucial to the proper development of T-cells in the thymus, but
has been shown to inhibit the development of regulatory T-cells, or Tregs, which
suppress inflammation and aid in the resolution of infection (Barra et al., 2015). Although
several methylation differences were detected within the promoter region of TCF7, no
difference in expression was measured in fibroblasts either basally or post LPS. There are
a couple of possible explanations for this discrepancy. Methylation itself may not be
sufficient to repress expression and it is likely an over-simplification to assume
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methylation always leads to repression. For example, in a study assessing the relationship
between methylation and gene transcription in the blood of 148 healthy human subjects,
the authors found that 276 of 798 local associations were actually positively associated,
where less methylation led to less transcription or more methylation led to more
transcription (van Eijk et al., 2012). Other factors, such as histone modifications and
transcription factors that also have an effect on transcription should be taken into
consideration as they can override any differences in methylation as has been shown in
the differentially imprinted gene IGF2R (Vu et al., 2004). Lastly, it is possible that splice
variants of TCF7 exist that exhibit differential expression in our samples but were not
measured in our RT-qPCR analysis.
Finally, RORA, or retinoic acid related (RAR) orphan receptor alpha, belongs to
a family of nuclear receptor transcription factors (RORs) that have known roles in the
innate and adaptive immune response, circadian rhythm, and metabolic regulation,
among others (Cook et al., 2015). Specifically, RORA is required for the development of
type II innate lymphoid cells and mice lacking the gene experience reduced eosinophilmediated lung inflammation in response to allergens (Halim et al., 2012) and are less
susceptible to obesity induced inflammation in response to a high fat diet (Kang et al.,
2011). We detected a small, but significant increase in RORA expression in older
fibroblasts at 8-hours post LPS. In this case, we identified 6 methylation differences all
within first intron of the gene, which can contain enhancer elements for gene activation
(Blattler et al., 2014).
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2.5.3 Expression of Differentially Methylated Genes in Angus versus Holstein
Fibroblasts
In our final experiment, we wanted to determine whether similar expression
differences could be detected in another high-low response phenotype, a breed difference
identified in our lab that shows the Holstein breed having a much higher in vitro response
as compared to the Angus breed (Benjamin et al., 2016a). Genes similarly up-regulated in
Holsteins might suggest a conserved mechanism of regulation, such as DNA methylation
or other epigenetic modifications. This of particular interest in the breed difference as
these two breeds are not only genetically selected for divergent purposes but also
experience highly dissimilar neonatal environments, leaving room for possible
environmental interventions. Many studies have shown that neonatal nutrition, maternal
care, and exposure to immune agonists can shape an individual’s adult epi-genotype, and
all three of these environmental influences differ between Holstein and Angus calves.
Angus calves are maternally cared for in a pasture setting, drink milk from their dam, and
are exposed to a variety of maternally-derived commensal and environmental microbes in
contrast to Holstein calves that are raised individually without maternal contact, fed milk
replacer, and are housed in a considerably more defined environment.
Expression analysis of fibroblasts isolated from the two breeds showed some
similar differences to our age-dependent differences. In the high responding Holstein
breed, FES, NFATC1, RORA, and to a lesser extent PIK3R1, were up-regulated.
Additionally, TCF7 was up-regulated, a difference not detected in the young-old culture
comparison. This discrepancy may indicate a genetic difference as a result of selection
for different traits (beef versus dairy) between Angus and Holstein breeds. No difference
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was measured in TNFSF13, suggesting the loss of methylation is unique to the aging
process. Most noteworthy of the differentially expressed genes were FES and NFATC1.
These two genes showed an identical pattern of up-regulation in Holstein cells as was
seen in older cells, indicating they may be similarly regulated. However, additional
experiments with the Holstein and Angus cultures would be necessary to confirm whether
expression differences are due to differences in methylation or other epigenetic factors,
genetic differences, or a combination of factors. Expression of FES is up-regulated
basally in both high response phenotypes, making it a candidate biomarker for selection
strategies, which would require a rapid test without the need of culturing cells and
treating with LPS. Additionally, NFATC1 is of interest due to its role in the response to
LPS and as a known contributor to many pro-inflammatory pathologies. Future studies
assessing methylation differences in Angus and Holstein breeds are underway and should
provide insight into how this phenotype is regulated.
One limitation of the current study was that the RRBS technique does not allow
for a comprehensive methylation analysis and as a result many CpG sites are missed.
This may be one reason why we failed to identify methylation differences in classic LPS
response genes that show similar up-regulation of expression in both high responding
phenotypes. Targeted bisulfite sequencing of candidate genes, such as TLR4 and IL8, will
be the subject of future experiments to determine whether methylation may influence
expression of genes that directly mediate LPS response.
2.6. Conclusions
Overall, the current study has shown that many sites differ in their methylation
status in young versus old cultures, with the majority of sites becoming less methylated
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as the animals increased in age. Candidate innate response genes that were hypermethylated in young cultures also exhibited lower expression in most instances,
indicating methylation may suppress expression in younger cultures making them less
responsive to TLR agonists, such as LPS. Expression analysis in a second high-low
response phenotype, Angus versus Holstein fibroblasts, identified two genes (FES and
NFATC1) that showed an identical response pattern as the young and old cultures. These
two genes may be useful as candidate biomarkers for predicting whether an animal will
have a high or low response phenotype, and subsequently, whether she is susceptible to
severe mastitis. In conclusion, knowledge of critical changes in methylation that
increases the magnitude of inflammatory response within an individual may allude to the
mechanisms of between-individual variation in the innate response. This is particularly
important in diseases where an unregulated innate response contributes to the pathology
of the disease, such is the case in bovine mastitis.
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Table 2.1: Real Time PCR Primers.
Gene Name

Sequence 5’ to 3’

Reference

β-Actin

F: GCAAATGCTTCTAGGCGGACT
R: CAATCTCATCTCGTTTTCTGCG
F: GTCTCAGACAAGTCCCCGTG
R: AGTCTGAACACAGCGTCAGG
F: TGAGGGAAATCAGGAAAATGT
R: CAGTGTTTGTGGCTGGAGTG
F: GCTGGCTGTTGCTCTCTTG
R:
AGGTGTGGAATGTGTTTTTATGC
F: GTCCGACGTCAAGCGGTAG
R: TTGACCGTTACGGGAATGGG

(Pareek et
al., 2005)
Designed
in house
(Pareek et
al., 2005)
(Pareek et
al., 2005)
Designed
in house

F: TCATTCCGGTAGCCGTTTCC
R: CTCAGAACTTGCTGCTGGGA

Designed
in house

F: ATAACATCTCGGCCAACGGG
R: GGAAGAAGCCTGATGCTGGT
F: GAGCCAAAGTCATTGCGGAG
R:
TCTTTTTCCTCCTGAGTTGGATTC
F: AGAAGCGCTCAGTTCTGCAT
R: CTGTTGTAGGCCCAGTCAGG

Designed
in house
Designed
in house

Feline Sarcoma Oncogene
(FES)
Interleukin 6 (IL6)
Interleukin 8 (IL8)

Nuclear factor of activated Tcells calcineurin dependent 1
(NFATc1)
Phosphatidylinositol 3-kinase
regulatory subunit alpha
(PIK3R1)
RAR-Related Orphan
Receptor A (RORA)
Transcription factor 7 (T-cell
specific, HMG-box) (TCF7)
Tumor Necrosis Factor Super
Family 13 (TNFSF13)
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Designed
in house

Table 2.1: Suggestive Transcription Factor Enrichment of Gene Promoters More
Methylated in Young Cultures.
Category
Term
Count* Fold Enrichment**
FDR***
UCSC_TFBS PAX5

288

1.32

4.35E-09

UCSC_TFBS LMO2COM

297

1.31

6.04E-09

UCSC_TFBS P53

321

1.25

2.23E-08

UCSC_TFBS EGR3

111

1.77

5.34E-08

UCSC_TFBS AP2

148

1.57

1.04E-07

UCSC_TFBS NMYC

174

1.48

1.57E-07

UCSC_TFBS ARNT

243

1.33

2.26E-07

UCSC_TFBS NRSF

265

1.29

3.42E-07

UCSC_TFBS MYCMAX

302

1.23

8.19E-07

UCSC_TFBS NFKB

246

1.30

1.43E-06

UCSC_TFBS AHRARNT

259

1.28

1.49E-06

UCSC_TFBS CREB

218

1.33

1.79E-06

UCSC_TFBS E47

290

1.23

2.99E-06

UCSC_TFBS COUP

209

1.33

5.73E-06

UCSC_TFBS TAXCREB

262

1.25

6.31E-06

*Number of inputted genes regulated by transcription factor listed.
**Fold enrichment as measured by Fisher’s Exact Test.
***Benjamini-Hochberg False Discovery Rate.
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Table 2.2: Suggestive Transcription Factor Enrichment of Gene Promoters More
Methylated in Old Cultures.
Category

Term

Count*

Fold Enrichment**

FDR***

UCSC_TFBS PAX5

187

1.43

8.40E-10

UCSC_TFBS SP1

95

1.73

1.66E-06

UCSC_TFBS ATF

113

1.58

3.02E-06

UCSC_TFBS NRSF

165

1.35

9.59E-06

UCSC_TFBS MIF1

136

1.43

1.06E-05

UCSC_TFBS P300

124

1.47

1.09E-05

UCSC_TFBS ZID

150

1.38

1.14E-05

UCSC_TFBS SREBP1

178

1.28

4.10E-05

UCSC_TFBS MYOGNF1

145

1.35

6.27E-05

UCSC_TFBS TAXCREB

162

1.30

8.37E-05

UCSC_TFBS ZIC3

123

1.41

8.80E-05

UCSC_TFBS MZF1

147

1.33

9.46E-05

UCSC_TFBS AHRARNT

158

1.31

9.57E-05

UCSC_TFBS HMX1

139

1.34

1.39E-04

UCSC_TFBS TAL1BETAITF2 158

1.29

1.50E-04

*Number of inputted genes regulated by transcription factor listed.
**Fold enrichment as measured by Fisher’s Exact Test.
***Benjamini-Hochberg False Discovery Rate.
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Table 2.3: Conserved Transcription Factor Enrichment of Gene Promoters More
Methylated in Young Cultures.
Category

Term

Count*

Fold Enrichment**

FDR***

49

1.67

0.007

UCSC_TFBS TAL1BETAITF2 60
UCSC_TFBS CDC5
52

1.40

0.024

1.46

0.027

UCSC_TFBS ROAZ

1.44

0.027

UCSC_TFBS P300

52

UCSC_TFBS P53

69

1.29

0.028

UCSC_TFBS COUP

48

1.46

0.031

UCSC_TFBS NFKB

56

1.42

0.032

UCSC_TFBS EGR3

25

1.92

0.032

UCSC_TFBS AP2

35

1.78

0.032

UCSC_TFBS AP2GAMMA

18

2.19

0.040

*Number of inputted genes regulated by transcription factor listed.
**Fold enrichment as measured by Fisher’s Exact Test.
***Benjamini-Hochberg False Discovery Rate.
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Table 2.4: Summary of Selected Innate Response Genes Hyper-Methylated in
Young Cultures.

Gene
Name

Number of
Differentially
Methylated
Sites*

Location of
Differentially
Methylated
Sites

Expression
(Old>Young)
at 0, 2 & 8 H
post LPS**

Expression
(Holstein>Angus)
at 0, 2, & 8 H
post LPS**

FES

2

Promoter,
Exon

5.7, 4.3, 6.3

3.7, 5.4, 4.8

NFATc1

3

Promoter,
Intron

1.8, 1.8, ---

2.2, 6.5, 1.7

PIK3R1

2

Promoter,
Intron

3.0, 2.6, 2.5

---, 2.4, (-1.9)

RORA

5

Intron

---, ---, 2.1

2.0, 2.2, ---

TNFSF13

1

Promoter

2.0, 1.6, 2.8

---, ---, ---

TCF7

2

Promoter

---, ---, ---

4.5, ---, 4.3

*Number of differentially methylated CpGs (P<0.05, >25% meth diff).
**Displayed as fold change at 0, 2 or 8 H post LPS. Positive values indicate (Old >
Young) or (Holstein >Angus), negative values indicate (Young > Old) or (Angus >
Holstein) and --- signifies P>0.10.
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Figure 2.1: Fibroblast Response to LPS in Young versus Old Cultures.

Interleukin-8 (A & C) and Interleukin-6 (B & D) protein production and gene expression
were measured in young and old dermal fibroblasts (n = 6 per group) at various time
points post LPS. Protein production is presented in pg/ml following 36 hours of LPS
stimulation. Gene expression was measured by RT-qPCR and is presented as the change
in cycles to threshold (dCT) of gene expression at 0, 2 & 8 hours post LPS in comparison
to β-actin. Fold change gene expression (Old>Young) is presented in parentheses above
each significant time point. All values are displayed as mean (+/- SEM). Significance was
measured using a paired Student’s t test at each time point and ** = P < 0.01 *** = P <
0.001.
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Figure 2.2: RRBS Project Workflow
Prior to methylation analysis, 6 pairs of fibroblasts isolated from the same animals at 5and 16-months of age were selected and challenged with LPS for 0, 2, 8 and 36 hours to
measure cytokine protein and gene expression. In preparation for RRBS, fibroblast DNA
was digested with MSPI to enrich for CpG rich regions of the genome, followed by endrepair and Poly-A tail addition. The digested DNA was then ligated to Illumina primers,
size selected and bisulfite converted prior to sequencing. The subsequent reads were
quality controlled by FastQC and Illumina adaptors were trimmed with TrimGalore.
Those that passed quality control were then aligned to the BosTau8 genome and uniquely
mapped reads were kept for analysis with a paired T test at each CpG site with greater
than or equal to 5X coverage. Once differentially methylated sites were identified,
clustering analysis was performed on the top 100 sites based on p-value. Functional
analysis to identify enriched KEGG pathways, GO terms and transcription factors was
performed by DAVID and gene expression
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analysis by RT-qPCR.

Figure 2.3: Gene Expression post LPS treatment of Selected Differentially
Methylated Genes in Young and Old Fibroblast Cultures.
Expression of six genes more methylated in young cultures A) PIK3R1, B) FES, C)
TNFSF13, D) NFATC1, E) TCF7 and F) RORA were measured in young and old
fibroblasts (n = 6 per group) at 0, 2 and 8 hours post LPS. Expression was measured by
RT-qPCR and values are presented as dCT in comparison to β-actin. Fold change gene
expression (Old>Young) is displayed in parentheses above each significantly different
time points. All values are displayed as mean (+/- SEM). Significance was determined
using a paired Student’s t Test at each time point post LPS treatment and *** = P <
0.001, ** = P<0.01, * = P < 0.05, † = P < 0.10.
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Figure 2.4: Gene Expression post LPS Treatment of Selected Genes from RRBS
Analysis in Angus and Holstein Fibroblast Cultures.
Expression of six genes more methylated in young cultures, A) PIK3R1, B) FES, C)
TNFSF13, D) NFATC1, E) TCF7 and F) RORA were measured in fibroblasts isolated
from 19-month Angus and Holstein cows at 0, 2 and 8 hours post LPS. Expression was
measured by RT-qPCR and values are presented as dCT in comparison to β-actin. Fold
change gene expression is displayed in parentheses above each significantly different
time point, whereby positive values indicate Holstein>Angus and negative values
indicate Angus>Holstein. All values are displayed as mean (+/- SEM). Significance was
determined using an unpaired Student’s t Test at each time point post LPS treatment and
** = P<0.01, * = P < 0.05, † = P < 0.10.

Additional files for Chapter 2 can be accessed on NCBI’s gene expression omnibus
(GEO) website through GEO accession number GSE91088.
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE91088
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CHAPTER 3: VARIATION IN FIBROBLAST EXPRESSION OF TLR4 AND
LPS-INDUCED CYTOKINE PRODUCTION BETWEEN-ANIMALS PREDICTS
CONTROL OF BACTERIAL GROWTH BUT NOT SEVERITY OF
ESCHERICHIA COLI MASTITIS
3.1 Abstract
Mastitis cases caused by environmental pathogens, such as Escherichia coli (E.
coli) are highly problematic to the dairy industry because milk producers incur substantial
cost and the disease tends to be difficult to manage. An effective innate immune response
by the host is key to controlling infection, but it should also limit collateral damage to the
mammary gland. Between-animal differences in mastitis severity have been attributed to
variability in the innate response. In the current study, the primary dermal fibroblast was
used as a model to rank animals based on composite expression of toll-like receptor 4
(TLR4) and lipopolysaccharide (LPS)-induced IL-8 and IL-6 protein production. Animals
ranked as high and low were then infected in the mammary gland with the P4 strain of E.
coli to determine how difference in rank would affect response to mastitis. All animals
developed an acute response to the infection with varying degrees in severity, however,
high responders had an elevated somatic cell count and fever response at 12-hrs. post
infection and higher quantities of milk IL-8 at 24-hrs. post infection. High responding
animals were also significantly more capable of limiting bacterial growth. No differences
were measured in post-infection milk production or tissue damage. The current study
indicates that high responding animals have an early up-regulation in their innate
response that is beneficial for bacterial clearance, however they are still equally
susceptible to tissue damage caused by an exuberant response to the infection. The
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dermal fibroblast can be used in conjunction with other cell types to determine how the
innate response is regulated to mitigate unnecessary injury to the mammary gland while
still effectively clearing the pathogen.
Keywords: LPS; experimental mastitis; dairy cow; innate immunity
3.2 Introduction
Infection of the mammary gland with Escherichia coli (E. coli), a common
opportunistic pathogen found within the dairy cow environment, causes clinical mastitis
that ranges from mild to severe. Although infections are typically transient and selflimiting, host response to the pathogen causes damage to milk-producing epithelial cells
that results in a substantial decrease in milk production and quality. In addition to lower
milk production and non-saleable milk, direct costs, such as veterinary care, and indirect
costs, such as early culling, contribute to mastitis-related economic losses that altogether
cost the producer approximately $450 per clinical case of mastitis occurring within the
first 30 days of lactation (Rollin et al., 2015). Treatment of E. coli mastitis with
antibiotics has shown very limited benefit (Lago et al., 2011b, a, Vasquez et al., 2017)
and, within the United States, effective treatments are restricted to hetacillin potassium, a
broad-spectrum ß-lactam antibiotic, and ceftiofur, a third generation cephalosporin and a
high priority drug for human diseases (Suojala et al., 2013); thus their use in animal
agriculture is not generally recommended. Use of the current J5 vaccine against E. coli
has shown a modest benefit in reducing severity of mastitis (Wilson et al., 2007),
however, it does not significantly reduce the incidence of disease. Both the desire to
reduce antibiotic usage and a lack of an efficacious vaccine has led to increased interest
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in the selection of animals based on natural disease resistance, however, genes that
contribute to resistance and susceptibility have remained relatively elusive.
Physiological state of the host is known to affect mastitis severity and
susceptibility, whereby early lactation, older age and increased parity are risk factors for
mastitis (Steeneveld et al., 2008, Taponen et al., 2017). Differences in strain of E. coli
may also contribute to variation in mastitis severity (Blum et al., 2017). It has been
suggested that strains adapted to the mammary gland, called mammary pathogenic strains
(MPEC), express virulence factors and more efficiently utilize nutrient sources that allow
for improved survival within the mammary gland environment (Blum et al., 2015).
However, a recent analysis comparing the gene sequences of eight MPEC strains versus
six fecal commensal strains did not reveal enrichment of virulence determinants or fitness
factors in strains isolated from bovine mastitis cases versus commensal organisms.
Instead, the authors suggest that each individual strain contains unique strain-specific
traits that enhance fitness and are the result of competition for resources associated with
commensalism rather than pathogenicity (Leimbach et al., 2017). In addition,
experimental infections controlling for host variables, such as stage of lactation and
parity, and with the same strain of E. coli, have shown that the severity of clinical
mastitis is quite variable between animals (Lee et al., 2006), albeit to a lesser extent in
primiparous cows (Vangroenweghe et al., 2004, Vangroenweghe et al., 2005a).
Additional host factors, such as the genetic or epigenetic regulation of immunity, may
help to explain variation in mastitis severity between animals that is independent of
bacteria and other host factors.

83

Genetic predisposition to infectious disease, including mastitis, has been widely
studied, but is complicated by the likely polygenic nature of this trait. In one study, using
the estimated breeding values (EBV) of bulls based on daughter somatic cell score (SCS)
as the primary risk factor for mastitis susceptibility, genetic polymorphisms in the gene
region of osteopontin (SPP1) were shown to have an effect on SCS and presumably
mastitis risk (Alain et al., 2009). In addition, a quantitative trait loci (QTL) on
chromosome 18 is associated with resistance or susceptibility to mastitis. Interestingly,
mammary epithelial cells that are isolated from animals with either the resistant or
susceptible QTL also exhibit differences in the up-regulation and kinetics of numerous
innate immune response genes in response to E. coli and S. aureus in vitro stimulation
(Brand et al., 2011). Furthermore, genes that exhibit differences in DNA methylation
have been identified in peripheral blood leukocytes isolated from cows with subclinical S.
aureus mastitis versus uninfected cattle, and include three inflammatory response genes
that are hypo-methylated and up-regulated in infected cattle (Song et al., 2016). The three
aforementioned studies, among many others, emphasize the importance of the innate
immune response to mastitis and seem to suggest that differences in innate immunity may
determine mastitis resistance or susceptibility.
In response to infection, the innate immune response is rapidly activated through
the interaction of germ-line encoded pattern recognition receptors (PRR) with conserved
microbial components. Toll-like Receptor 4 (TLR4) is the main PRR that is activated in
response to Gram-negative bacteria, such as E. coli, as a result of its interaction with
bacterial endotoxin, or LPS (Chow et al., 1999). Following recognition of LPS facilitated
by co-receptors CD14 and MD2, TLR4 activates both a MyD88-dependent and 84

independent signaling cascade that allows transcription factors NF-κB, AP-1 and IRFs to
up-regulate the transcription of inflammatory response genes, such as IL-8, IL-6, TNF-α,
IL-1ß, and IFN-γ, among many others (Lu et al., 2008). To determine how innate
immunity contributes to between-animal differences in response to mastitis-causing
pathogens, we have developed a primary bovine dermal fibroblast model to assess the
immune response of a large number of animals in cell culture prior to testing the in vivo
response of selected animals to intra-mammary infection. The dermal fibroblast was
chosen as a model cell for its repeatability of response (Kandasamy et al., 2011), ease of
isolation and cryopreservation, and low activation at baseline. Furthermore, a comparison
of model cell types including primary bovine epithelial cells, fibroblasts and
macrophages showed that while both fibroblasts and epithelial cells distinguished
between pathogen-specific immune responses, macrophages fail to make the distinction
(Gunther et al., 2016b).
Using this approach, we have previously ranked cohorts of adult Holsteins on
fibroblast IL-8 production in response to LPS or PAM2CSK4 to mimic E. coli and S.
aureus mastitis, respectively. Animals that were designated as high responders and low
responders, based on high or low fibroblast IL-8 production, were then infected with the
pathogen of interest. Both experiments showed that high responders had elevated tissue
damage and somatic cell count within the mammary gland in response to infection. High
responders challenged with E. coli also had a slower return to pre-infection milk
production levels, and high responders challenged with S. aureus had significantly
elevated milk IL-8. In either case, no difference was measured in bacterial clearance,
suggesting that high responders do not benefit from the enhanced response and that the
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innate response contributes to mammary gland tissue damage and lower milk production
(Kandasamy et al., 2011, Benjamin et al., 2015b).
To further characterize the high response phenotype and potentially identify
genetic markers for severe mastitis susceptibility, the current experiment utilizes a multivariable approach to rank a cohort of adult Holsteins on LPS-induced fibroblast
production of IL-8 and IL-6 and gene expression of TLR4. High and low responders were
subsequently infected with E. coli to determine if fibroblast phenotype would accurately
reflect the immune response within the mammary gland.
3.3 Materials and Methods
3.3.1 Ethics Statement
All animal procedures performed in this experiment were approved by the
Institutional Animal Care and Use Committee at the University of Vermont. Animals
enrolled in the study were handled by authorized personnel approved by the
aforementioned committee and all efforts were made to minimize animal suffering in
accordance with IACUC standards. In particular, Banamine® was administered to animals
that developed a febrile response of greater than 105.7 ºF (40.9ºC).
3.3.2 Experimental Animals
Adult Holstein cows were housed at a large (1,400 lactating cows), local
collaborating dairy farm and 60 early lactation animals were selected to be included in
the study. At the time of the initial skin sampling, all animals were in early lactation (78
± 10 DIM) and were in their second or greater (2.9 ± 1.1) lactation. The 12 animals
selected for the intra-mammary treatment with E. coli were transported to the University
of Vermont’s Miller Research farm when they were in late lactation (238 ± 6 DIM). They
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were housed in a tie-stall barn, fed a standard total-mixed ration ad libitum, and allowed a
seven-day acclimation period prior to challenge. Selected cows were in their 2nd – 4th
lactation.
3.3.3 Dermal Fibroblast Isolation and Culturing
Ear notches from 60 animals were collected over a 4-week period with 15
animals sampled per week. The section of the ear to be sampled was clipped and shaved
to remove hair and scrubbed three times, alternating between povidone iodine and 70%
ethanol. After the last ethanol wash, a large v-cut ear notch was taken using an aluminum
ear notcher (Model# WI-0002433, Livestock Concepts, Hawarden, IA), while carefully
avoiding main arteries and vein. Ear notch samples were transported to the laboratory on
ice in Dulbecco’s PBS (DPBS; Hyclone Laboratories, Logan, UT) containing a 1x
antibiotic-antimycotic solution (1x AB/AM; 100 U/ml penicillin, 100 µg/ml streptomycin
and 0.25 ug/ml of amphotericin B; Hyclone Laboratories). Tissue samples were then
minced into smaller pieces using opposing scalpel blades and washed 4 times with fresh
DPBS containing 1x AB/AM. After the last wash, 10 ml of Dulbecco’s modified Eagle
medium (DMEM; Hyclone) containing 1x AB/AM and 0.5% collagenase type I enzyme
(Gibco, Gaithersburg, MD) was added to each sample and samples were incubated
overnight at 37°C with orbital shaking. The collagenase-digested tissue was then filtered
with a 70 µM nylon mesh filter (Thermo Fisher, Pittsburgh, PA) and centrifuged at 1100
x g for 5 minutes at room temperature. Supernatant was discarded and the cell pellet was
reconstituted in DMEM containing 10% fetal bovine serum (FBS; Omega Scientific,
Tarzana, CA), 1x insulin-transferrin-selenium (ITS; Gibco), and 1x AB/AM. Cells were
cultured in a 25 cm2 flask in a humidified incubator containing 5% CO2 at 37°C until
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reaching approximately 70% confluency. Cells were then detached using 0.25% trypsin
(MP Biomedical, Santa Ana, CA) and transferred to a 75-cm2 flask with DMEM
containing 5% FBS, 1x ITS, and 1x antibiotic only (1x AB; 100 U/ml penicillin and 100
µg/ml streptomycin). Upon confluency, cells were trypsinized and split into three 75-cm2
flasks. Confluent third passage cells were then trypsinized and transferred to DMEM
containing 20% FBS, 1x ITS, 1x AB/AM, and 10% dimethyl sulfoxide (DMSO; Thermo
Fisher). Cells were cryopreserved in liquid nitrogen for future experiments.
3.3.4 Treatment of Dermal Fibroblasts with LPS and Heat-Killed E. coli
Two fibroblast challenges were performed within the study. First, we challenged
all 60 cultures with LPS to determine the initial ranking. Second, to compare the side-byside response of the animals that were selected for the intra-mammary E. coli treatment,
we challenged fibroblasts from the 6 high-ranked and 6 low-ranked animals (see below)
with LPS and heat-killed E. coli. In both challenges, cells were revived from
cryopreservation into pre-warmed DMEM containing 5% FBS, 1x ITS, and 1x AB/AM,
and cultured to confluency. Fourth passage cells were detached with trypsin and seeded
in 6-well plates at a concentration of 7.5 x 104 cells/ml (challenge 1) or 1.25 x 105
cells/ml (challenge 2) in a total volume of 2.0 ml. After a 24-hour incubation, media was
removed and replaced with fresh media only (negative control), or with media containing
either 100 ng/ml of ultra-pure LPS isolated from E. coli O111:B4 (Millipore Sigma, St.
Louis, MO) or heat-killed E. coli strain P4 at an MOI of 10.
To rank the whole cohort of 60 animals, cells were incubated for 24-hours in
LPS and negative control media. To compare the 6 highs and 6 lows, cells were
incubated for 0, 2, 8, and 24-hours with LPS and for 24-hours with heat-killed E. coli.
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Media was collected from 0 hour cultures as the negative control. After 24-hours,
challenge media was removed from all cells and stored at -20°C until further analysis.
Cell lysate was also obtained by applying 800 µl of lysis buffer (PureLink™ RNA Mini
Kit, Thermo Fisher) directly to the wells and stored at -80ºC until RNA extraction.
3.3.5 Quantification of IL-8 and IL-6 Protein in Challenge Media
Production of IL-8 in conditioned media was measured using a commercially
available sandwich ELISA per manufacturer’s instructions with slight modifications
(Mabtech, Cincinnati, OH). Capture antibody was diluted to a concentration of 1 µg/ml in
0.05 M bi-carbonate buffer. Biotinylated detection antibody was diluted to 0.025 µg/ml in
PBS-0.05% Tween-20. Streptavidin-horseradish peroxidase (Strep-HRP; Millipore
Sigma) was diluted to a concentration of 0.07 µg/ml in PBS-0.05% Tween-20.
Recombinant bovine IL-8 (Thermo Fisher) was used as the assay standard with a
detection limit of 78.125 pg/ml.
Production of IL-6 was similarly measured by sandwich ELISA per
manufacturer’s instructions (R&D Systems, Minneapolis, MN). Recombinant bovine IL6 (R&D Systems) was used as the assay standard with a detection limit of 156.25 pg/ml.
For both assays, plate washing was performed 3 times with PBS-0.05% Tween-20
between each step. After the final plate wash, development of IL-8 and IL-6 assays was
done by adding 3,3’,5,5’-tetramethylbenzidine substrate (TMB; Thermo Scientific) and
the reaction was stopped with 1 M H2SO4 after 3-5 minutes. Absorbance was measured at
450 nm with a plate reader (Synergy-HT, Bio-Tek, Winooski, VT) to quantify protein
levels using a 4-parameter analysis with optical density corrected against blank wells.
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3.3.6 Fibroblast Gene Expression
Extraction of RNA from cell lysate was done using the PureLink™ RNA Mini
Kit (Thermo Fisher), which included a 15-minute DNase treatment that was performed
using the PureLink™ DNase Set (Thermo Fisher). Concentration of RNA was
determined using a Qubit™ 2.0 Fluorometer (Life Technologies, Carlsbad, CA) and firststrand cDNA synthesis was done using the Improm-II™ Reverse Transcriptase Kit
(Promega, Madison, WI) on 400 – 600 ng of RNA. Gene expression analysis of select
immune response genes was measured by real-time quantitative PCR (RT-qPCR) on a
CFX96 Touch™ Real-Time PCR Detection System (BioRad, Hercules, CA) using
Thermo Scientific™ Maxima™ SYBR™ Green/Fluorescein qPCR Master Mix (Thermo
Fisher). Cycling conditions were as follows: 95°C for 2 min followed by 40 cycles of 95
°C for 15 s, 60 °C for 1 min and 72 °C for 1 min after which a melt curve was inserted.
All oligonucleotide primer sequences are listed in Table 3.1. Unless already validated and
published, primers were designed using the Primer 3 program on NCBI. Primers were
designed to amplify a 100-300 base pair region without any known SNPs and if possible,
to span an exon-intron junction and include a GC clamp. Primer sequences were then
analyzed by the NCBI nucleotide BLAST program to ensure only the target Bos taurus
gene was detected. Melt curve analysis of all primer sets was analyzed and only one peak
could be detected, indicating a single amplicon without primer-dimer contamination. No
amplification was detected in negative (no cDNA controls).
3.3.7 Preparation of E. coli for Intra-mammary Infection
An aliquot of cryopreserved E. coli strain P4, originally isolated from an acute
case of clinical mastitis (Bramley, 1976) and classified as O32:H37, ECOR phylogenetic
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group A and multilocus sequence type ST10 (Blum et al., 2012) was initially grown
overnight on trypticase soy agar containing 5% sheep’s blood (SBA; Northeast
Laboratory Services, Waterville, ME) at 37ºC to isolate a single colony. One colony was
then inoculated into 3 mL of trypticase soy broth (TSB; Thermo Fisher) and incubated at
37ºC with shaking for 6 hours. One mL of the 6-hour culture was then inoculated into 99
mL of TSB and incubated for 16 hours at 37ºC with shaking. The stock culture was kept
at 4ºC until concentration of bacteria was determined by serial dilution and plating. Once
determined, stock culture was diluted to 40 cfu/ml in sterile, endotoxin free, isotonic
saline (Phoenix, St. Louis, MO) in preparation for intra-mammary challenge.
3.3.8 Experimental Mastitis Challenge
Twelve animals, determined to be either high (n=6) or low (n=6) responders based
on their fibroblast phenotype, were chosen for an experimental mastitis challenge with E.
coli. Fibroblast ranking was based primarily on baseline expression of TLR4 followed by
cytokine response to LPS. Using this ranking strategy, 4 high responders (HR) and 4 low
responders (LR) were within the top and bottom 20% of TLR4 expression, respectively.
The 2 HR and 2 LR that were not within the 20% cutoff were chosen based on their ranking
within the top or bottom 20% of IL-8 or IL-6 response and on their mastitis free status and
availability from the collaborating farm.
All 12 animals were transported to the UVM Miller Research Farm and allowed
to acclimate for 7 days before the infusion. Ten of the animals were pregnant and the 2
non-pregnant animals were maintained in diestrus using controlled internal drug release
inserts containing progesterone (Eazi-Breed™ CIDR®, Zoetis US, Parsippany, NJ).
Cows were milked twice daily at 12-hour intervals using individual milking units.
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Quarter milk samples were taken prior to the challenge to ensure quarters were free of
mastitis-causing pathogens and composite SCC was below 200,000 cells/ml. Following
morning milking on the day of the challenge, teat ends were disinfected with 70% ethanol
and 5 mL of the bacterial solution was infused into the right hind quarter using a teat
cannula. The infusion solution was plated in triplicate and plate counting was done to
determine the actual infusion dose, which was 37 cfu/ml and 185 cfu total. Following the
intra-mammary challenge, rectal temperature was monitored for 96 hours. Blood samples
were taken by venipuncture of the tail vein at 0, 12, 24 and 36 hours post-infection for
serum cytokine analysis and at 7 and 14 days post infection to measure antibody
response. Blood samples were collected in vacutainer tubes containing sodium-heparin
(BD, Franklin Lakes, NJ) and transported to the lab on ice. Blood was centrifuged at
1,000 x g for 15 minutes at 4ºC. Plasma layer was removed and stored at -20ºC for
downstream experiments.
Aseptic milk samples were taken at 12-hour intervals for 5 days, at 24-hour
intervals for an additional 5 days and at 48-hour intervals for the remainder of the study.
Bacterial clearance was measured from infected quarters by plating 10 µl of undiluted
milk or milk diluted in sterile PBS onto SBA, incubating overnight at 37ºC, and counting
colonies. Infected quarter SCC was measured using a portable cells counter (DCC,
DeLaval, Tumba, Sweden). Infected quarter milk was collected using a separate quarter
milker at each milk sampling time-point to measure infected quarter production.
3.3.9 Whey Preparation
Whole milk samples were centrifuged at 16,000 x g at 4°C for 30 minutes. Top
cream layer was removed and skim milk samples were centrifuged again at 16,000 x g at
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4°C for 30 minutes. The whey supernatant was removed and stored at -20°C for
downstream analysis.
3.3.10 Measurement of Proteins in Whey
Concentrations of IL-8 and IL-6 in whey were measured as previously
described. Whey was diluted 1:5 in PBS-0.05% Tween-20 for IL-8 assays and 1:10 in
PBS-0.05% Tween-20 for IL-6 assays.
Bovine serum albumin (BSA) concentrations were measured per manufacturer’s
instructions using a commercially available ELISA kit (Bethyl Laboratories,
Montgomery, TX) with slight modifications. Briefly, capture antibody was diluted 1:100
in 0.05 M bi-carbonate buffer to a concentration of 10 µg/ml and incubated at room
temperature for 1 hour. Plates were blocked overnight at 4ºC with PBS-0.05% Tween-20.
Whey samples were diluted 1:40,000 in PBS-0.05% Tween-20. Samples and standards
were incubated at room temperature for 1 hour. Horseradish peroxidase-conjugated
secondary antibody was diluted 1:50,000 in PBS-0.05% Tween-20 to a concentration of
20 ng/ml and incubated at room temperature for 1 hour. Plates were washed between
each step 3 times with PBS-0.05% Tween-20. After the last wash step, plates were
developed by adding TMB and allowed to develop for 5-7 minutes. The reaction was
stopped by adding 1 M H2SO4 and absorbance was read at 450 nm with a plate reader as
previously described. Detection limit of the BSA assay was 6.25 ng/ml.
3.3.11 Circulating Cytokine Response
Serum TNF-α levels were measured by radioimmunoassay (RIA) as previously
described (Elsasser et al., 2005) and serum IL-6 was measured by ELISA as previously
described.
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3.3.12 Heat Killing Bacteria
A cryopreserved stock of the same E. coli P4 challenge strain was grown as
described earlier for the intra-mammary challenge preparation. A plate dilution was set
up to determine concentration of stock bacteria. Stock bacteria was then subjected to heat
killing by incubating in a water bath at 70ºC for 45 minutes with shaking every 10
minutes. Heat killed bacteria was then stored at 4ºC overnight while 100 μl of heat killed
bacteria was plated onto SBA and incubated overnight to ensure bacteria were killed. The
following day, heat killed bacteria was spun at 3600 x g for 15 minutes at 4ºC and resuspended in 50 mL of double distilled water. Heat killed bacteria was then aliquoted and
stored at -20ºC for downstream applications.
3.3.13 Antibody Response to challenge strain
Total anti-E. coli IgG levels were measured in plasma at 0, 7 and 14 days post
infection using a custom indirect ELISA. Heat killed E. coli was diluted 1:100 in 0.05 M
bi-carbonate buffer to a concentration of 1 x 107 heat-killed bacteria. Diluted E. coli and
bi-carbonate buffer only (blank wells) were incubated overnight at 4ºC. Blocking was
then performed for 1 hour at room temperature with PBS-2% non-fat milk (Lab
Scientific, Highlands, NJ). Plasma was plated at a dilution of 1:1000 in PBS-0.05%
Tween-20 and incubated at room temperature for 1 hour. Horseradish peroxidaseconjugated goat anti-bovine IgG was diluted 1:20,000 in PBS-0.05% Tween-20 to a
concentration of 0.025 μg/ml and incubated at room temperature for 1 hour. Plates were
washed three times with PBS-0.05% Tween-20 between each step. After the final plate
wash, TMB was added and the reaction was allowed to develop for approximately 5
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minutes. The reaction was stopped with 1 M H2SO4. Optical density at 450 nm was
measured as previously described.
3.3.14 Statistical Analysis
An unpaired Mann-Whitney U test in GraphPad Prism 7.0 (GraphPad Software
Inc., La Jolla, CA) was performed to compare concentrations of IL-8 and IL-6 in dermal
fibroblast challenge media and to compare 12-hr. SCC response. Spearman rank
correlation and linear regression analysis of IL-8 and IL-6 production in challenge media
from LPS vs. heat-killed E. coli cultures was also performed in GraphPad. Analysis of
dermal fibroblast gene expression, serum cytokine response and humoral response was
done using a 2-way repeated measures ANOVA in GraphPad with time as the repeated
measure to determine time x fibroblast response significance. A post-hoc Bonferroni’s
multiple comparisons test was then done to determine significance at each time point.
Finally, comparison of phenotype (LR vs HR) on concentrations of whey IL-6, IL-8 and
BSA, infected quarter milk production, rectal temperature and infected quarter SCC and
bacteria counts, both transformed for normal distribution, were analyzed using a linear
regression model assuming a first order auto-regressive covariance structure with time
post-infection as the repeated measure. A least square means test was performed to
determine effect of time, time x fibroblast response and to compare fibroblast response at
each time point. This analysis was performed using the MIXED procedure in SAS
version 9.4 (SAS Institute Inc., Cary, NC). All values are presented as the mean of each
group ± SEM. Statistical significance is defined as P<0.05 and a trend as P<0.10.
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3.4 Results
3.4.1 Dermal Fibroblast Response to LPS
The sixty fibroblast cultures were revived from cryopreservation in five separate
batches of twelve cultures. The cells were mixed by sampling date, such that each
challenge batch contained fibroblasts that were isolated on all four sampling dates.
Unfortunately, 2 of the 60 cultures did not survive cryopreservation, leaving 58 LPSchallenged cultures.
Fibroblasts were treated with either media alone or media supplemented with
100 ng/ml of LPS for 24 hours. Fibroblast production of IL-8 and IL-6 were measured in
all media samples following the challenge and were adjusted for final cell number. Levels
of IL-8 and IL-6 in negative controls were minimal but were subtracted from the
challenge values. In addition, to normalize for batch-to-batch variation between
challenges, protein amounts were adjusted for batch mean and standard deviation.
Adjusted rank, ranging from -1.50 to 2.33 for IL-8 and from -1.65 to 2.54 for IL-6, were
used as response variables. As with previous experiments (Kandasamy et al., 2011,
Benjamin et al., 2015b), a large range in response to LPS was measured in conditioned
media, with a significant correlation between LPS-induced IL-6 and IL-8 production
(data not shown) (R2 = 0.28, P<0.0001).
3.4.2 Dermal Fibroblast Expression of TLR4 and Ranking
Expression of TLR4 was measured in cultures from negative, media-only control
wells. Of the 58 challenged cultures, three cultures had very low RNA yield and were
excluded from further ranking. Expression of TLR4 was measured in the remaining 55
cultures using two primer sets that showed a 40- and 70-fold difference in expression
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between the lowest and highest cultures. The two primer sets also exhibited a significant
correlation in ranking of TLR4 expression (data not shown) (R2 = 0.77, P<0.0001). As
such, measurement of TLR4 will be presented using one of the two primer sets for the
remainder of experiments.
Fibroblast phenotype was determined by sorting and ranking on all three
variables as shown in figure 3.1. Selection was then based on identifying the tail ends of
TLR4 expression and whenever possible, choosing animals with a positive or negative
rank for both IL-8 and IL-6 as our high and low responders, respectively. Using this
strategy, 6 selected high responders (figure 3.1, red dots) and 6 selected low responders
(figure 3.1, blue dots) were selected for subsequent in vitro and in vivo experiments.
3.4.3 Phenotype Confirmation of 12 Selected Animals
To confirm that our ranking strategy accurately predicts fibroblast response to
LPS and to compare whether LPS and heat-killed E. coli would elicit a similar response,
fibroblasts from the 12 selected highs and lows were revived a second time from
cryopreservation and treated for 24 hours with media alone, media supplemented with
100 ng/ml of LPS, and media supplemented with heat-killed E. coli at an MOI of 10.
As predicted, LPS-induced production of IL-6 protein was higher in animals
ranked as high responders versus those ranked as low responders (figure 3.2, panel A).
High responding fibroblasts produced 32.5 ± 3.3 fg/cell of IL-6 as compared to low
responders that produced 20.2 ± 3.9 fg/cell. Interestingly, this difference did not extend to
fibroblast response to heat-killed E. coli, even though LPS and heat-killed E. coli
production of IL-6 was significantly correlated (R2=0.76, P<0.01) within animals (figure
3.2, panel C). No detectable IL-6 was measured in fibroblasts cultured with media alone.
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Similar results were measured in LPS-induced production of IL-8. High
responding cultures produced significantly more IL-8 in response to LPS in comparison
to low responding cultures (2.51 ± 0.2 vs 1.4 ± 0.1 fg/cell, P<0.001, figure 3.2, panel B).
However, IL-8 production was also significantly elevated in high responding cultures in
response to heat-killed E. coli (1.8 ± 0.1 vs 1.0 ± 0.1 fg/cell, P<0.05, figure 3.2, panel B).
Fibroblast cultures that were treated with media alone did have low background levels of
IL-8 and notably, these levels were significantly elevated (0.25 ± 0.1 vs. 0.1 ± 0.04
fg/cell, P<0.001) in high responding cultures but did not affect differences in response to
LPS or heat-killed E. coli (figure 3.2, panel B). As with IL-6 production, fibroblast
production of IL-8 is significantly correlated (R2=0.61, P<0.01) within-animals when
comparing response to LPS and to heat-killed E. coli (figure 3.2, panel D). Fibroblasts
also produce more IL-8 in response to LPS than to heat-killed E. coli, the opposite of
which is true for fibroblast production of IL-6.
3.4.4 Fibroblast Gene Expression in Response to LPS
To determine whether protein differences would also be reflected at the mRNA
level and to measure the expression of other innate response genes, gene expression
analysis was performed on high and low responding fibroblasts at 0 (control), 2, and 8
hours post LPS treatment. Expression of both IL-8 and IL-6 were up-regulated by 2 hours
post LPS treatment and were significantly higher (P<0.05, figure 4.3, panels A & B) in
high responding cultures, confirming the protein response difference. The largest
difference in IL-8 and IL-6 expression between the two sets of cultures was measured at
2-hrs post LPS at which time high responding cultures exhibited a 4.6- and 4.8-fold
higher level of expression, respectively. Interestingly, difference in TLR4 expression was
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not as high as expected based on our initial ranking, perhaps due to technical variation of
the RT-qPCR assay. However, expression of TLR4 was higher in high responding
cultures with a time x response difference that trended towards significance (P<0.10,
figure 3.3 panel C). Again, the greatest difference between the two sets of cultures was
measured at 2-hrs. post LPS treatment, at which time a significant (P<0.05) 2-fold higher
level of expression was seen in high responding cultures. There was also a small (3.5fold), but significant increase in TLR4 expression by 8-hrs post-LPS treatment.
The expression of three other innate immune response genes were also measured
to determine whether the high and low phenotype was unique to our ranking variables.
The expression of TNF-α was measured as this is a crucial early-response cytokine with a
similar, but not identical role in the innate response as IL-6. As expected, a large increase
in TNF-α expression was measured by 2-hrs. post LPS treatment that returned close to
baseline by 8 hrs (figure 3.3, panel D). Overall, there was a time x response trend towards
significance (P<0.10) for higher expression in high responding cultures. As with the
previously measured genes, the greatest difference was measured at 2-hrs. post LPS at
which time high responding cultures exhibited a 2-fold higher level of TNF-α expression.
Expression of serum amyloid A-3, a member of the SAA family of acute phase proteins,
was also measured in response to LPS treatment. Although expression was higher in high
responding cultures at all time points, no significant differences were measured between
the two groups of animals (figure 3.3, panel E). Finally, a large increase in expression of
CCL20, a CC-family chemokine, was measured in response to LPS treatment, with no
differences observed between high and low responding cultures (figure 3.3, panel F).
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3.4.5 Intra-mammary Infection with E. coli
To determine how dermal fibroblast phenotype relates to in vivo response, the 6
high responders and 6 low responders were given an infusion of 185 cfu of E. coli in their
right-hind quarter following morning milking. Clinical signs of coliform mastitis, such as
lethargy, fever and anorexia, were evident by 12-hrs. post infection. One high responding
animal developed acute toxic mastitis and was humanely euthanized at 48 hrs. post
infection. Her data was utilized for milk samples up to 12-hrs. post infection and rectal
temperatures and blood samples up to 36-hrs. post infection. Rectal temperatures were
monitored for 96-hrs. post-infection and peaked at 15-hrs. in all animals (figure 3.4),
indicative of an acute case of mastitis, and returned to baseline by 21-hrs. post-infection.
Overall, there was no difference in febrile response between high and low responders,
however, high responders had an early and significant increase (39.4 ± 0.2 vs 38.7 ±
0.2ºC, P<0.05) in temperature by 12-hrs. post-infection in comparison to low responding
animals, suggesting that high responders may react more quickly to E. coli infection. In
contrast, low responders had a significantly elevated temperature at 18-hrs. post-infection
(39.4 ± 0.4 vs 38.8 ± 0.3ºC, P<0.05). This result should be taken with caution, however,
as a non-steroidal anti-inflammatory (Banamine®, flunixin meglumine) was administered
to half of the animals (4 HR and 2 LR) at 15-hrs. post-infection per IACUC requirements.
All temperatures returned to baseline by 21-hrs. post-infection.
A notable drop in infected (figure 3.5) and uninfected (data not shown) quarter
milk production was measured by 24-hrs. post infection. No difference in post-infection
milk production was measured in the high versus low responding animals. All animals
recovered to pre-infection milk production levels by the end of the study, with the
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exception of one low responder that stayed close to dry-off from 144-hrs post-infection
until the end of the study and one high responder that had very low production on the last
day of sampling due to re-infection in her right hind quarter.
Leukocyte influx into the mammary gland was assessed by measuring increase
in infected quarter somatic cell count (SCC) for 14 days following E. coli infection
(figure 3.6, panel A). Using a linear regression model, there was no difference in SCC
between high and low responders, with the exception of a trend towards elevated SCC in
high responders at 60 and 108-hrs. post infection. Interestingly, it was noted that at 12hrs. post infection high responders had already increased their SCC above baseline,
whereas low responders remained near pre-infection levels. In light of this observation,
we performed an assessment of just the increase in SCC at 12-hrs. post infection (figure
3.6, panel B) that showed that high responders had an up-regulated SCC that was
significantly (183,000 ± 98,000 vs. 26,000 ± 11,000 SCC/ml, P<0.05) higher than low
responders at this early time point post-infection. The difference in SCC was gone by 24hrs. post infection, but in conjunction with their elevated febrile response, may indicate
that high responding animals respond more quickly to infection. Somatic cell count
remained elevated in all animals through the end of the study.
Recovery of E. coli from the infected gland was similarly measured for 14 days
post-infection to determine how phenotype impacts bacterial clearance. As shown in
figure 3.6 panel C, bacteria quickly multiply post-infection, reaching maximal levels at
12-24-hrs. post-infection. Interestingly, while high responding animals peak at 12-hrs
post-infection, levels of bacteria keep increasing in low responding animals until 24-hrs.
post infection. Over the entire course of infection, high responding animals trended
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(P=0.10) towards lower bacterial levels and enhanced bacterial clearance which reached
significance (P<0.05) at 24, 72, and 84 hours post infection. All animals were clear of
infection by 12 days post infection, however, one high responding animal became reinfected with E. coli at 14 days post infection.
3.4.6 Infected Quarter Cytokine Response and Tissue Damage
Infected quarter whey concentrations of IL-8, IL-6 and bovine serum albumin
(BSA) were measured to determine how phenotype affects local inflammatory response
and tissue damage. A dramatic increase in IL-8 was measured by 24-hrs. post infection
(figure 3.7, panel A) that returned to baseline by 96-hrs. post infection. Overall, there was
no difference between high and low responders in infected quarter levels of IL-8,
however, high responding animals had significantly (27.8 ± 5.9 vs. 18.5 ± 3.5 ng/ml,
P<0.05) higher concentrations of IL-8 at 24-hrs. post-infection. This difference at 24-hrs.
may partially contribute to the higher SCC levels measured at 12-hrs. post-infection in
high responding animals as IL-8 is the primary chemokine resulting in neutrophil
chemotaxis.
Whey concentrations of IL-6 also peaked at 24-hrs. post-infection, however no
differences were measured between high and low responders at any time point postinfection (figure 3.7, panel B). Levels of IL-6 returned to baseline by 144-hrs. postinfection, indicating IL-6 has a prolonged role in response to E. coli infection in
comparison to IL-8. Whey concentrations of BSA, an indicator of blood-milk barrier
damage, were again significantly elevated in all animals by 24-hrs. post-infection and,
with the exception of one animal, returned to baseline by 144-hrs. post-infection (figure
3.7, panel C). One low responder had elevated levels of BSA and very low milk yield
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until 216-hrs. post-infection due to persistence of the E. coli infection. No significant
differences in BSA levels were measured between high and low responders at any time
point post-infection.
3.4.7 Systemic Response to E. coli Infection
Concentrations of plasma TNF-α and IL-6 were measured every 12 hrs. for 36
hrs. following the infection as markers of systemic response to E. coli. Peak TNF-α levels
were detected at 24-hrs. post-infection, with no significant difference between low and
high responders, overall. A trend towards higher levels of TNF-α in low responders was
detected at 24-hrs. post-infection (0.13 ± 0.03 vs 0.09 ± 0.02 ng/ml, P<0.10) (figure 3.8,
panel A). Concentrations of plasma IL-6 was also highest at 24-hrs, with no significant
differences measured between high and low responding animals (figure 3.8, panel B).
3.4.8 Humoral Response to E. coli Infection
Finally, to determine if levels of total anti-E. coli serum IgG would differ by
fibroblast phenotype following infection, blood samples were taken to measure antibody
response at 0, 7 and 14 days post-infection. A significant increase in E. coli-specific IgG
was measured by day 7 that remained elevated through day 14, however, no difference
was measured between the high and low responding animals (figure 3.9).
3.5 Discussion
In the current analysis, we aimed to refine the high and low fibroblast phenotype
based on earlier, promising results that animals whose fibroblasts produce more IL-8 in
response to synthetic TLR agonists, LPS and PAM2CSK4, have a more severe response
to E. coli and S. aureus mastitis, respectively. If able to accurately predict cow response
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to infection, the dermal fibroblast could be used as a valuable tool to discover genetic or
epigenetic markers that cause resistance or susceptibility to severe mastitis.
In addition to increased profitability for the dairy producer, selection of
replacement heifers based on genetic resistance to mastitis has shown increased interest
due to an effort to reduce antibiotic usage in food-producing animals and to improve
animal welfare. Genetic variability that results in increased susceptibility or severity of
infection has already been observed in various species in response to a wide range of
pathogens. In one report, a polymorphism in the IL17A gene was shown to lead to
increased susceptibility to Gram-positive infection and sepsis mortality (Nakada et al.,
2011). Copy number variants are another, less common type of gene variant that have
been shown to contribute to differences in susceptibility to malaria and HIV infection in
humans (Hollox and Hoh, 2014) and are also gaining attention in agriculture species as
another potential source of variation in mastitis susceptibility (Duran Aguilar et al.,
2017). Genetic differences in CXCR1, the main receptor for IL-8 signaling, was also
recently shown to impact severity of experimental intra-mammary infection with
Streptococcus uberis, whereby a haplotype was discovered to be protective against both
inflammation and bacterial growth (Siebert et al., 2017).
Using a slightly different approach, our hypothesis was that mastitis severity
would be reflected in the fibroblast innate response phenotype, such that fibroblasts could
be utilized in the future to identify the genetic or epigenetic basis of severe mastitis
resistance and/or susceptibility using genome-wide sequencing techniques. The decision
to use dermal fibroblasts over other cell culture models was based on their ease of
isolation, ability to cryopreserve, responsiveness to TLR agonists, low baseline
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activation, and on previous research suggesting that the primary fibroblast accurately
reflects progression of natural infection. Primary dermal fibroblasts have been used as a
model cell to identify strain-specific differences in the virulence of Herpesvirus subspecies in infections of non-natural hosts (Rogers et al., 2007) and in cattle to mimic
pathogen-specific differences in mammary gland response to mastitis (Gunther et al.,
2016b). Furthermore, mammary-derived stromal fibroblasts (BMFs) isolated from E.
coli-infected versus healthy cows exhibit a pro-inflammatory phenotype at isolation and
are able to induce epithelial cell expression of TNF-α and IL-8 in a co-culture system
(Chen et al., 2016). Conversely, epithelial cells pre-treated with LPS or lipoteichoic acid
(LTA) are able to induce pro-inflammatory gene expression in BMFs isolated from
healthy cattle (Zhang et al., 2016). Both studies are evidence of the cross-talk that occurs
between the epithelial cell and fibroblast within the mammary gland and the importance
of the fibroblast in initial response to infection.
In the current study, primary bovine dermal fibroblasts were isolated from ear
notch biopsies and used to study the cow-to-cow variation in mastitis severity that exists
independent of pathogen type and host physiological state. Fibroblasts were initially
isolated from a cohort of 60 multiparous, adult Holsteins at the same stage in lactation,
and their fibroblast phenotype was ranked from high to low innate response based on
LPS-induced IL-8 and IL-6 protein production and TLR4 gene expression. Six high
responders and six low responders were then chosen, primarily on differences in TLR4
gene expression and subsequently on their high or low production of both IL-8 and IL-6,
for additional experiments. Since fibroblast response was measured in different batches,
high and low cultures were re-challenged side-by-side and their difference in LPS105

induced production of IL-8 and IL-6 was confirmed. Bacterial endotoxin, or LPS, has
been used in countless studies to mimic the response to E. coli and other Gram-negative
bacteria, however, E. coli can also activate the innate response through receptors other
than TLR4, such as TLR5 that is activated by flagellin (Andersen-Nissen et al., 2007),
TLR9 that is activated by bacterial DNA (Magnusson et al., 2007), and DAP (Dglutamyl-meso-diaminopimelic acid)-dependent NOD1 activation (Kumar et al., 2011).
As such, in the second challenge, we stimulated fibroblasts isolated from high and low
responders with heat-killed E. coli along with LPS and showed that LPS-induced IL-8
production, and to a lesser extent IL-6 production, corresponds to response to E. coli.
Fibroblast IL-8 production is also higher in response to LPS than to E. coli, the opposite
of which is true for IL-6 that is produced in higher quantities in response to E. coli. The
IL-8/IL-6 discrepancy could be due to increased signaling pathways that induce IL-6
production following E. coli stimulation or in differential post-transcriptional regulatory
mechanisms such as mRNA stabilization that is shown to occur through interaction with
Arid5a for IL-6 transcripts (Nyati et al., 2017) and through p38 MAPK kinase and MK2
for IL-8 transcripts (Bhattacharyya et al., 2011, Moretto et al., 2012).
LPS-induced gene expression was then measured in high and low responding
fibroblasts to confirm that mRNA also reflects protein level differences and to measure
the expression of other important innate response genes. As expected, mRNA levels of
IL-8, IL-6, and TLR4 were significantly higher in high responding cultures at 2-hrs. post
LPS stimulation. We were, however, surprised that baseline (0-hr.) TLR4 expression only
trended towards significance with a 1.9-fold higher level of expression in high
responders, when in our initial ranking high responders exhibited a significant 6.9-fold
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higher level of expression using identical primer sets. In addition to inherent betweenassay variation, this discrepancy could be explained by length of cryopreservation and by
differences in initial cell density between the two sets of experiments. Expression of
TNF-α also trended towards higher levels in high responding cultures. This difference is
somewhat expected based on the role of TNF-α as a canonical pro-inflammatory and
pleiotropic cytokine with similar regulatory mechanisms to IL-6. Serum amyloid a3
(SAA3), an acute-phase protein that is induced by pro-inflammatory cytokines TNF-α, IL1ß and IL-6 following infection (Ye and Sun, 2015), was also measured post-LPS
treatment to determine if differences in fibroblast IL-6 production would be reflected in
SAA3 expression. Although expression of SAA3 was higher in high responders at all three
time points, no significant differences were measured, and the weak induction of SAA3
post-LPS stimulation suggests that more time may be required following LPS treatment
for IL-6 to elicit its effect on SAA3 expression. Finally, expression of CCL20, a CC-motif
chemokine that is induced in response to E. coli mastitis (Petzl et al., 2012) and has also
been shown to differ in expression in two other groups of high and low responding
fibroblasts (Green et al., 2015, Benjamin et al., 2016a), was measured. The chemokine
was highly up-regulated by 2-hrs. post LPS-treatment and overall, expression was higher
in high responding cells, but again the difference did not reach significance.
With the high and low fibroblast phenotype established, all 12 animals were
infected with the P4 strain of E. coli in their right-hind quarter to test their immune
response to infection. Overall, the response to intra-mammary challenge with E. coli
followed a similar magnitude and kinetics as has been noted in previous challenges with
E. coli (Bannerman et al., 2008, Kandasamy et al., 2011) and were reflective of acute,
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clinical mastitis. Unfortunately, very few differences were measured between the high
and low responding animals and in general, the responses were extremely variable
between all 12 animals. At the most severe, one high responder developed acute toxic
mastitis first evidenced by dysstasia at 24-hrs post-infection, which resulted in our
decision to humanely euthanize the animal at 48-hrs post-infection, as she did not
respond to treatment with Banamine® and systemic antibiotic therapy. Another low
responding animal completely dried off in her infected quarter at 192-hrs. post-infection
and remained very low in infected quarter milk production until the end of the study. In
general, milk production was drastically reduced by 24-hrs. post-infection in all animals
with no differences measured between high and low responders. Again, there was
significant animal-to-animal variation in their time to recovery to pre-infection milk
production, ranging from 5 to >14 days post-infection. Increase in somatic cell count,
mainly due to neutrophil recruitment into the mammary gland, tended to occur faster in
high responding animals. High responders already had an elevated SCC at 12-hrs. postinfection, whereby it took low responders until 24-hrs. post infection to see a significant
SCC increase. The role of the neutrophil as a beneficial first-line responder to clear
bacteria versus that of a main source of inflammatory-related damage through the
production of ROS, proteases and NET formation in the mammary gland has been the
subject of debate (Aitken et al., 2011). Efficient leukocyte influx into the mammary gland
is, however, thought to be beneficial for mastitis outcome (Burvenich et al., 2007) and in
the current study we show that early up-regulation of SCC does occur with enhanced
bacterial clearance. High responding animals that had an elevated SCC at 12-hrs. had
lower overall bacterial counts throughout the study, and this difference reached
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significance at several time points. Notably, while high responders peaked in their cfu/ml
of bacteria by 12-hrs., concurrent with their elevated SCC, cfu/ml of E. coli continued to
increase until 24-hrs. post infection in low responders. The difference in SCC was
abolished by 24-hrs., remaining at similar levels between the two groups for the
remainder of the study, and at 2-weeks post-infection SCC was still up-regulated in all
animals in comparison to pre-infection levels. There is the potential that if SCC were
measured for a longer period of time post-infection differences could be detected and
perhaps longer sampling time should be considered for future experiments.
Interestingly, in addition to higher SCC at 12-hrs. post-infection, high
responders had a significantly elevated febrile response at 12-hrs. in comparison to low
responders, and both groups peaked at 15-hrs. post-infection before returning to baseline
at 21-hrs. Although hyperpyrexia can be detrimental to the host, the febrile response is an
ancient and conserved innate defense to infection and is likely another factor that limited
bacterial growth in high responders (Cavaillon, 2012). Serum cytokine levels of TNF-α
and IL-6, two of the three main pyrogenic cytokines, did not correlate with fever
response, however, this may be due to the timing of serum collection and to the
administration of Banamine® or flunixin meglumine, a non-steroidal anti-inflammatory.
Flunixin inhibits the activity of cyclooxygenase enzymes that synthesize prostaglandin
(PGE2) from arachidonic acid, a process known to affect the innate response and systemic
cytokine production (Kalinski, 2012). The NSAID was administered to 7 of the 12
animals (4 HR and 3 LR) between 15-18-hrs. post-infection, in accordance with animal
welfare protocols, and represents one of the major but necessary limitations of the current
study.
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No differences were detected between high and low responders in the mammary
gland proteins that were measured, IL-8, IL-6 and BSA. Nevertheless, a comparison of
the area under the curve of milk cytokines versus milk BSA showed a significant
correlation (Figure 3.10) in their production over the duration of the infection, such that
animals with a prolonged cytokine response also exhibited more tissue damage.
Concentration of IL-8 was also significantly higher in high responders at 24-hrs. postinfection and likely contributes to the early elevation of milk SCC in high responders at
12-hrs. Unfortunately, the lack of any real difference in milk IL-6 and IL-8 indicates that
the fibroblast model may not accurately reflect the mammary gland environment,
contradicting the results of our previous studies. The strength and duration of proinflammatory cytokine and chemokine production in the mammary gland is, however,
directly related to tissue damage. Follow-up experiments should focus on the initial
response to infection, likely mediated by resident epithelial and immune cells, as this
response seems to be crucial for efficient leukocytosis and bacterial clearance. In
addition, more emphasis should be placed on down-regulation of the inflammatory
response as the majority of animals had a sufficient response to clear bacteria, but those
that did not recover as well tended to have a sustained inflammatory response.
Interleukin-10, an anti-inflammatory cytokine that exerts its negative effect on proinflammatory cytokine production through STAT3-dependent upregulation of SOCS3
(Mosser and Zhang, 2008), is also up-regulated in response to mastitis-related infections,
however, the role of IL-10 and other anti-inflammatory proteins in between-animal
variation in mastitis severity has not been established. Proteins, such as WISP-1 and IL22 have been shown to mediate epithelial cell recovery and proliferation following
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mechanical or infection related injury (Pociask et al., 2013, Quiros et al., 2017), a
response that would be crucial to the recovery of milk-producing cells that become
damaged during mastitis infection. The ability of the animal to clear apoptotic cells that
accumulate following infection could also affect recovery efforts since apoptotic cells
will become necrotic if not efficiently cleared, resulting in chronic autoimmune-related
inflammation (Munoz et al., 2017).
Finally, no difference was measured between high and low responders in their E.
coli-specific circulating IgG response and importantly, antibody response did not
correlate with ability to clear infection. This result agrees with previous literature stating
that antibody response is not a major contributor to E. coli or S. aureus clearance within
the mammary gland (Benjamin et al., 2015b, Herry et al., 2017). The role of the adaptive
response in determining between-cow differences in mastitis severity and duration should
be the subject of future research, specifically the role of Th-17 cells, which have been
shown to be the predominant T-cell responder in E. coli mastitis (Porcherie et al., 2016)
and are associated with a primarily neutrophilic response. However, other immune cell
types whose functions remain completely unknown in bovine mastitis, such as innate
lymphoid cells that are present in high numbers in mucosal tissue and γδ T cells that are
expressed at much higher levels in the bovine than other species, may also contribute to
differences in mastitis severity.
The current study shows that while the primary dermal fibroblast derived from
ear notch tissue is highly responsive to TLR agonists, the magnitude in innate
responsiveness does not correlate with severity of E. coli mastitis. This result contradicts
previous experiments in our lab where high responding animals, based on fibroblast IL-8
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production, develop more severe mastitis when challenged with either E. coli or S.
aureus. The main difference between the two studies was the location of fibroblast
isolation. Previously, fibroblasts were isolated through a shoulder biopsy, whereas in the
current experiment fibroblasts were isolated using an ear punch biopsy. It is possible that
cellular phenotype in fibroblasts isolated from shoulder biopsies more accurately reflect
mammary gland cellular response. Future experiments should consider reevaluating
whether the fibroblast is a useful model for response to mastitis and if location of
isolation affects cellular response. Cellular phenotype in the current study did reflect an
ability to more effectively clear bacteria from the mammary gland, as evidenced by high
responders having lower bacterial burden throughout the trial. It is tempting to speculate
that this difference in bacterial clearance is due to an earlier increase in leukocyte influx
into the mammary gland, but this result should be confirmed in follow-up studies.
Finally, as has been observed in both natural and experimental mastitis, significant
animal-to-animal variation was noted in the current experiment, whereby some animals
recovered very quickly from a milder infection, whereas others experienced severe
pathology and never recovered from infection. While it is known that in severe cases,
SCC, cytokine levels and tissue damage are elevated, and that milk production is
inhibited, the underlying factors that determine mastitis severity remain elusive and are
reflective of our relative lack of understanding of the optimal immune response to
mastitis. Future studies should aim to identify the precise cellular and molecular
components that determine a rapid, efficient and effective response that clears infection
while limiting collateral damage to mammary gland tissue.
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Table 5: Real-Time Quantitative PCR Primer Sequences
Gene Name
ß-Actin

Primer Sequence (5’ → 3’)
F: GCAAATGCTTCTAGGCGGACT
R: CAATCTCATCTCGTTTTCTGCG
F: TGAGGGAAATCAGGAAAATGT
R: CAGTGTTTGTGGCTGGAGTG

Reference
(Pareek et al.,
2005)
(Pareek et al.,
2005)

F: GCTGGCTGTTGCTCTCTTG
R: AGGTGTGGAATGTGTTTTTATGC

(Pareek et al.,
2005)

Serum Amyloid A3

F: CCTCAAGGAAGCTGGTCAAG
R: TACCTGGTCCCTGGTCATAC

(Bougarn et
al., 2011)

Tumor Necrosis Factor-α

F: TCTTCTCAAGCCTCAAGTAA
R: CCATGAGGGCATTGGCATAC

(Bougarn et
al., 2011)

Toll-like Receptor-4 [1]

F: AGGCAGCCATAACTTCTCCA
R: GCCCTGAAATGTGTCGTCTT

(Sheridan et
al., 2016)

Toll-like Receptor-4 [2]

F: CCTCTCTAGCCTTCAGGTGC
R: TAAAGGCTCTGCACACATCA

Designed in
house

Interleukin-6
Interleukin-8
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Figure 3.1: Dermal fibroblast ranking by TLR4 expression and LPS-induced IL-6
and IL-8 production.
Fibroblasts were revived from cryopreservation and treated with 100 ng/ml of LPS or
media alone for 24 hours. Protein levels of IL-8 and IL-6 were measured in challenge
media. A normalized rank for LPS response was generated by adjusting IL-8 and IL-6
fg/cell to the challenge batch mean and standard deviation. The resulting variables are
presented here as an adjusted rank from -1.50 to 2.33 for IL-8 and from -1.65 to 2.54 for
IL-6. Expression of TLR4 was measured in untreated (media only) cultures using two
different primer sets, which had a high degree of correlation. Gene expression values are
presented as the change in cycles to threshold (ΔCT) of TLR4 versus a housekeeping
119

gene, β-Actin. The 6 selected high responders are highlighted in red and the 6 selected
low responders are highlighted in blue.

Figure 3.2: Fibroblast production of IL-6 and IL-8 in response to LPS and heat
killed E. coli.
Fibroblasts that were isolated from the 6-selected high (HR) and 6-selected low (LR)
responders were revived a second time and challenged side-by-side with heat-killed E.
coli (MOI 10), 100 ng/ml of LPS or media alone for 24 hrs. Protein concentrations of IL6 (panel A) and IL-8 (panel B) were then measured in the challenge media and compared
using an unpaired Mann-Whitney U test. Results are presented as fg/cell ± SEM and
*=P<0.05 and ***=P<0.001. A Spearman rank correlation analysis was performed to
compare fibroblast production of IL-6 (panel C) and IL-8 (panel D) when challenged
with heat-killed E. coli versus LPS and **=P<0.01.
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Figure 3.3. Fibroblast gene expression in response to LPS treatment.
Fibroblasts from 6 selected high responders (HR) and 6 selected low responders (LR)
were treated with 100 ng/ml LPS for 0, 2 and 8 hours. Total RNA was extracted at each
time point to determine gene expression levels of (A) IL8, (B) IL6, (C) TLR4, (D) TNFα, (E) SAA3 and (F) CCL20. Values are presented as the change in cycles to threshold
(ΔCT) ± SEM in comparison to β-Actin. The p-values presented in each panel signify the
results of a 2-way repeated measures ANOVA that was done to determine the
significance of Response x Time gene expression. A Bonferroni’s multiple comparisons
test was then done to determine significance at each time point where *=P<0.05. Values
presented above each time point indicate fold change in gene expression where
expression is greater in HR cultures and fold change is ≥2.0.
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Figure 3.4: Temperature response.
Febrile response to E. coli infection was measured in high (HR, n=5) and low (LR, n=6)
responding animals by monitoring rectal temperatures for 96 hrs. post infection.
Temperatures are presented as mean ºC ± SEM. A linear mixed model was used to
determine significance based on Response x Time and the corresponding p-value is
presented. In addition, multiple comparisons testing was performed using the least square
means method to determine significance at each time point where *=P<0.05.
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Figure 3.5: Infected quarter milk production.
Milk production was measured in the infected right hind quarter for up to 14 days post E.
coli infection. Milk yield for high (HR, n=5) and low (LR, n=6) responding animals is
presented as mean milk weight in lbs. ± SEM. A linear mixed model was used to
determine significance based on Response x Time and the corresponding p-value is
presented. In addition, multiple comparisons testing was done using the least square
means method to determine significance at each time point. There was no significant
difference in milk production between HR and LR animals at any time point infection.
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Figure 3.6: Infected quarter somatic cell count and bacterial clearance.
Somatic cell count (SCC/ml) and cfu/ml of E. coli were measured in milk collected from
the infected right hind quarter for up to 14 days post E. coli infection. Somatic cell counts
for high (HR, n=5) and low (LR, n=6) responding animals are presented as SCC/ml (x
106) (panel A) and SCC/ml (x 103) (panel B) ± SEM. Colony forming units (cfu/ml) of
bacteria were log-transformed and are presented as mean cfu/ml ± SEM. A linear mixed
model was used to determine significance based on Response x Time for overall SCC and
bacteria and corresponding p-values are presented in each panel. In addition, multiple
comparisons testing was done using the least square means method to determine
significance at each time point where✝=P≤0.10 and *=P<0.05. An unpaired MannWhitney U test was used to determine significance of SCC increase at 12-hrs. post
infection (SCC at 12 HPI – SCC at 0 HPI).
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Figure 3.7: Infected quarter protein response.
Concentrations of IL-8 (panel A), IL-6 (panel B) and BSA (panel C) were measured in
whey collected from the infected right-hind quarter for 240 hours post infection. Levels
of IL-8 and IL-6 from high responding (HR, n=5) and low responding (LR, n=6) animals
are presented as ng/ml ± SEM. BSA levels from each group are presented as mg/ml ±
SEM. A linear mixed model was used to determine significance based on Response x
Time and corresponding p-values are presented in each panel. In addition, multiple
comparisons testing was performed using the least squares means method to determine
significance at each time point and *=P<0.05.
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Figure 3.8: Systemic response to infection.
Concentrations of circulating TNF-α (panel A) and IL-6 (panel B) were measured for 36
hrs. post infection. Serum cytokine concentrations are presented as mean ng/ml ± SEM
and significance was determined using a 2-way repeated measures ANOVA with
Bonferroni’s multiple comparisons testing to determine significance at each time point
where✝=P<0.10.
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Figure 3.9: Humoral response to infection.
E. coli-specific total IgG was measured in plasma from high (HR, n=5) and low (LR,
n=6) responding animals at days 0, 7 and 14 following E. coli infection. Values are
presented as the mean (± SEM) optical density of E. coli-specific ELISA wells minus
blank control wells. Significance was determined using a 2-way repeated measures
ANOVA with Bonferroni’s multiple comparisons testing. No significant differences were
measured between HR and LR animals at any time post infection.
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Figure 3.10: Comparison of milk cytokine response to tissue damage following E.
coli infection.

Area under the curve values of IL8, IL6, and BSA concentrations was determined in milk
of all infected animals (5 high responders and 6 low responders) for 10 days postinfection. A Spearman rank correlation analysis was then performed to determine
whether milk concentrations of IL-8 (panel A) and IL-6 (panel B) were significantly
associated with milk BSA and *=P<0.05 and **=P<0.01.
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CHAPTER 4: NEONATAL LPS EXPOSURE DOES NOT DIMINISH THE
INNATE IMMUNE RESPONSE TO A SUBSEQUENT LPS CHALLENGE IN
HOLSTEIN BULL CALVES.
4.1. Abstract
The innate immune response following experimental mastitis is quite variable
between individual dairy cattle. An inflammatory response that minimizes collateral
damage to the mammary gland while still effectively resolving the infection following
pathogen exposure is beneficial to dairy producers. The ability of an LPS exposure in
early life to generate a low-responding phenotype and thus reduce the inflammatory
response to a later life LPS challenge was investigated in neonatal bull calves. Ten
Holstein bull calves were randomly assigned to either an early life LPS (ELL) group
(n=5) or an early life saline (ELS) group (n=5). At 7 days of age, calves received either
LPS or saline, and at 32 days of age all calves were challenged with an intravenous dose
of LPS to determine the effect of the early life treatment (LPS or saline) on the immune
response generated towards a subsequent LPS challenge. Dermal fibroblast (DF) and
monocyte-derived macrophage (MDM) cultures from each calf were established at age
20 and 27 d, respectively, to model sustained impacts from the early life LPS exposure on
gene expression and protein production of components within the LPS response pathway.
The ELL calves had greater levels of plasma IL-6 and TNF-α than the ELS calves
following the early life LPS or saline treatments. However, levels of these two immune
markers were similar between ELL and ELS calves when both groups were subsequently
challenged with LPS. A comparison of the in vitro LPS-responses of the ELL and ELS
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calves revealed similar patterns of protein production and gene expression following an
LPS challenge of both DF and MDM cultures established from the treatment groups.
While an early life exposure to LPS did not result in a dampened inflammatory response
towards a later LPS challenge in these neonatal bull calves, the potential that exposure to
inflammation or stress in early life or in utero can create an offspring with a lowresponding phenotype as an adult is intriguing and has been documented in rodents.
Further work is needed to determine if an inflammatory exposure in utero in a dairy
animal would result in a low-responding innate immune phenotype.
Keywords: early life LPS, inter-animal variation, inflammatory response
4.2. Introduction
The innate immune system plays a key role in the clearance of pathogens
following an infection such as bovine mastitis. This acute, non-specific response is
initiated when conserved pathogen associated molecular patterns (PAMP) from a diverse
number of pathogens are recognized by germ-line encoded receptors known as pattern
recognition receptors (PRR) that are expressed on a variety of cell types.
Lipopolysaccharide (LPS) from the cell wall of Gram-negative bacteria, a major
causative agent of bovine mastitis, is recognized by the PRR toll-like receptor (TLR) 4.
Once LPS is recognized by TLR4, an intracellular signaling cascade activates
transcription factors such as nuclear factor-kappa B (NF-κB) that promote the
transcription of cytokines including interleukin (IL) -1β, -6, and tumor necrosis factor
alpha (TNF-α) (Kawai and Akira, 2007). These three cytokines play major roles in
driving the pro-inflammatory response by promoting febrility, inflammation, and
activation of leukocytes to aid in the clearance of the pathogen (Bannerman, 2009).
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However, an excessive inflammatory response can be detrimental to the host, causing
collateral damage to tissues, such as the mammary gland (Schukken et al., 2011), thereby
reducing future milk production and profit for dairy producers (Grohn et al., 2004). The
factors that lead to a more robust inflammatory response in some animals and not in
others have not been fully elucidated. Even in controlled intra-mammary challenge
models of mastitis, inter-animal variation has been observed in cytokine concentrations in
milk or blood, milk bacterial counts, and severity of clinical signs (Schukken et al., 1999,
Lee et al., 2006, Simojoki et al., 2009), supporting the belief that host factors play a
major role in determining the severity and outcome of mammary infections (Burvenich et
al., 2003).
Genetic polymorphisms in components of the host’s pathogen recognition
pathways could lead to the variable immune responses between animals. Within cattle, a
number of single nucleotide polymorphisms (SNP) have been identified in genes
encoding the toll-like receptors (Novak, 2014), and SNPs in these and other genes
involved in the inflammatory response have been associated with individual differences
in their resistance to mastitis (Thompson-Crispi et al., 2014). Epigenetic modifications of
an animal’s DNA can also contribute to the observed phenotypic differences in the
immune response of individuals. DNA methylation in particular, has been shown to
influence transcription of genes (Moore et al., 2013). In human diseases such as
periodontitis and rheumatoid arthritis, aberrant methylation within immune response
genes has been linked to an increased risk of disease or severity of signs (Benakanakere
et al., 2015, Kojima et al., 2015). The role that epigenetics may play in modulating the
bovine innate immune response is now being investigated (Paibomesai et al., 2013, Green
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and Kerr, 2014, Chang et al., 2015a) and may provide a more complete picture of how
genetic and epigenetic factors combine to produce inflammatory responses following
bovine mastitis that range from mild to severe.
While pathogen detection by innate immune cells prompts a robust inflammatory
response that is essential to resolving the infection, this response must be under tight
regulation to prevent excessive inflammation and extensive tissue damage. There are
some mechanisms that can generate a low responding phenotype in an animal, either
transiently or long-term, following pathogen exposure. An animal exposed to a low level
of LPS can develop a short-term reduction or even an abolished inflammatory response
towards a subsequent LPS exposure, thereby exhibiting endotoxin tolerance (Biswas and
Lopez-Collazo, 2009). It has been suggested that this tolerized state, generated primarily
through macrophages and their reduced production of TNF-α, could be due to a variety of
events, including methylation of histone tails, which modify the chromatin structure of
anti- and pro-inflammatory genes (El Gazzar et al., 2007), up-regulation of antiinflammatory or inhibitory genes (Fan and Cook, 2004), and micro-RNA regulation of
immune response genes (Baltimore et al., 2008). Additionally, there is abundant evidence
that inflammation or disease in early life can have long-term consequences on the innate
immune response of an animal. Several studies completed on rodents have shown that
neonatal LPS exposure can cause a reduction in the cytokine or febrile response
following LPS challenge of the adult rat (Ellis et al., 2005, Spencer et al., 2011). Thus, it
would appear that an early life exposure to LPS has the potential to modify the
inflammatory response in the adult animal, creating a low-responding phenotype.
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In this current study, we investigated if a single exposure to LPS during the
neonatal period would modify the in vivo inflammatory response to a subsequent LPS
challenge in dairy calves. Additionally, two cellular models, dermal fibroblasts and
monocyte-derived macrophages, were utilized to explore if early life exposure to LPS
would result in sustained epigenetic modifications of the LPS response of these cells,
thereby influencing the innate immune response.
4.3. Materials and Methods
4.3.1 Experimental design and animal use
Holstein bull calves that were free of clinical disease and had received 4 L of
pooled colostrum within 1 h of birth and a second feeding of pooled colostrum 12 h later
were purchased from a collaborating dairy farm. The calves (n=10) were brought to the
University of Vermont Miller Research Farm at 3.3 ± 0.5 days of age and given a fourday acclimation period. Calves were housed in individual plastic calf hutches and had
access to a fenced-in outside area of approximately 3 m x 3 m. Free choice water and a
commercially available calf starter were offered to each calf throughout the trial. Calves
were bucket-fed an ad libitum amount of a 23% protein, 22% fat milk replacer (OptiMilk
Nature’s Formula, Arctic Blend; Poulin Grain, Newport, VT) divided between two
feedings per day throughout the study period. The University of Vermont Institutional
Animal Use and Care Committee approved of all experimental procedures prior to the
commencement of this study.
4.3.2 Early life treatment
Calves were randomly divided into two groups: Early Life LPS (ELL) and Early
Life Saline (ELS), each consisting of five calves. At approximately 7 days of age,
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roughly 2 h after the morning feeding, the early life treatment was administered to each
calf. Calves in the ELL group received a jugular injection of 0.5 μg of LPS/kg of body
weight isolated from Escherichia coli O111:B4 (Sigma, St. Louis, MO) diluted in saline,
while the calves in the ELS group received an equal volume of saline. The dose of LPS
was based on our previous experiments with 14 month-old heifers (Green et al., 2011b).
Prior to a single injection of either the LPS solution or saline, the fur along the jugular
vein area was clipped and the area was thoroughly cleansed with 70% ethanol. Rectal
temperatures were collected immediately prior to the injection (hour 0) and hourly for
seven hours. Blood samples were collected at hours 0, 2, and 6 post-LPS infusion with an
18-gauge Vacutainer needle (BD, Franklin Lakes, NJ) and a 10 ml Vacutainer tube
containing 158 USP Units of Sodium Heparin (BD). Tubes were inverted several times to
ensure adequate mixing of the anti-coagulant and stored on ice for approximately 2 h
before centrifugation at 800 x g for 20 min at 4°C. Plasma was then collected and stored
at -20°C for future analysis.
4.3.3 LPS challenge
Each calf was fitted with a jugular catheter for the LPS challenge to allow for
easier administration of the LPS solution and blood sampling. Twenty-four hours prior to
the catheterization, a 50 cm section of polyethylene tubing (I.D. 1.19mm, O.D. 1.70mm;
Intramedic, BD) was cut per calf and sanitized in a Nolvasan S solution (Pfizer, NY,
NY). The day of catheterization, each calf was secured in a headlock, the fur was clipped
on top of the jugular vein, and the area was cleansed with 70% ethanol. A 12-gauge, 1.5inch metal hub needle (Hamilton, Reno, NV) was then inserted into the jugular vein, and
20-25 cm of the polyethylene tubing was inserted through the needle. The needle was
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then removed, an 18-guage luer stub adapter (Intramedic) attached, and the catheter filled
with heparinized saline. The following day, after morning feeding, a single dose of 0.25
μg of LPS/kg of body weight isolated from E. coli O111:B4 (Sigma) was infused into
each calf at hour 0. Heparinized blood samples were collected at -30 min, and then at
hours 1, 2, 3, 5, and 7 post-infusion and stored on ice. Plasma was isolated within 2 h and
stored at -20°C for future analysis.
4.3.4 Plasma IL-6 and TNF-α quantification
Concentrations of IL-6 in plasma samples were determined with a commercially
available bovine IL-6 ELISA kit (Thermo Scientific, Rockford, IL). The capture and
detection antibodies were both plated at 1:100 and the streptavidin-horseradish
peroxidase was plated at 1:400. Recombinant bovine IL-6 (Thermo Scientific) was used
at the assay standard. Concentrations of tumor necrosis factor alpha (TNF-α) were
determined via RIA as previously described (Elsasser et al., 2005).
4.3.5 Dermal fibroblast isolation
Skin biopsies were collected from the ELL (n=5) and ELS (n=5) calves as
previously described (Kandasamy et al., 2011). Briefly, dermal fibroblasts (DF) were
isolated following a 6 h digest with 0.5% collagenase type I enzyme (Life Technologies,
Grand Island, NY). The collagenase-digested tissue was filtered, centrifuged, and the cell
pellet was reconstituted with Dulbecco’s modified Eagle medium (DMEM; Hyclone
Laboratories, Logan, UT) containing 10% fetal bovine serum (FBS; Hyclone
Laboratories), a 1X antibiotic cocktail (100 U/ml of penicillin, 100 μg/ml of
streptomycin, and 0.25 μg/ml of amphotericin B; Hyclone Laboratories), and 1X insulintransferrin-selenium (ITS; Mediatech, Herndon, VA) and seeded into a 25-cm2 flask
135

(Corning Inc., Corning, NY). Media was replaced after an initial 16 h incubation with
fresh DMEM (10% FBS, 1X antibiotic cocktail, and 1X ITS). Once confluency was
reached, cells were detached with 0.25% trypsin (MP Biomedical, Santa Ana, CA) and
seeded into a 75-cm2 flask. After approximately 4 days, cells were expanded into three
75-cm2 flasks. Finally, confluent cultures were lifted with trypsin and aliquots of the third
passage were diluted in DMEM supplemented with 20% FBS and 10% dimethyl
sulfoxide (Sigma) and cryopreserved in liquid nitrogen for subsequent revival, expansion,
and challenges.
4.3.6 Adherent mononuclear cell isolation and culturing
A 180 ml blood sample was obtained from each of the ELL (n=5) and ELS (n=5)
calves via jugular venipuncture with a 60 cc syringe pretreated with heparin (10,000 USP
units/ml; Sagent Pharmaceuticals, Schaumburg, IL) and immediately transferred to
heparinized vacutainer tubes (BD). Samples were stored on ice for approximately one
hour prior to processing. Vacutainer tubes were centrifuged at 800 x g for 20 min at 4°C.
Peripheral blood mononuclear cells (PBMC) were removed and treated with red blood
cell lysis buffer (Biolegend, San Diego, CA). No more than five buffy coats were treated
with 7.5 ml of 1X red blood cell lysis buffer and inverted for 30 s. Two washes were then
performed using sterile Dulbecco’s phosphate-buffered-saline (DPBS, Hyclone
Laboratories) by centrifuging samples at 500x g for 5 min at room temperature. After the
second wash, cells were resuspended in 30 ml of DPBS and 10 ml of a Percoll (GE
Healthcare, Sweden) solution with a specific density of 1.077 g/cm3 (mixture with 1.5 M
NaCl and 30% endotoxin-free water) was carefully underlain below the sample. The
Percoll gradient was centrifuged at 400 x g for 40 min at room temperature with no
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brake. The PBMC layer was removed from the interface of the DPBS and Percoll then
placed into a clean polypropylene tube. One more DPBS wash was performed as stated
above to remove residual Percoll. After washing, PBMC were resuspended in 30 ml
DPBS and centrifuged at 250 x g for 12 min at room temperature to remove platelets.
After the platelet spin, the cells were resuspended in DMEM, 15% FBS, 1X ITS and 1X
penicillin-streptomycin (100 U/ml of penicillin and 100 μg/ml of streptomycin). The
PBMC were then transferred to a 25-cm2 flask and incubated in a humidified chamber at
37°C and 5% CO2 for 3 h. Non-adherent cells were removed and placed in a clean
polypropylene tube and adherent cells were washed with DPBS and fresh DMEM media
was added. Non-adherent cells were transferred to a second 25-cm2 flask and those that
had adhered overnight were washed the next morning at which time fresh media was
added. Mononuclear cells were incubated for 5 d and media was replaced as needed.
After 5 d, cells were lifted with 0.25% trypsin, and the 3 h cultures and overnight cultures
were combined and transferred to a 12-well plate at a concentration of 1.0 x 105 cells/ml
in a total volume of 1 ml. The cells were cultured for 3 more days to allow for complete
macrophage differentiation.
4.3.7 In vitro challenges
Aliquots of fibroblast cultures isolated from the ten bull calves were revived in
parallel and grown to confluency in a 75-cm2 flask. Cells were then detached with
trypsin, counted, and seeded into 6-well plates at a concentration of 1.25 x 105 cells/ml in
2 ml total/well. Following a 24 h incubation, cells were exposed to 500 ng/ml of ultrapure LPS isolated from E. coli O111:B4 (Sigma) or fresh culture media for 24 h. Media
was then collected and centrifuged at 10,000x g for 1 minute to remove cell debris and
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the supernatant was stored at -20°C for future analysis. Cells were lysed at hours 0 and 24
post-LPS, and RNA was extracted at stored at -80°C (5 Prime, Gaithersburg, MD) until
future analysis.
After 8 days in culture, macrophages were treated with either media or media
containing 100 ng/ml of LPS isolated from E. coli O111:B4 for 24 h, after which media
was removed and centrifuged at 10,000x g for 1 min and supernatant was stored at -20°C
until further analysis. Cells were lysed at hours 0 and 24 post-LPS, and RNA was
extracted at stored at -80°C (5 Prime, Gaithersburg, MD) until future analysis.
4.3.8 Quantification of in vitro immune response proteins
Levels of IL-8 protein produced from fibroblast and MDM cultures following an
LPS challenge were determined in duplicate with a commercially available bovine IL-8
ELISA kit (Mabtech, Cincinnati, OH) as per manufacturer’s instructions with some
modifications. A solution of 1 μg/ml of the monoclonal coating antibody (MT8H6) was
plated in 0.05 M bi-carbonate buffer on a high affinity 96-well ELISA plate (Corning
Life Sciences, Tewksbury, MA) and incubated overnight at 4°C. Media samples or
recombinant bovine IL-8 standard (Thermo Scientific) were plated following a series of
three washes with a solution of DPBS and 0.05% Tween-20 (DPBS-T; Fisher
Bioreagents, Fair Lawn, NJ) and incubated for 2 h at 20°C. Plates were washed with
DPBS-T and a monoclonal detection antibody (26ES-Biotin) was plated at 0.025 μg/ml
and incubated for 1 h at 20°C. After a series of washes, streptavidin-horseradish
peroxidase (Sigma) was plated at 0.1 μg/ml and incubated for 1 h. Lastly, 3,3′,5,5′tetramethylbenzidine (TMB) substrate (Fisher Scientific, Pittsburgh, PA) was added for
approximately 7 min, and the reaction was stopped with 1M H2SO4.
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Concentrations of TNF-α protein in macrophage-conditioned media were
determined in duplicate using a custom sandwich ELISA as described above except:
coating antibody (polyclonal rabbit anti-bovine TNF-α, 1 mg/ml, Thermo Scientific) was
diluted 1:200 in 0.05 M bi-carbonate buffer, recombinant bovine TNF-α (Kingfisher
Biotech, Inc., St. Paul, MN) was used as standard, and biotinylated secondary antibody
(rabbit anti-bovine TNF-α, Thermo Scientific) was diluted 1:1,000 to a concentration of
0.25 µg/ml in DPBS-T. The detection limit of the assay was 156 pg/ml. The
concentrations of IL-1β were similarly quantified using a commercially available
sandwich ELISA (Thermo Scientific). The detection limit of the assay was 62 pg/ml. All
ELISA reactions were quantitated by measuring absorbance at 450nm and analyzed by a
4-parameter analysis with optical density corrected against blank wells (Synergy-HT,
Bio-Tek, Winnoski, VT).
4.3.9 Quantitative real time-PCR
Dermal fibroblasts (DF) and monocyte-derived macrophages (MDM) were
isolated and cultured for an LPS challenge as described above for each of the ten calves
and cell lysate was collected at hours 0 and 24 post-LPS for each culture. The
PurefectPure RNA Cultured Cell extraction kit (5 Prime), which includes a DNase
treatment step to eliminate DNA contamination, was used to extract total RNA from the
cell lysate. RNA concentration was determined using a Qubit Spectrofluorometer (Life
Technologies, Carlsbad, CA). The Improm II Reverse Transcriptase Kit (Promega,
Madison, WI) was utilized to complete first strand cDNA synthesis. The following genes
were selected for real-time PCR analysis: TLR4, IL6, IL8 (in both DF and MDM cultures)
and CD14, IL-1β receptor, and IL-1β (in MDM cultures only). Expression levels of these
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genes were determined by quantitative real-time PCR (qRT-PCR) with a 7500 Fastrun
Machine (Applied Biosystems, Carlsbad, CA) using Fermentas Maxima SYBR
Green/Fluorescein qPCR Mastermix (Thermo Scientific). An endogenous control gene,
β-actin was used for normalization of the target genes. Sequences for the constructed
primers are listed in Table 1.
4.3.10 Statistical analysis
Differences in rectal temperatures, as well as concentrations of plasma TNF-α and
IL-6, were determined between the ELL and the ELS calves following the early life
treatment and the LPS challenge by a repeated measures ANOVA using Prism 6.0
(GraphPad Software Inc., La Jolla, CA). Differences in immune response proteins and
gene expression following an LPS challenge between the fibroblast and monocytederived macrophage cultures collected from the ELL and ELS calves were determined by
an unpaired t-test in Prism 6.0.
4.4. Results
Blood samples were collected from each calf at hours 0, 2, and 6 following the
early life treatment (LPS or saline) to determine concentrations of two key inflammatory
cytokines, IL-6 and TNF-α. Prior to the treatment, levels of IL-6 (Figure 4.2A) and TNFα (Figure 4.2B) were similar between the ELL and ELS calves. However, by hour 2 posttreatment, levels of IL-6 and TNF-α in the ELL calves had reached peak values (P < 0.05;
14.4 ± 3.1 and 3.2 ± 1.0 ng/ml, respectively), while no increase in either cytokine was
observed in the ELS calves. At 6 h post-treatment, IL-6 levels remained elevated (P <
0.05) in the ELL calves, and plasma TNF-α had decreased to pre-treatment levels, with
no detectable changes in plasma IL-6 or TNF-α from the ELS calves. Moderate
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respiratory distress and lethargy was typically observed in the ELL animals. Rectal
temperatures did not increase due to the early life treatment in either group and were
similar between the ELL and the ELS calves (Figure 4.2C).
Twenty-five days after the early life treatment, an LPS challenge was performed
on all ten calves to compare the LPS response between calves that had received LPS
(n=5) and calves that had received saline (n=5) in early life. Following an LPS bolus of
0.25 μg/kg of body weight, plasma levels of IL-6 increased in both the ELL and ELS
calves, reaching similar peak values (6.7 ± 0.6 and 6.1 ± 0.7 ng/ml) at hour 3, and
decreasing slightly by hour 7 post-infusion (Figure 4.3A). Plasma TNF-α reached
maximum concentrations in ELL calves 1 h following LPS (4.8 ± 1.3 ng/ml) while TNFα concentrations peaked in ELS calves 2 h post-LPS (3.9 ± 1.1 ng/ml). Despite the early
temporal differences, TNF-α levels were similar between ELL and ELS calves for the
remainder of the challenge (Figure 4.3B). Rectal temperatures following the LPS
challenge decreased slightly in both groups, as shown in Figure 4.3C, however, there
were no differences observed between the ELL and ELS calves.
Skin biopsies were collected from each calf 13 days after the early life treatment
and 12 days before the LPS challenge to isolate dermal fibroblasts (DF). This time point
was selected in anticipation that any epigenetic modifications resulting from the early life
LPS treatment that could influence the fibroblast LPS response would be present in our
cellular model. Aliquots of fibroblasts from each animal were revived and challenged in
parallel with LPS (500 ng/ml) for 24 h, and levels of IL-6 and IL-8 protein secreted in
media were used as indicators of that fibroblast culture’s LPS response. Fibroblasts
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isolated from the ELL and ELS calves at approximately 20 d of age produced similar
levels of IL-6 (Figure 4.4A) and IL-8 (Figure 4.4C) protein following LPS exposure.
Mononuclear cell-derived macrophages (MDM) were isolated from each of the
calves (n=10) 21 days after the early life treatment and 4 days before the LPS challenge
to determine if the in vitro LPS response from the MDM would be dampened due to the
early life LPS treatment. MDM cultures were seeded into 6-well plates, incubated for 24
h, and then challenged with LPS (100 ng/ml) for 24 h. Concentrations of IL-6 and IL-8
protein produced by the MDM cultures following LPS exposure were similar between the
treatment groups (Figure 4.4B and 4.4D). Additionally, levels of IL-1β and TNF-α were
determined in MDM supernatant following LPS treatment (Figure 4.4E and 4.4F,
respectively). Each of the immune response proteins measured in MDM cultures
established from the calves were similar between the two early life treatment groups
(ELL vs. ELS).
Expression levels of genes involved with the LPS recognition and response
pathway were investigated in both the DF and MDM cultures established from all calves.
Total RNA was collected from DF and MDM at hours 0 and 24 post-LPS, and gene
message was determined by qRT-PCR. Expression of TLR4, the receptor responsible for
LPS recognition, was consistent following LPS stimulation and was not different between
the ELL and ELS groups in either DF or MDM cultures, but was much greater in the
MDM cultures (Figure 4.5A and D). The cytokine IL6 and chemokine IL8 are critical
immune response genes following LPS exposure, and the expression of these genes
increased from hour 0 to hour 24 in both cellular models (Figure 4.5B and E). However,
no differences were observed between the ELL and ELS calves in either cellular model,
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although the expression of both IL-6 and IL-8 was much greater in the MDM cultures.
Levels of expression of three other genes (CD14, IL-1β receptor, and IL-1β) were
determined in control and LPS-treated MDM cultures from the ELL and ELS calves
(Figure 4.5G, H, and I). The expression of IL-1β was markedly induced by LPS treatment
of the MDM cultures, while the expression of CD14 and the IL-1β receptor were not
affected. However, there were no differences in gene expression between the cultures
established from the ELL and ELS calves.
4.5. Discussion
Previous work from our laboratory and others has shown that dairy cattle manifest
a wide range of immune responses following experimentally induced E. coli
(Kornalijnslijper et al., 2003, Bannerman et al., 2004, Kandasamy et al., 2011) or
Staphylococcus aureus (Schukken et al., 1999, Bannerman et al., 2004, Benjamin et al.,
2015a) mastitis. Some animals exhibit a much more robust inflammatory response during
mastitis, characterized by high levels of IL-8, IL-6, and TNF-α, which can lead to severe
clinical signs and damage to the mammary tissue. Inter-animal variation in the expression
of genes within the LPS response pathway, including TLR4, the receptor for LPS, may
lead to individual differences in the ability to recognize and respond to Gram-negative
pathogens (Kandasamy and Kerr, 2012). A genetic component to individual differences is
highly likely, but new research suggests that epigenetics may also play a role. For
example, we have found that the LPS responsiveness of an animal’s fibroblasts changes
with age. In side-by-side cultures of cells recovered from cryopreservation but originally
collected from the same animals at different ages, we find a marked increase in response
to LPS stimulation. Furthermore, the age-dependent difference in LPS response of these
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cells can be abolished by treatment with epigenetic modifiers (Green and Kerr, 2014).
Expanding on the inter-animal variation observed in the fibroblast model, cultures
established from dairy and beef animals displayed contrasting responses following an in
vitro LPS exposure. Whole transcriptome analysis of LPS-treated cultures revealed large
breed-dependent differences in the expression of many LPS-responsive genes, including
TLR4, IL8, TNF, CCL5, and CCL20 (Benjamin et al., 2016b). These genes, which are
associated with the inflammatory response to LPS, were expressed between 2.5- and 7.0fold higher in Holstein fibroblast cultures as compared to Angus cultures. While genetics
may contribute to the contrasting in vitro LPS responses between these breeds, offspring
from each breed experience very different early life environments, which could lead to
varying degrees of epigenetic modifications between the dairy and beef breeds,
potentially moderating inflammatory gene expression.
4.5.1 Impact of neonatal inflammation
Several studies have shown that inflammation in the neonatal period (shortly after
birth) can lead to sustained suppression of the innate immune response to a subsequent
inflammatory challenge. Ellis et al. (2005) observed reduced plasma levels of TNF-α and
IL-1β as well as a suppressed febrile response following an LPS challenge of adult rats
that had been exposed to LPS at 14 days of age compared to saline-exposed controls.
Similarly, adult rats that had previously received a neonatal dose of LPS (100 μg/kg) at
14 or 21 days of age produced a lower febrile response compared to neonatal saline
controls during a subsequent LPS (50 μg/kg) challenge (Spencer et al., 2006). However,
the timing of the neonatal exposure was found to be critical in that LPS treatments given
at 7 or 28 days of age were not effective. Additionally, the suppressive effect is not
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observed if the adult challenge dose of LPS is increased to a septic dose of 1 mg/kg
(Spencer et al., 2010). In the current study, we hypothesized that an early life LPS
exposure would generate a low-responding phenotype in Holstein calves towards a
subsequent LPS challenge. Surprisingly, ELL calves mounted a similar inflammatory
response as the ELS calves during the later LPS challenge that was completed on all
calves 25 days after the first LPS or saline exposure. Plasma levels of TNF-α and IL-6
during the later LPS challenge were comparable between treatment groups, showing the
early life treatment with LPS (0.5 μg/kg) at 7 days of age did not dampen the subsequent
inflammatory response to LPS (0.25 μg/kg). The doses used did produce substantial
inflammation and may have been too high to generate the expected result.
Although other studies have shown that administering LPS in the neonatal period
does reduce the LPS response in the adult, most of these studies have been completed in
rats (Spencer et al., 2011, Wang et al., 2011). Different rates of development and maturity
within the immune system between calves and rodents may be one explanation for the
lack of differences between our LPS- and saline- treated calves. Offspring from species
with a comparatively short gestation period, such as rats (length of 21 days), are born
with a less mature immune system than offspring from species with a longer gestation,
for example cattle (length of 9 months) (Holsapple et al., 2003). A less mature immune
system during the neonatal period in a rat pup may provide an opportunity for
inflammation to epigenetically modify the genes of the immune response in the adult,
whereas the immune system of a neonatal calf may be less vulnerable to those types of
modifications during that same stage of life. Following parturition, the humoral and cellmediated immune response of the calf is much lower than an adult cow, but within the
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first month of life, B-cell numbers increase and the cell-mediated response is similar to
that of an adult animal (Barrington and Parish, 2001). The immune system in newborn
rats is immature, and continues to develop during the postnatal period and although an
immune response can be mounted at 21 days of age, it is not of the same magnitude as an
adult animal (Holsapple et al., 2003). A comparison of the degree of immune system
development of the rat pups in studies mentioned previously and the calves in this current
study suggests the timing of the LPS exposure in the neonatal calves may have been too
late to obtain a reduction in the inflammatory response towards an LPS challenge.
4.5.2 Fetal programming: maternal inflammation and nutrition
Exposure to bacterial molecules or inflammation in utero can also alter aspects of
an offspring’s behavior, health, and development. Increases in anxiety and depressionlike behaviors, as well as an increased propensity towards developing schizophrenia have
been observed in rodents whose dams suffered stress or inflammation during gestation
(Ashdown et al., 2006, Depino, 2015). Additionally, several studies have shown that the
inflammatory response of the offspring can be suppressed following in utero LPS
exposure. For example, Lasala and Zhou (2007) found that an intraperitoneal injection of
LPS given to rats on day 18 of pregnancy greatly reduced the inflammatory response
(serum levels of TNF-α, IL-1β, and IL-6) of the resulting pups when they were
challenged with LPS at 21 days of age. In a similar study, adult rats that were exposed to
LPS in utero at days 16, 18, and 20 of gestation have a blunted inflammatory response
towards an LPS challenge as compared to saline-exposed rats (Hodyl et al., 2007).
Similarly, offspring of mouse dams that were administered LPS approximately 12 h after
fertilization had a diminished cytokine response following an LPS challenge at 40 weeks
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of age (Williams et al., 2011). Perhaps an in utero exposure of LPS, or maternally derived
inflammatory cytokines, would cause a reduction in the inflammatory response towards a
later LPS challenge in dairy calves. However, careful consideration of the timing and
dosing of the immune stimulant for such a study must be taken, as previous studies
conducted in dairy cattle have shown that experimental uterine bacterial infections and
LPS infusions can cause abortions prior to gestational term (Miller et al., 1983, Giri et al.,
1990).
4.5.3 LPS tolerance
Endotoxin tolerance is a protective mechanism that allows for innate immune
cells to experience a transient unresponsive period following exposure to low levels of
LPS (Biswas and Lopez-Collazo, 2009). Depending on the species, this refractory period
can vary in duration, from roughly a week in rats (West and Heagy, 2002), 10 days in
dairy cattle (Petzl et al., 2012), to at least two weeks in human patients suffering from
endotoxemia (Kox et al., 2011). Several studies have shown that a primary result of
endotoxin tolerance is a reduction or complete abolishment of TNF-α transcript and
protein following a second exposure to LPS (West and Heagy, 2002). Within our study,
the calves that were treated with LPS in early life were likely outside the range of a
tolerant state during the subsequent LPS challenge that was given 25 days later. The
levels of plasma TNF-α in these calves were actually higher during the later LPS
challenge compared to levels reached during the LPS treatment in early life (4 ng/ml vs. 3
ng/ml, respectively). This demonstrates that the cells primarily responsible for executing
LPS tolerance, monocytes and macrophages (Kox et al., 2011), were able to mount an
unabated inflammatory response towards the later LPS challenge.
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4.5.4 Cellular models of innate immunity
Extensive use of in vitro models to study the bovine innate immune response is
evident, with several different cell types, including mammary epithelial cells (Pareek et
al., 2005, Gilbert et al., 2013), neutrophils (Sohn et al., 2007, Revelo and Waldron,
2012), and whole blood (Ballou et al., 2015, Jahan et al., 2015) being utilized. However,
each of these models has drawbacks, including invasive collection procedures, inability
to cryopreserve for subsequent challenges, and a heterogeneous cell population.
Conversely, monocyte-derived macrophages do provide a classical innate immune cell
model that is relatively easy to collect and culture. Bovine monocyte-derived
macrophages have been shown to be responsive to challenges with Mycobacterium bovis
(Magee et al., 2012) and LPS (Taraktsoglou et al., 2011), resulting in the induction of
many immune -response genes such as IL-8, CCL5, and TLR4.
In the current study, the establishment of fibroblast and adherent mononuclear cell
cultures from each animal provided two cellular models to determine if the early life LPS
induced epigenetic modifications within innate immune response genes would be
reflected in the in vitro LPS-response. Additionally, collection of these two cell types
from each animal allowed for a comparison of the LPS response of two cellular models
from the same animal. Fibroblasts are long-lived cells that are capable of modulating the
inflammatory response as they express innate immune receptors such as TLRs and
secrete various cytokines and chemokines following pathogen recognition (Buckley et al.,
2001, Kandasamy et al., 2011, Benjamin et al., 2015a). Alternatively, circulating
monocytes are released from bone marrow, and depending on the environmental
conditions, undergo apoptosis within a few days or migrate into tissues (Parihar et al.,
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2010). Once inside the tissue, monocytes will differentiate into macrophages that aid in
the clearance of a pathogen or damaged cells (Parihar et al., 2010). These tissue-resident
macrophages can survive for days to months depending on the needs of the host. Within
this study, the main objective in collecting both adherent mononuclear cells and
fibroblasts from the saline- and LPS-treated calves was to observe if the early life LPS
exposure created a change, either permanent or temporary, in the in vitro LPS response
between the early life treatment groups. Monocytes are continually produced in the bone
marrow by myeloid progenitor cells, and a systemic cytokine response following LPS
exposure may reach these stem cells and induce permanent epigenetic DNA
modifications that could be detected in monocytes collected three weeks later. Dermal
fibroblasts however are a more stable cell type than monocytes, but may still be
susceptible to epigenetic modifications following exposure to a systemic inflammatory
response. While epigenetic modifications could be induced within fibroblast progenitor
cells, it is more likely that the fibroblast cells we collected three weeks post-challenge
were the same cells present at the time of the early life LPS treatment. This may create
more transient epigenetic modifications, such as histone modifications, that are still
capable of influencing the inflammatory response, but are potentially too short-lived to
detect the effect after several rounds of cell division while in cell culture. While
progenitor fibroblast cells could be affected, they proliferate at a slower rate, and this
effect may not be evident only three weeks post early life treatment. Surprisingly, the in
vitro response following an LPS challenge on each of these cell types revealed similar
profiles in both cytokine secretion and gene expression between the LPS- and salinetreated calves, which confirmed the lack of differences observed in vivo during the
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second LPS challenge. Interestingly, the monocyte-derived macrophages exhibited a
much more robust IL-6 response following LPS stimulation as compared to the
fibroblasts (Figure 4). Other groups have observed a similar induction of IL-6 in
macrophages following LPS stimulation (Jian et al., 1995, Taraktsoglou et al., 2011), but
there have been few studies examining differences in the IL-6 response following LPS
stimulation between bovine MDM and DF cultures. A comparison between mouse
gingival fibroblasts and macrophages revealed that the mouse alveolar macrophage cell
line produced less IL-6 following stimulation with LPS compared to the fibroblast
cultures (Jones et al., 2010). While this is inconsistent with our findings, Jones et al.
(2010) utilized a commercially available cell line from mice and challenged with a LPS
dose of 1 μg/ml for 24 h. Our MDM model is derived from primary bovine mononuclear
cells that are allowed to differentiate into macrophages in culture, and we exposed the
cells to a lower LPS dose (100 ng/ml) for 24 h. Additional challenges that compare the
LPS response of primary bovine MDM and DF may be of interest.
4.6 Conclusions
Variation in the innate immune response towards mammary infections exists in
dairy cattle, with some animals exhibiting a mild inflammatory response and others
suffering a severe inflammatory reaction that results in collateral damage or death. It has
been shown that exposure to inflammation or stress either during early life or in utero can
cause epigenetic modifications to the animal’s innate immune response. The potential for
this type of exposure to create a low responding phenotype in the offspring, one that
mounts an effective inflammatory response without inflicting damage on host’s tissue, is
exciting. However, based on the results from this study, an early life exposure to LPS
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does not cause a dairy calf to mount a milder inflammatory response to a subsequent LPS
challenge 25 days later compared to saline-treated control calves. Through the use of
mononuclear cell-derived macrophages and dermal fibroblasts, the lack of difference in
vivo between LPS-treated and saline-treated calves was confirmed in vitro.
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Table 7: Oligonucleotide primers for expression quantification with real-time PCR
(The top and bottom sequences are the forward and reverse, respectively)

Gene Name

Primer (5’ to 3’)

Reference

Toll-like receptor 4

ACTGCAGCTTCAACCGTATC
TAAAGGCTCTGCACACATCA

Interleukin - 6

TGAGGGAAATCAGGAAAATGT
CAGTGTTTGTGGCTGGAGTG
GCTGGCTGTTGCTCTCTTG
AGGTGTGGAATGTGTTTTTATG
CTCCAGCACCAAAATGAC
TCCTCTTCCCTCTCTTCC
GCTCGTGTCCTCTCATCACA
ACCTTTGTGCTGGTGAATCC

IbeaghaAwemu et al.
(2008)
Pareek et al.
(2005)
Pareek et al.
(2005)
Sohn et al.
(2007)
Mills et al.
(2009)

CTCTCACAGGAAATGAACCGAG
GCTGCAGGGTGGGCGTATCACC
GCAAATGCTTCTAGGCGGACT
CAATCTCATCTCGTTTTCTGCG

Bougarn et al.
(2011)
Pareek et al.
(2005)

Interleukin - 8
Cluster of differentiation 14
Interleukin – 1 beta receptor
Interleukin – 1 beta
Β-actin
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Figure 4.1: Timeline of the Study
The effects of an early life LPS exposure on response to a subsequent LPS challenge
were determined in ten neonatal Holstein calves. Trial days are shown in the gray bar,
with the calf arrival date on day 0 and completion of the trial on day 30, at which point
calves were sold. The average age of the calves and key events within the trial are
denoted below and above the gray bar, respectively. Early life treatment at day 4
consisted of either an LPS or saline intravenous injection (n=5/treatment). Skin biopsies
and blood samples were collected from each calf to isolate dermal fibroblasts (DF) and
adherent mononuclear cell-derived macrophages (MDM), respectively. An LPS
challenge was completed on all calves at day 29 of the trial to determine the effect of the
early life treatment on response to the subsequent LPS challenge.
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Figure 4.2: Plasma cytokine responses and rectal temperatures following the early
life treatment
Calves were split into two groups, one of which received LPS and the other received
saline at 7 days of age. Blood samples were collected from each calf at hours 0, 2, and 6
following administration of the early life treatment. Plasma levels of IL-6 (A) and TNF- α
(B) were determined after the early life treatment, and rectal temperatures were taken on
animals from both groups (C). ELL= early life LPS and ELS= early life saline. Values
are mean ± SEM.

159

A

B

20

10

ELL

15
10
5

NS

ELS

8

TNF-α (ng/ml)

IL-6 (ng/ml)

ELL

NS

ELS

6
4
2
0

0
0

1

2

3

4

5

6

0

7

1

2

3

4

5

6

7

Hours Post LPS

Hours Post LPS

C
Rectal Temps. (° C)

42

ELL

NS

ELS

40
38
36
34
0

1

2

3

4

5

6

7

Hours Post LPS

Figure 4.3: Plasma cytokine response and rectal temperature profiles following an
LPS challenge
Holstein bull calves were divided into two groups (n=5/group) based on an early life
treatment consisting of either LPS (ELL) or saline (ELS) that was given at 7 days of age.
A subsequent LPS challenge was completed on all calves at 32 days of age to determine
if the early life treatment had an effect on the systemic response to the later LPS. Plasma
concentrations of IL-6 (A) and TNF- α (B) were measured in the calves from the ELL
and ELS groups following the LPS challenge. Rectal temperatures (C) of calves
following the LPS intravenous infusion at 32 days of age were not different between the
treatment groups. Values are mean ± SEM.
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Figure 4.4: Effect of early life LPS on cellular response to LPS in vitro.
Dermal fibroblasts (DF) and adherent mononuclear cell-derived macrophages (MDM)
were isolated from each calf (n=10) to determine if an in vivo LPS exposure during early
life would influence the response of these cell types to an in vitro LPS challenge. A 24 h
LPS challenge was completed on each cell type, however DF were treated with 500
ng/ml of LPS and MDM were treated with 100 ng/ml of LPS. The amount of secreted IL6 from DF (A) and MDM (B), IL-8 from DF (C) and MDM (D) following LPS exposure
was determined via an ELISA. Panel (E) and (F) represent the levels of IL-1β and TNF-α
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secreted by MDM post-LPS (concentrations of IL-1β and TNF-α were undetectable in
LPS-treated fibroblast cultures). ELL= early life LPS, ELS= early life saline. There were
no significant differences between treatment groups. Values are mean ± SEM
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Figure 4.5: Expression levels of LPS recognition and response genes.
Dermal fibroblasts (DF) from each calf were revived and challenged with 500 ng/ml of
LPS for 24 h and total RNA was collected at hours 0 and 24. A similar challenge was
completed on adherent mononuclear cell-derived macrophages (MDM) isolated from
each calf; however, an LPS dose of 100 ng/ml was used. Gene expression levels of
TLR4, IL-6, and IL-8 post-LPS were investigated on both DF and MDM cultures using
qRT-PCR. Expression levels from DF cultures are presented in panels (A) TLR4, (B) IL6, and (C) IL-8, while expression levels of MDM cultures are in panels (D) TLR4, (E)
IL-6, and (F) IL-8. Panels (G), (H), and (I) represent the expression levels of CD14, IL1β receptor, and IL-1β from MDM, respectively. Expression values for these three genes
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were not determined in DF cultures. ELL= early life LPS, ELS= early life saline. There
were no significant differences between treatment groups. Values are mean ± SEM.
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CHAPTER 5: GENERAL CONCLUSIONS
Both dairy producers and researchers have struggled with the challenge of
effectively controlling bovine mastitis. Although obstacles still remain in the control of
contagious pathogens, there has been a significant reduction in cow-to-cow transmission
since the implementation of mastitis control plans in the 1960’s, specifically the “FivePoint Plan” developed by the National Institute for Research into Dairying (Bramley and
Dodd, 1984, Hillerton et al., 1995). Beginning in the 1970’s environmental pathogens
started gaining attention and have risen to become the most important mastitis-causing
pathogens in the modern dairy industry (Oliveira et al., 2013, Ruegg, 2017). Although
limited in their duration, coliform bacteria, such as E. coli, almost always cause clinical
mastitis that is extremely costly to the dairy industry, mainly due to drastic losses in milk
production and lowered milk quality. Estimates on the cost of clinical mastitis have
ranged from $179 to $444 per episode, depending on age, stage of lactation, cow
productivity and parity (Bar et al., 2008, Cha et al., 2011, Rollin et al., 2015, Liang et al.,
2017).
There is also substantial between-animal variation in the severity of clinical
mastitis that appears to be due to innate differences in host response factors. The
contribution of genetic differences to between-cow variation in susceptibility to mastitis
has been estimated to be quite low, however the accuracy and magnitude of response to
infection that results in differential severity can be addressed through the inclusion of
new, more reliable variables in prediction equations. Currently, genetic factors that affect
mastitis susceptibility have mainly been linked to infrequent measures of milk somatic
cell score which has some inherent flaws. First, somatic cell count is typically taken only
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on prescribed monthly basis, without regard to udder health, and will likely miss many
transient infections that are characteristic of environmental pathogens or have little value
in relation to the dynamic nature of SCC response to infection. Second, a snapshot of
somatic cell count shows a very limited picture of the cow’s current health status and it
may be more valuable to know the duration of elevated somatic cell count and the
efficiency of response to recovery. Furthermore, the accurate phenotype has been the
subject of considerable debate, whereby some believe that a higher neutrophil response is
favorable to infection outcome and others are of the belief that a subdued, but effective
response is more desirable to limit tissue damage. In support of the latter supposition,
animals ranked as high responders based on fibroblast phenotype that were
experimentally infected with E. coli had more tissue damage, elevated somatic cell count,
and slower return to pre-infection milk production without any benefit in their ability to
clear bacteria (Kandasamy et al., 2011).
Although not insubstantial, genetic heritability of mastitis is considered to be
quite low, indicating that non-genetic factors may have an equal or greater contribution to
mastitis susceptibility. Epigenetic modifications are known to contribute to interindividual differences in disease susceptibility and severity, including in asthma (Runyon
et al., 2012) and Salmonella enteritidis infection in chickens (Gou et al., 2012), among
many others. In addition, infection status, such as intra-mammary infection with E. coli
(Chang et al., 2015a) and bovine tuberculosis (Doherty et al., 2016), has been shown to
induce epigenetic changes following infection. However, a large gap in knowledge exists
in the role of epigenetics in regulating between-animal differences in mastitis severity.
Therefore, there is considerable room to improve on producer selection of replacement
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calves if epigenetic determinants of mastitis susceptibility are discovered. Selection
strategies could be improved using technologies similar to SNP-chips that are currently
advancing genetic selection, such that methylation chips in known susceptibility regions
could be used to select animals based on epigenetic markers. One concern may be that
milk production would suffer as a result of selecting calves with lower risk of mastitis,
since increased milk production has been associated with increased risk of mastitis (Rupp
and Boichard, 2003). However, knowing the exact genetic and epigenetic factors that
account for both reduced severity of mastitis and increased milk production would allow
producers to choose animals based on both superior milk production and disease
resistance. Furthermore, since epigenetic modifications are closely linked to alterations in
environment, it may be possible to treat a calf with a genetic predisposition for high milk
production to be more resistant to severe infection.
With these goals in mind, I sought to identify the molecular mechanisms that
regulate response to LPS, given that LPS likely reflects the predominant response to E.
coli. The role of DNA methylation in within-animal variation in response to LPS was
first determined with the intent of gaining insight into how between-animal variation in
response to E. coli is regulated. Dermal fibroblasts isolated from the same animals at 5and 16-months of age, which exhibit a significant age-related up-regulation of IL-8 and
IL-6 response to LPS, were assessed for differences in DNA methylation in unstimulated
cultures. Methylation analysis revealed numerous genes that are subject to differential
methylation as a result of an increase in fibroblast age and showed that DNA tends to
become less methylated with age, a result that correlates with previous studies (Gowers et
al., 2011, Marttila et al., 2015). Although we failed to identify any canonical LPS167

response genes that were differentially methylated between the two sets of cultures,
numerous innate response genes were hyper-methylated in young cultures, in line with
their lower response to LPS. Furthermore, many of the genes hyper-methylated in young
cultures have been shown to be regulated by NF-κB and represent potential biomarkers if
their relevance can be confirmed with in vivo response to E. coli.
Next, with a panel differentially methylated genes established, we wanted to
clarify the role of TLR4 expression and signaling as a potential contributor to mastitis
severity. As such, fibroblasts were isolated from a cohort of sixty adult, lactating animals
and differences in baseline TLR4 expression and LPS-induced IL-8 and IL-6 protein
production were measured. Animals were subsequently ranked from low to high based on
the three variables, and phenotypes of high and low responders were confirmed. The
impact of TLR4 expression and signaling on severity of mastitis was then determined by
challenging six high- and six low-responders with an intra-mammary E. coli infection.
Interestingly, high responders had an earlier elevation in somatic cell count and fever
response that corresponded with their ability to clear bacteria more efficiently from the
infected gland. However, significant between-animal variation in response was still
evident, and mammary gland recovery, as measured by tissue damage and milk
production, was highly variable and similar between high and low responders. These
results suggest that while rapid-responding animals are able to clear bacteria more
effectively, down-regulation of response and tissue recovery does not differ between high
and low responders, and likely requires the identification of additional parameters within
the resolution phase of infection. Furthermore, results from Chapter 3 contradict earlier
research within the lab that first assessed whether fibroblast responsiveness, based on
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LPS-induced IL-8 production, could predict mastitis severity. In this study, animals
whose fibroblasts produce more IL-8 in response to LPS exhibit increased tissue damage
and lower milk production, but lack any difference in their ability to clear bacteria in
comparison to animals with lower responding fibroblasts (Kandasamy et al., 2011).
In light of this discrepancy, I re-analyzed the animals described in chapter 3, in
addition to a second set of 12 animals that were infected with E. coli in an identical pilot
study. Using milk production recovery at 14-days post-infection as a marker for mastitis
severity, the five animals with the most severe mastitis and the five animals with the most
mild mastitis were identified and compared. As shown in figure 5.1, there is a significant
variation between-animals in their ability to return to pre-infection milk production that is
concomitant with large differences in the duration of their neutrophil response. Although
neutrophil influx is identical between the two groups of animals until 48-hrs. postinfection, severe animals maintain an elevated response. Milk IL-8 is similarly sustained
in severe animals and consequently, severe animals have dramatically higher amounts of
mammary gland tissue damage, as measured by milk BSA (figure 5.2).
Interestingly, while it was anticipated that high and low responders would not
exhibit differences in their ability to clear bacteria, animals ranked as severe responders
have a much higher bacterial burden (figure 5.3). This led to the question of whether
initial leukocyte levels differed between animals with varying abilities to recover from
infection. A Pearson correlation analysis comparing the ratio of baseline somatic cell
count to bacterial dose and milk production at 10 days post-infection in 32 animals
infected with E. coli (24 from the previous analysis and 8 from the original 2011 study)
showed no correlation of initial leukocyte levels and mastitis severity (figure 5.4). At 14
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days post-infection, there is a small, but statistically significant correlation between initial
SCC to bacteria ratio (24 animals only, figure 5.4) and mastitis severity, however the
biological relevance of this association should be confirmed in a much larger cohort of
animals. Perhaps just as important is the effectiveness of leukocyte response, which may
be lessened in animals with severe mastitis, as has been shown with patients that become
septic in response to Gram-negative infection (Rinchai et al., 2012). Future studies should
assess other cell types, perhaps in conjunction with fibroblasts, to gain a more accurate
picture of mammary gland response.
Finally, to determine whether early life endotoxin would result in a more
subdued response to a subsequent LPS treatment as was hypothesized, neonatal bull
calves were treated intravenously with either LPS or saline at one-week of age. Following
early life treatment, cellular changes were measured in two different cell types, primary
dermal fibroblasts and monocyte-derived-macrophages. Unfortunately, no differences in
LPS response were measured in fibroblast cultures and surprisingly, we also failed to
detect any changes in MDM response, although literature suggests that they are amenable
to epigenetic modulation following exposure to endotoxin. The second intravenous LPS
challenge also confirmed the lack of difference in cellular response in that calves treated
with early life LPS responded similarly to saline treated calves.
Although much more work is still required, our results lend significant insight
into the epigenetic regulation of the bovine innate immune response to LPS and how
differences in TLR4 expression and signaling contributes to mastitis severity.
Furthermore, this is the first study to determine the effects of neonatal LPS exposure on
calf innate immunity. While considerable research has focused on the bovine innate
170

immune response to mastitis-causing pathogens, it has been mostly limited to the ideal
cellular and cytokine response to pathogens. Conversely, there is significantly less known
about how the mammary gland recovers from the assault of both bacteria and leukocytes,
and as our results have shown, this may prove to be the missing link into our
understanding of severe mastitis susceptibility. In addition, as has already been
established in rodent models, it will be necessary to define the crucial developmental time
frame when epigenetic modifications exhibit the most plasticity to environmental stimuli
before early-life interventions can be used to modulate immunity. To conclude, the
current work is one of the first to integrate the collective impact of DNA methylation,
differential regulation of TLR4 signaling and neonatal environmental exposures on dairy
cow response to E. coli mastitis. Our results show that there is still significant room to
improve on reducing severe mastitis susceptibility based on the collaborative effect of
both environment and epigenetics on genetic predisposition.
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Figure 5.1: Infected quarter milk yield and somatic cell count in animals with severe
and mild mastitis. Milk production was measured in the infected quarter of 24 animals
experimentally treated with 200 cfu of E. coli in two separate challenges. Animals with
the highest (Mild, n=5) and lowest (Severe, n=5) recovery at 14-days post infection (milk
yield day 14 – milk yield day 0) are summarized in panel A and mean milk weight is
presented in lbs. ± SEM. Somatic cell count (SCC/ml) was also measured in the infected
quarters of severe and mild animals and is presented as SCC/ml (x 106) ± SEM in panel
B. P-values presented in each panel were measured using a 2-way repeated measures
ANOVA with Bonferroni’s multiple comparison testing to determine Phenotype X Time
significance where *=P<0.05 at each time
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Figure 5.2: Infected quarter IL-8 and bovine serum albumin in animals with severe
and mild mastitis. Milk IL-8 and BSA were measured in the E. coli infected quarter of
10 animals with phenotypic differences in mastitis severity (Mild, n=5) (Severe, n=5).
Interleukin-8 concentrations are summarized in panel A and presented as ng/mL ± SEM.
Bovine serum albumin concentrations are summarized in panel B and presented as
Ug/mL ± SEM. P-values presented in each panel were determined using a 2-way repeated
measures ANOVA with Bonferroni’s multiple comparison testing to determine
Phenotype X Time significance where *=P<0.05 at each time point.
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Figure 5.3: Infected quarter bacterial recovery in animals with severe and mild
mastitis. Recovery of bacteria was measured in the E. coli infected quarter of 10 animals
with phenotypic differences in mastitis severity (Mild, n=5) (Severe, n=5) and is
presented as log-transformed CFU/mL ± SEM. P-values presented above were
determined using a 2-way repeated measures ANOVA with Bonferroni’s multiple
comparison testing to determine Phenotype X Time significance where *=P<0.05 at each
time point.
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Figure 5.4: Correlation of baseline SCC to bacteria ratio and milk yield recovery at
day 10 and day 14. The ratio of baseline (0 h) somatic cell count (SCC/ml) and initial
inoculum (200 cfu E. coli) was calculated and compared to milk yield recovery (lbs) at
day 10 (panel A, n=32) and day 14 (panel B, n=24). A Pearson correlation analysis was
then conducted to determine whether baseline ratio of SCC to bacteria was associated
with a difference in ability to recover to pre-infection milk production. Correlation as
measured by R-squared values and significance are displayed in their corresponding
panels.
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